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The main objective of this thesis is to develop an ideal bone graft material which 
possess osteoconductive, osteogenic and osteoinductive properties without using 
expensive growth factors. Poly(L-lactic acid) (PLLA), type I collagen (Col) and 
hydroxyapatite (HA) ± biocompatible and biodegradable materials ± were employed. 
These materials were fabricated into nanocomposites consisted of PLLA/Col 
nanofibers and nano-HA crystals to mimic native bone extracellular matrix (ECM). 
We hypothesized that the biomimetic scaffolds with nanotopography and a 
sustainable local supply of calcium/phosphate (Ca/P) ions would effectively induce 
osteogenic differentiation of stem cells without the need for osteogenic solutes. The 
scaffolds were enriched with mesenchymal stem cells (MSCs) to provide the 
osteogenic property. Our in vitro and in vivo studies showed that PLLA/Col/HA 
nanocomposite enriched with MSCs was an ideal scaffold for bone regeneration 
which had osteoconductive, osteoinductive and osteogenic properties. Three-
dimensional (3D) nanofibrous scaffolds with macroporous structure were then 






An ideal bone graft should possess the three properties namely osteoconduction, 
osteogenesis and osteoinduction. Our goal is to develop the ideal bone graft which can 
possess all of these properties. The structure of natural bone contains collagen fibrils 
of less than 500nm in diameter with interconnected pores. Among existing 
biomaterials, nanofibrous scaffolds produced by electrospinning technique can create 
cellular environments mimicking the nanoscale structure and complexity of the native 
ECM. We hypothesized that electrospun biodegradable nanofibers mimicking native 
bone ECM can enhance the osteogenic differentiation of mesenchymal stem cells and 
promote bone formation. 
By culturing human MSCs on PLLA electrospun nanofibrous scaffolds in osteogenic 
(Ost) medium, we showed that the nanofibrous scaffolds had the osteoconductive 
properties. The differentiated human MSCs grew continuously on the scaffolds during 
28 days of culture. This study also demonstrated that serial passage (passage 2 to 
passage 8) of human MSCs caused adverse changes in human MSCs characteristics 
which were indicated by the decline in both proliferation and osteogenic 
differentiation abilities. However, interestingly, the PLLA nanofibrous scaffolds 
showed a significant support in recovering the osteogenic abilities of human MSCs 
which had been severely affected by prolonged culture. 
To create a scaffold with osteoinductive property, we first blended dexamethasone 
(Dex) into PLLA nanofibrous scaffolds by electrospinning with the concentration of 
0.333 wt%. The Dex-loaded PLLA nanofibers increased the tensile strength in 
comparison with pure PLLA nanofibers. A sustained release profile for over 2 months 
with the initial burst release after 12 hr of 17% was shown. Importantly, the amounts 
of Dex released from the PLLA nanofibers every three days were close to the ones 
 xi 
 
used for the standard Ost medium. The sustained osteoinductive environment created 
by released Dex strongly differentiated human MSCs cultured in the Ost-Dex medium. 
Alkaline phosphatase (ALP) activity, bone sialoprotein (BSP) expression and calcium 
deposition were significantly higher than those of the cells cultured on the PLLA 
scaffolds without Dex. As such, the PLLA nanofibers loaded with 0.333 wt% Dex 
was shown as an effective osteoinductive scaffold. In addition, these scaffolds were 
osteoconductive as indicated by the continuous cell growth during 28 days of culture. 
Recently, modulating stem cell behaviourVXVLQJVXEVWUDWHV¶SK\VLFDOSURSHUWLHVKDYH
become a preferable approach than those using chemical treatments (such as Dex, 
bone morphogenetic proteins, fibroblast growth factors and transforming growth 
factor-beta 1, etc.) since the osteogenic solutes are normally unstable, expensive and 
difficult to control the differentiation without side effects. Bone ECM is a 
nanocomposite with an intricate hierarchical structure, assembled through the orderly 
deposition of nano-HA within a type I Col fibril matrix. Therefore, biomimetic 
nanocomposites consisted of nanofibrous topography and nano-HA were designed to 
mimic the native bone matrix for bone tissue engineering. We hypothesized that the 
biomimetic scaffolds with a sustainable local supply of Ca/P ions would effectively 
induce osteogenic differentiation of stem cells without the need for osteogenic solutes. 
Human MSCs grown on these nanocomposites were stimulated to rapidly produce 
bone minerals in situ, even in the absence of osteogenic supplements in the cell 
culture medium. Nanocomposites comprising PLLA/Col nanofibers and nano-HA 
were found to be especially efficient at inducing mineralization. When 
subcutaneously implanted into nude mice, this biomimetic nanocomposite was able to 
form a new bone matrix within only two weeks. Furthermore, when the 
nanocomposite was enriched with human MSCs before implantation, development of 
the bone matrix was accelerated to within one week. To the best of our knowledge, 
 xii 
 
this study provides the first clear in vitro and in vivo demonstration of osteoinduction 
controlled by the material characteristics of a biomimetic nanocomposite. Our 
approach could potentially facilitate the translation of de novo bone-formation 
technologies to the clinic. 
As such, the PLLA/Col/HA nanocomposite enriched with MSCs is an ideal scaffold 
for bone regeneration which had osteoconductive, osteoinductive and osteogenic 
properties. However, the scaffolds studied above were two-dimensional (2D) 
nanofibrous meshes. In the body, almost all tissue cells reside in a 3D environment 
where cell-cell interactions as well as the presentation of chemical, physical, 
mechanical and electrical stimuli cues in the surrounding fluid and ECM provide the 
guidance for cellular responses. Thus, developing 3D scaffolds plays a key role in 
studying and regulating cellular characteristics. We aimed to demonstrate the novelty 
of 3D nanofibrous scaffolds and compare their efficiency with 2D nanofibrous 
scaffolds. The 2D PLLA/Col nanofibrous scaffolds were 2D meshes fabricated by the 
conventional electrospinning technique, whereas the 3D PLLA/Col nanofibrous 
scaffolds fabricated by a modified electrospinning technique using a dynamic liquid 
support system. The morphology, proliferation and differentiation abilities of human 
MSCs in Ost medium on both scaffolds were investigated. Compared to the 2D 
scaffolds, the 3D ones significantly increased the expression of osteoblastic genes as 
well as the formation of bone minerals. In addition, scanning electron microscopic 
(SEM) and micro-computed tomographic (PCT) images on days 14 and 28 showed 
the dense deposition of bone minerals aligned along the nanofibers. Further studies 
should be done with 3D PLLA/Col/HA nanocomposite to demonstrate the novelty of 
this scaffold in animal studies. 
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Chapter 1  
 Introduction 
1.1 Background 
Bone is a highly specialized connective tissue, which serves structural and metabolic 
functions in the body. It is composed of several cell types and an organic matrix 
which is strengthened by bone minerals (primarily calcium and phosphate (Ca/P) in 
the form of hydroxyapatite (HA)) and arranged in a hierarchical assembly [1]. The 
organic matrix, called osteoid, makes up approximately 30% of bone by weight, 
whereas this proportion of bone minerals is approximately 60% [2,3]. The majority of 
the organic matrix is type I collagen (Col, approximately 95%), the remaining 
components of about 5% consist of proteoglycans and non-collagenous proteins [1].  
Bone is usually able to repair itself without the need for intervention. Bone repair 
process closely resembles the pathway of normal embryonic development of the 
skeleton. Most fractures heal by indirect fracture healing through the combination of 
intramembranous and endochondral ossification [4-6]. However, in non-union 
fractures, large bone defects, and revision arthroplasty, this spontaneous regeneration 
can be problematic. In most of these cases, bone fails to regenerate itself and bone 
grafts are required to support the healing [7]. The market of bone grafts and bone graft 
substitutes was valued at $1.9 billion in 2010, and is forecast to reach $3.3 billion in 
2017, with a Compound Annual Growth Rate (CAGR) of 8.3% [8]. Due to an aging 
population, and increases in the incidences of degenerative intervertebral disc 
diseases, the number of revision orthopaedic surgeries, spinal fusions in private 
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healthcare, and the number of seniors seeking an active lifestyle, the market of bone 
grafts and bone graft substitutes is projected to record steady growth [9]. 
An ideal bone graft should possess three properties namely osteoconduction, 
osteogenesis and osteoinduction. Osteoconduction is the ability of biocompatible 
scaffolds to promote the attachment, survival, proliferation and migration of cellular 
elements involved in bone formation. Osteogenic graft materials contain osteogenic 
stem cells or progenitors to create new bone through the differentiation process. 
Lastly, osteoinductive bone grafts contain soluble or matrix-bound signals, principally 
bone morphogenetic proteins (BMPs), to initiate stem cells or progenitors towards 
osteoblastic cell type [10,11]. 
To date, the gold standard for bone graft materials is autologous bone graft. It 
possesses all those three properties to induce bone growth and regeneration. 
Additionally, it offers excellent success rate, low risk of transmitting disease, and 
histocompatibility. However, autografts have limitations, including limited 
availability, donor-site morbidity, increased operative time, wound complications and 
chronic pain. These disadvantages can be overcome by the use of allografts [12-17]. 
Allografts can either be collected from cadavers or living donors, thus they have 
inherent risks of host-versus-graft immune response and disease transmission. Tissue 
processing and sterilization have been employed to minimize immune response and 
disease transmission by removing living cells. Nevertheless, these processes make 
allografts lack the osteogenic property. They are primary osteoconductive and retain 
variable degrees of osteoinduction [12-18]. Allogenic bone is available in many forms 
including demineralized bone matrix (DBM), morselized and cancellous chips, 
corticocancellous and cortical grafts, and osteochondral and whole-bone segments 
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[19].  Allografts can be used alone or in combination with other materials to produce 
allograft-based bone graft substitutes such as Grafton®, Opteform®, Optecure®, 
DBX®, Allomatrix®, InterGro®, ProgenixTM and Allomatrix® RCS [19]. In spite of the 
efforts to eliminate disease transmission, allografts and allograft-based bone graft 
substitutes retain the risk of transmission of viral infections [especially human 
immunodeficiency virus (HIV) and hepatitis B and C], malignancy or toxins [12-
15,17-18,20-21]. 
Instead of depending on natural bone, other bone graft substitutes have been 
developed based on rhBMPs, calcium sulphate, calcium phosphate and polymers 
[15,19]. BMPs are powerful osteoinductive molecules. Commercialized products of 
rhBMP-based bone graft substitutes include Infuse® (rhBMP-2 protein on an 
absorbable Col sponge) and OP-1® (rhBMP-7 with Type I bone Col) [19]. However, 
they are more expensive than many other bone graft substitutes and subject to a 
limited shelf life. Additionally, undesired ectopic bone formation can be induced in 
surrounding tissues such as adjacent muscles, nerves, and blood vessels if the carrier 
is placed incorrectly. There is also an issue related to safety of the supraphysiological 
concentrations of rhBMPs to achieve the desired osteoinduction [12,13,15,18,20,21].  
Calcium sulphate-based (such as BonePlast®, Calceon® 6, Osteoset® and Pro-dense® 
injectable regenerative graft) [19], Ca/P-based (such as ProOsteon® 500R, OpteMx®, 
MasterGraft® Granules, Conduit® TCP Granules, Integra MozaikTM, Vitoss®, 
ChronOS®, Norian® SRS® and CopiOs®) [19] and polymer-based (such as Healos®, 
CortossTM, Immix, OPLA, Osteoplug and Osteomesh) [15] bone graft substitutes at 
most possess only osteoconductivity. Among them, the calcium phosphate graft 
materials are commonly used because of their similarity in chemical composition to 
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the mineral phase of native bone.  Some of the synthetic bone grafts are mixed with 
bone marrow aspirate ± such as OpteMx®, Vitoss®, CopiOs® and Healos® - to create 
the graft materials with the osteogenic property [15,19].  
It is still challenging to create novel synthetic bone grafts which can possess all of the 
osteoconductive, osteogenic and osteoinductive properties like autograft, the gold 
standard, without the use of the osteogenic growth factors (e.g., BMPs, fibroblast 
growth factors (FGFs)), because these factors are very expensive and have the risk of 
side-effects. 
1.2 Motivation 
To create osteogenic bone graft materials, scaffolds should be enriched with stem 
cells. Stem cells DUHJHQHULFDOO\GHILQHGDV µLPPDWXUH´RUXQGLIIHUHQWLDWHGFHOOV WKDW
are capable of self-renewal or proliferation as well as differentiation into specific cell 
lineages under appropriate conditions [22]. Although mature cells isolated from the 
body can be potentially used for re-implantation into the same donor to eliminate the 
immune response, they are not the best cell sources for tissue repair. The mature cells 
are generally differentiated cells, thus they have low proliferative ability. It is, 
therefore, difficult to generate a sufficient number of cells for tissue regeneration. 
Additionally, there are issues raised on accessibility of tissue sites where the mature 
cells can be harvested [23-30]. Among several types of stem cells, mesenchymal stem 
cells (MSCs) have been shown to be an interesting source, because they can be 
isolated, expanded ex vivo, and used in an autologous fashion which can avoid the 
problem of finding a compatible donor [31]. 
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Previous studies have demonstrated the influence of topographical cues on controlling 
stem cell fate and guiding stem cell differentiation [32-34]. The topographical cues 
include surface geometry (smooth/flat, groove/ridge, pit/pore, and disordered/ordered 
structure), size (from macro-, micro- to nanoscale), and dimensionality (two-
dimension (2D) vs. three-dimension (3D)). They not only can modulate the cell 
differentiation in the presence of soluble differentiation agents [35-37], but also can 
induce the differentiation in the absence of those factors [38-40]. Compared to MSCs 
on smooth scaffolds (tissue-culture polystyrene (TCPS) plates, smooth surfaces, and 
3D smooth scaffolds), the cells on unsmooth scaffolds such as micro-patterned 
poly(N-isopropylacrylamide) (pNIPAM) films (channels with 10Pm groove width, 
2Pm ridge width and 20Pm depth) [35], 3D texture polydimethylsiloxane (PDMS) 
scaffolds with 10Pm diameter/height posts [41], and poly(H-caprolactone) (PCL) 
nanofibers [42] showed greater osteogenic differentiation ability through higher 
specific ALP activity, osteopontin (OPN) and osteocalcin (OCN) expressions, and 
calcium phosphate mineralization. In the absence of soluble osteogenic inducers, 
MSCs on nanopillar surfaces (approximately 20nm in diameter) had up-regulated 
osteogenic specific matrix components compared to micropillar surfaces [43]. In 
another study, after 3 weeks of culture in the osteogenic (Ost) medium, embryonic 
stem cells (ESCs) in 3D porous poly(lactic-co-glycolic acid) (PLGA) had 
significantly higher expressions of ALP and OCN than those on TCPS plates coated 
with gelatin (2D control) [37]. These findings suggested that the development of 
unsmooth scaffolds (especially aligned patterns) with nanoscale and 3D structure 
might bring novel impacts on directing stem cell fate.  
As mentioned above, bone extracellular matrix (ECM) is formed by Col nanofibrils 
deposited with nano-HA mineral crystals. However, none of the availably synthetic 
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bone grafts mimics this nanostructure of native bone so far. These commercialized 
bone graft substitutes are all in macro- or micro-structures. Thus, developing 
biomimetic materials is necessary in order to create ideal bone graft substitutes. It has 
been hypothesized that, the body can recognize the biomimetic nanofibrous scaffolds 
DV ³VHOI´ DQG WKHUHIRUH DOO RI WKH LQWHUFHOOXODU DQG LQWUDFHOOXODU UHVSRQVHV FDQ EH
mimicked which help to stimulate the healing and the regeneration of tissues and 
organs [44-46]. In addition, due to their large surface-area-to-volume ratio, nanofibers 
provide more binding sites to cell membrane receptors, promote the adsorption of 
serum proteins and change the profile of adsorbed proteins [47,48]. The adsorption of 
serum fibronectin and vitronectin, which are known to mediate cell-matrix 
interactions, are improved significantly with nanofibrous structures [49]. As such, 
changes in the amount or type of adsorbed serum proteins may provide cells with a 
better niche to enhance cellular functions. Also, the conformation of cellular proteins 
on the nanofibers may expose additional cryptic binding sites and be more favorable 
for cell-matrix interactions [47,50]. 
Electrospinning [51,52], self-assembly [53,54] and phase separation [55,56] are the 
most common techniques to fabricate polymeric nanofibers for biomedical 
applications. Among them, electrospinning is the most popular technique because it 
can produce long and continuous nanofibers with uniform diameters, is flexible in 
material selection and is able to create various architectures and form bulk structure 
[51,52]. In this project, we utilized the conventional electrospinning technique to 
fabricate polymeric nanofibrous meshes that were loaded with an osteoinductive drug 
± dexamethasone (Dex), or further mineralized with nano-HA. In addition, a modified 
electrospinning technique using a dynamic liquid support system was employed to 
create 3D nanofibrous scaffolds. 
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1.3 Hypothesis and objectives 
1.3.1 Hypothesis 
Electrospun biodegradable nanofibers mimicking native bone ECM can enhance 
the osteogenic differentiation of MSCs and promote bone formation. 
a) Electrospinning technique can be employed to fabricate nanofibrous 
architectures in bone graft substitutes to resemble the natural ECM structure. 
b) Nanotopographical cue of biomimetic nanofibers can increase the osteogenic 
differentiation of MSCs. 
c) Biodegradable synthetic polymer and a dominant protein in native bone ECM 
± Type I Col ± can be blended to provide the synthetic bone grafts with 
appropriate mechanical strength and biomolecular cell recognition signals for 
cell-matrix interactions. 
d) An osteoinductive drug ± Dex ± can be loaded into nanofibrous scaffolds by 
electrospinning, and the sustained release of this drug can induce the 
osteogenic differentiation of MSCs. 
e) Incorporation of Type I Col into nanofibrous scaffolds can improve nano-HA 
mineralization on the nanofibers. 
f) Synergistic effects of nanotopography and Ca/P in nano-HA can create an 
osteoinductive nanocomposite without the use of soluble osteogenic factors. 
g) Biomimetic nanocomposite can effectively induce ectopic bone formation in 
nude mice. 
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h) 3D nanofibrous scaffolds can enhance the osteogenic differentiation of MSCs 
and support the cells to create a bone ECM-like structure. 
1.3.2 Objectives 
a) To determine the osteoconductivity and the importance of nanofibers to the 
osteogenic differentiation of MSCs. 
b) To produce an osteoconductive and osteoinductive bone graft material by 
incorporation of Dex ± an osteoinductive drug ± into polymeric nanofibers 
during electrospinning process. 
c) To create a novel osteoinductive bone graft substitute without the use of 
soluble osteogenic factors by mineralization of polymeric nanofibers with 
nano-HA. 
d) To demonstrate the biomimetic nanocomposite (polymeric nanofibers and 
nano-HA) enriched with MSCs as a novel bone graft substitute which 
possesses all of the three ideal properties (osteoconduction, osteogenesis and 
osteoinduction) by subcutaneous implantation into nude mice. 
e) To determine the importance of 3D structure to the osteogenic differentiation 
of MSCs. 
1.4 Research strategy and rationale 
1.4.1 Research strategy 
Our main research strategy in this project is illustrated in Figure 1.1. Biodegradable 
nanofibers of blended PLLA and type I Col were fabricated by electrospinning. The 
nanofibrous scaffold was then mineralized with nano-HA using an alternate Ca/P 
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solution dipping method. The produced biomimetic nanocomposite was enriched with 
MSCs by incubation with the cells for 30 min. The scaffold/cell construct was used to 
subcutaneously implant into nude mice to access its osteoconductive, osteogenic and 
osteoinductive properties. 
 
Figure 1.1 The schematic illustration of research strategy 
1.4.2 Research rationales 
The rationales of using the nanocomposite PLLA/Col/HA+MSC as a bone graft 
substitute in this project are as follows: 
a) PLLA and Type I Col are biocompatible and biodegradable polymers which 
can provide the graft with appropriate mechanical strength and biomolecular 
cell recognition signals, respectively. 
b) The mineralization with nano-HA can be achieved at room temperature by the 
alternate Ca/P solution dipping method. This process is similar to the 
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mineralization that normally occurs during native bone formation, thus the 
powdered mineral layer is more easily resorbed in vivo than sintered calcium 
phosphate ceramics used widely in commercialized bone graft substitutes. 
c) The nanofibers mineralized with nano-HA mimic the nanostructure of native 
bone ECM, and the presence of HA resembles the mineral phase of the ECM. 
d) The nanotopographical cue with biomimetic property and large surface-area-
to-volume ratio can promote the osteogenic differentiation of MSCs.  
e) MSCs can be easily isolated, expanded ex vivo, and used in an autologous 
fashion in clinical settings. 
1.5 Work scope 
In this thesis, a detailed literature review is presented in Chapter 2 that includes 
knowledge related to native bone (bone structure, bone cells, bone formation and bone 
repair), bone grafts and available bone graft substitutes, stem cell response to 
biomaterial topography, the importance of nanofibers in tissue engineering and 
especially bone tissue engineering. The project scopes from Chapter 3 to Chapter 6 
are summarized in Table 1.1. Conclusions for this thesis and recommendations for 
future work are described in Chapter 7. 
Table 1.1 Overview of project scope 
Hypothesis Objective Descriptions Thesis 
Nanotopographical 





MSCs, and recover 
To determine the 
osteoconductivity and 
the importance of 
nanofibers to the 
osteogenic 
differentiation of MSCs. 
1) PLLA nanofibers 
were fabricated by 
electrospinning 
2) MSCs from passage 
2 to passage 8 were 
cultured on both 
PLLA nanofibers to 
Chapter 
3 
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the lost in the cellular 
osteogenic 
differentiation caused 
by serial passage. 
investigate the 
influences of 
prolonged culture as 




function of the stem 
cells. 
An osteoinductive 




and the sustained 
release of this drug 




To produce an 
osteoconductive and 
osteoinductive bone 
graft material by 
incorporation of Dex ± 




1) PLLA and Dex 
were mixed well and 
then electrospun. 
2) The release profile 
of Dex from the 
nanofibers was 
investigated. 
3) The efficacy of the 
Dex-loaded PLLA 
nanofibers in the 
osteogenic 
differentiation of 
MSCs was evaluated. 
Chapter 
4 
1) Incorporation of 
Type I Col into 
nanofibrous scaffolds 
can improve nano-
HA mineralization on 
the nanofibers. 
2) Synergistic effects 
of nanotopography 
and Ca/P in nano-HA 
can create an 
osteoinductive 
nanocomposite 







formation in nude 
mice. 
1) To create a novel 
osteoinductive bone 
graft substitute without 
the use of soluble 








and nano-HA) enriched 
with MSCs as a novel 
bone graft substitute 
which possesses all of 











then mineralized with 
nano-HA using the 





osteoinductivity of the 
nanocomposites were 
evaluated by in vitro 
cell culture in growth 
medium and 
subcutaneous 





scaffolds can enhance 
To determine the 
importance of 3D 









MSCs and support the 
cells to create a bone 
ECM-like structure. 
structure to the 
osteogenic 
differentiation of MSCs. 
were fabricated by a 
modified 
electrospinning 
technique using a 
dynamic liquid 
support system. 
2)  The novelty of the 
3D nanofibrous 
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Chapter 2  
 Literature Review 
2.1 Native bone 
2.1.1 Bone structure 
Bone is a highly specialized connective tissue (Figure 2.1A), which serves structural 
and metabolic functions in the body. It provides a rigid structure for muscle 
attachment and form a system of levers which turn muscle contraction into 
determined movements. Bone also presents mechanical support to protect vital soft 
tissues/organs from traumatic injury. Additionally, bone acts as a source of important 
minerals (most notably Ca/P), and is intimately involved in the homeostasis of 
calcium ± an essential cation in several body functions [1,3,57].  
2.1.1.1 Macroscopic structure of bone 
At the gross level, all of the bones in the adult skeleton have two basic structural 
components: compact and spongy bone (Figure 2.1B). Compact (or cortical) bone is 
the solid and dense bone found in the wall of bone shafts and on external bone 
surfaces, whereas spongy (or cancellous, trabecular) bone has a more spongy, porous, 
lightweight and honeycomb structure which is found in the vertebral bodies, in the 
ends of long bones, in short bones, under protuberances where tendons attach and 
sandwiched within flat bones. Compact and spongy bone tissues are identical in 
molecular and cellular compositions [58]. 




Figure 2.1 Structure of bone tissue: (A) human bone system (Adapted from [59], Copyright 2010, with permission 
from Elsevier), (B) macroscopic structure of bone (Adapted from [60], Copyright 2006, with permission from 
Elsevier), and (C) microscopic structure of bone (Reprinted from [61], Copyright 2011, with permission from 
Elsevier). 
In the growing skeleton, spongy bone contains red marrow, a blood-forming, or 
hematopoietic, tissue which produces red and white blood cells and platelets. 
Meanwhile, compact bone surrounds yellow marrow, a source of fat cells found in the 
medullary cavity (hollow inside the shaft) of tubular bones. In most of the long bones, 
the red marrow is gradually replaced by the yellow marrow during growth. As such, 
bone tissues play an important role in blood cell production and fat storage [58]. 
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All bone surfaces not covered by cartilage are coated by a thin tissue called 
periosteum, whereas the inner surface of bones is lined with endosteum, an illed-
defined and largely cellular membrane. Both periosteum and endosteum are 
osteogenic tissues, which contain numerous and active bone-forming cells during 
youth. In adulthood, the number of these cells is reduced, but they still remain 
potentially active [58]. 
2.1.1.2 Microscopic structure of bone 
At the microscopic level, bone can be distinguished as woven and lamellar types. 
Woven bone is an irregular array of loosely packed Col fibrils and initially formed in 
the embryo and during bone growth. It is then replaced by lamellar bone, leading to a 
practical absence from the adult skeleton, except under pathological conditions of 
rapid bone formation. Lamellar bone presents in both compact and spongy bone in the 
adult, and is made of densely packed Col fibers with parallel or concentrically 
arranged patterns [57,62]. 
 
Figure 2.2 Woven bone (A) and lamellar bone (B) (Reprinted from [2], Copyright 2008, with permission from 
Elsevier) 
Bone is made of basic units called bone structural units (BSUs). In compact bone, 
these are osteons, or Haversian systems, which are hollow cylinders of concentric 
lamellae with osteocytes located in between. The center of each osteon contains a 
canal of nutrient blood vessels. Various osteons are communicated with each other 
through these vessels (Figure 2.1C). Regardless of species, the diameter of osteon is 
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always about 200 Pm due to the limitation of transport distance for nutrients. 
Different osteons are separated by so-called cement lines [62]. 
 
Figure 2.3 Compact bone (A) and spongy bone (B) (Reprinted from [2], Copyright 2008, with permission from 
Elsevier) 
In spongy bone, the BSUs are packets and also separated by cement lines. Generally, 
spongy bone do not possess blood vessels, therefore, it is nourished from the surface. 
It may be also vascularized from the adjoining bone marrow. The thickness of spongy 
bone cannot become much thicker than about 200 ± 300 Pm [57,62]. 
2.1.1.3 Molecular structure of bone 
Bone is composed of several cell types and an organic matrix which is strengthened 
by bone minerals (primarily Ca/P in the form of HA) and arranged in a hierarchical 
assembly [1]. The organic matrix, called osteoid, makes up approximately 30% of 
bone by weight, whereas this proportion of bone minerals is approximately 60% [2,3]. 
The majority of the organic matrix is type I Col (approximately 95%), the remaining 
components of about 5% consist of proteoglycans and non-collagenous proteins [1]. 
The key components of non-collagenous proteins of the ECM are shown in Table 2.1 
[2]. 
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Albumin Transports proteins; inhibits HA crystal growth 
D-2HS 
glycoprotein 
Promotes endocytosis; chemoattractant for monocytic cells; 
mineralization inhibitor 
Glycoproteins 
Osteonectin Expressed in a variety of connective tissues; strong affinity for 
Ca2+; may mediate deposition of HA; binds to growth factors; 
may influence cell-cycle anti-adhesive protein 
Tetranectin Binds to plasminogen; may regulate matrix mineralization 
RGD-containing glycoproteins 
Thrombospondins 
(I, II, III, IV) 
Cell attachment 
Fibronectin Binds to cells 
Vitronectin Cell-attachment protein 
OPN Expressed by a variety of cells; highly expressed in bone and 
inflammatory tissues; supports osteoblasts attachment to bone; 
may regulate proliferation; binds tightly to HA; inhibits crystal 
growth; binds and activates MMP-3; inhibits nitric oxide 
synthase; may regulate tissue repair 
BSP Made by osteoblasts and hypertrophic chondrocytes; binds Ca2+ 
with a high affinity; may initiate mineralization; supports cell 
attachment; binds and activates MMP-2 
BAG-75 Binds to Ca2+; may act as a cell-attachment protein; may regulate 
bone resorption 
J-carboxy glutamic acid containing proteins 
Matrix Gla 
protein 
May function in cartilage metabolism; may inhibit mineralization 
OCN Restricted to the osteoblast lineage; high affinity for Ca2+ and HA; 
inhibits crystal growth; regulates mineral maturation; may 
regulate activity of osteoclasts and their precursors; may mark 
turning point between bone formation and resorption 
Protein S Protein S-deficiency may result in osteopenia 
Glycosaminoglycan-containing proteins 
Veriscan 0D\µFDSWXUH¶VSDFHWKDWLVGHVWinated to become bone 
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Decorin Binds to Col and may regulate fibril diameter; binds to TGF-ȕ
inhibits cell attachment to fibronectin 
Biglycan Involved in the regulation of fibrillogenesis; modulates BMP-2 
induced osteogenesis; binds to TGF-ȕ 
Fibromodulin Binds to Col; may regulate fibril formation; binds to TGF-ȕ 
Osteoadherin May mediate cell attachment 
Hyaluroan May work with versican-like molecule to capture space destinated 
to become bone 
Enzymes 
ALP Secreted by osteoblasts, but also by other cells (e.g. liver, gut, 
kidneys); potential Ca2+ carrier; hydrolyze inhibitors of mineral 
deposition such as pyrophosphates 
MMPs The matrix metalloproteinases (MMPs) includes collagenases 
(MMP-1 and -13) and gelatinases (MMP-2 and -9); MMPs are 
required for Col degradation; most are expressed in mature 
chondrocytes and osteoblasts 
TIMPs Tissue inhibitors of MMPs (TIMPs) are the inhibitors of MMP 
activity 
Lysyl oxidase Copper-dependent extracellular enzyme that catalyzes oxidative 
deamination of elastin and Col precursors leading to the formation 
of a mature ECM 
Stromelysin Member of the MMP family (MMP-3); degrades most 
components of the ECM; activates other MMPs 
 
Figure 2.4 Mineralized Col fibrils (Adapted from [64], Copyright 2005, with permission from Nature Publishing 
Group) 
Col fibrils had a diameter range in nanometer scale, 50 to 500nm, and orderly 
deposited by nano-HA mineral crystals (Figure 2.4) [65,66]. Bone is hierarchical 
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multi-scale structure with seven hierarchical levels as shown in Figure 2.5 [67]. As 
such, the basic structure of bone matrix is the mineralized Col fibril in nanoscale. 
 
Figure 2.5 Hierarchical multi-scale structure of bone (Adapted from [67], Copyright 2009, with permission from 
Elsevier) 
2.1.2 Bone cells 
There are four cell types in bone tissue: osteoblasts, lining cells, osteocytes, and 
osteoclasts. While the first three types are differentiated from MSCs under the 
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influence of appropriate paracrine and autocrine stimuli, osteoclasts are derived from 
hematopoietic stem cells, probably of the monocyte series (Figure 2.6) [3]. 
 
Figure 2.6 Four cell types of bone tissue (Reprinted from [68], Copyright 2010, with permission from Elsevier) 
2.1.2.1 Osteoblasts 
Osteoblasts are derived from MSCs, and responsible for synthesizing osteoid, the 
organic matrix. They form an epithelial-like structure at the surface of the bone. The 
osteoblasts appear as plump, cuboidal cells with basophilic cytoplasm (Figure 2.7). 
They secrete the osteoid and then mineralize the matrix. Active osteoblasts are rich in 
ALP which may play a role in mineral deposition and subsequent crystallization. 
Osteoblast functions are influenced by a variety of endocrine (hormone) and cytokine 
mediators such as parathyroid hormone, prostaglandins, estrogens, 1,25(OH)2D3, 
insulin-like growth factor (IGFs), transforming growth factor-beta (TGF-ȕ, FGFs, 
platelet derived growth  factor (PDGF), and BMPs. The role of osteoblasts in matrix 
mineralization is further described in the following sections. In addition to the osteoid, 
the osteoblasts produce several UHJXODWRU\ IDFWRUV VXFK DV 1)ț% OLJDQG 5$1./
and osteoprogerin (OPG), which are critical to bone remodeling [2,3,57,62]. 




Figure 2.7 Osteoblasts with eccentric nuclei, basophilic cytoplasm and prominent Golgi zone in many of the cells. 
Osteoblasts surrounded with osteoid are osteocytes (Reprinted from [3], Copyright 2007, with permission from 
Elsevier). 
2.1.2.2 Bone-lining cells 
Bone-lining cells are inactive, or resting, osteoblasts, which are not in the process of 
bone formation. They are flattened cells with few organelles that cover endosteal bone 
surfaces. The bone-lining cells are the most abundant cells on the endosteal surface of 
the adult skeleton and important to forming a functional barrier between the 
extracellular fluid compartment of bone tissue and that of surrounding tissues. The 
exchange of calcium and other ions, such as sodium and magnesium, may be 
regulated by this barrier under the influence of parathyroid hormone, which is 
involved in calcium homeostasis. Additionally, the bone-lining cells may play a role 
in nutritional and metabolic support of osteocytes, and the initiation of osteoclast 
resorption [3,57,62]. 




Osteocytes are osteoblasts entrapped and buried in the bone matrix during active bone 
formation. They are the most abundant cells of bone tissue, making up 95% of all 
bone cells. Relative to the other bone cells, the osteocytes are long lived, up to 25 
years, compared to 3 months of the osteoblasts. The osteocytes reside in small spaces, 
called lacunae, within the mineralized matrix. They maintain contact with adjacent 
osteocytes, and with osteoblasts or bone-lining cells on the surface, by long 
cytoplasmic processes extending through canaliculi. The osteocytes may be able to 
produce or resorb bone in their immediate vicinity, thereby decrease or increase the 
size of their lacunae. They are believed to be important in calcium homeostasis and 
the regulation of other plasma minerals in the bone fluid compartment. The 
interconnection between osteocytes allows for the transmission of mechanical or 
chemical signals, suggesting them as a mechanical or damage sensor to initiate bone 
remodeling or repair [2,3,57,62]. 
2.1.2.4 Osteoclasts 
Osteoclasts are large multinucleated cells derived from hemopoietic stem cells (Figure 
2.8). A mature multinucleated osteoclast is formed by the fusion of mononuclear 
progenitors of the monocyte/macrophage family. Therefore, it is a member of the 
mononuclear phagocyte series and may be thought as a specialized type of 
macrophage. The osteoclasts are typically situated on the surface of the compact or 
VSRQJ\ ERQH DQG RIWHQ ZLWKLQ VKDOORZ SLWV FDOOHG +RZVKLS¶V ODFXQDH They are 
primarily responsible for bone resorption. To begin resorption, the osteoclasts need to 
be activated by anchoring the cells to the bone surface through actin-like filaments in 
the filamentous adhesion, or µclear¶, zone. Bone resorption is facilitated by a highly 
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specializeGµUXIIOHG¶, or brush, border which is located between the clear zone and the 
resorption area of bone surface. The ruffled border is the site where enzymes and 
acids are released to facilitate the degradation of matrix and the dissolution of 
minerals. Proteolytic enzymes digesting the matrix include cathepsins (especially 
cathepsin K) and possibly collagenases (such as matrix metalloproteinase 1). 
Hydrogen ions dissolving the bone minerals are generated from carbon dioxide and 
water by the action of carbonic anhydrase II. An ATP-mediated proton pump, located 
on the brush border, actively transfer these ions into the resorption area. In addition to 
the demineralization of the bone, the acidity of the local environment enhances the 
activity of the acid hydrolases produced by osteoclasts. The degraded mineral and 
matrix products are internalized, transported across the cell and released into the 
extracellular space opposite to the ruffled border. Once the osteoclasts completed their 
responsibilities, they most likely undergo apoptosis and disappear from the resorption 
sites [2,3,57,62] 
 
Figure 2.8 Multinucleated osteoclast on a bone surface undergoing resorption (Reprinted from [3], Copyright 
2007, with permission from Elsevier). 
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2.1.3 Bone formation 
Bone formation, or osteogenesis, occurs during embryonic development through two 
distinct processes: intramembranous ossification and endochondral ossification 
[69,70]. Flat bones, such as several craniofacial bones and the lateral part of clavicles, 
are formed by intramembranous ossification, whereas the long bones of the limbs, 
basal part of the skull, vertebrae, ribs and medial part of the clavicles are formed by 
endochondral ossification [69-73].  
2.1.3.1 Intramembranous ossification 
In intramembranous ossification, osteoblasts are directly differentiated from 
condensed mesenchymal cells. The osteoblasts then start secrete osteoid, mineralize 
the matrix and reorganize it into compact bone. The osteoblasts entrapped in the 
compact bone reside in lacuna and become osteocytes (Figure 2.9) [70,72-75]. 
 
Figure 2.9 Intramembranous ossification (Reprinted from [73], Copyright 2009, with permission from Elsevier) 
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2.1.3.2 Endochondral ossification 
The endochondral ossification involves synthesis of a cartilage template that is 
replaced as bone forms and grows (Figure 2.10). Mesenchymal condensations (Figure 
2.10a) differentiate into chondrocytes (Figure 2.10b) that proliferate and secrete 
cartilage matrix to form a cartilage anlage prefiguring the future skeletal element. 
Chondrocytes in the center of the cartilage anlage stop proliferating, undergo further 
maturation and become hypertrophic chondrocytes, which are characterized by an 
increase in size, vacuolization and secretion of a distinct ECM (Figure 2.10c). 
Mesenchymal cells surrounding the cartilage anlage are differentiated into osteoblasts, 
forming a perichondrial collar of membranous bone (Figure 2.10d). The hypertrophic 
chondrocytes in the center secrete vascular endothelial growth factor (VEGF) and 
possibly other angiogenic factors to induce sprouting angiogenesis from 
perichondrium (Figure 2.10e). Blood vessels bring along with osteoclasts, osteoblasts 
and hematopoietic cells into the anlage. As most of the terminally differentiated 
chondrocytes die by apoptosis, the osteoclasts degrade most of the matrix surrounding 
hypertrophic chondrocytes. This degradation leaves fragments serving as scaffolds for 
bone matrix deposition by osteoblasts. The hematopoietic cells form bone marrow 
established in spaces between the bony trabeculae. As a result, the primary 
ossification center is formed (Figure 2.10f). The ossification then spreads centripetally 
as a front within the anlage (Figure 2.10g). At growth plate, a thin band of tissue 
located between the expanding front of bone and epiphyseal cartilages, chondrocytes 
terminally differentiate into hypertrophic chondrocytes, facilitating the replacement of 
cartilage. Much of the cartilage anlage is converted to bone. Secondary ossification 
centers formed in the epiphyseal cartilages are eventually converted to bone except 
for a thin layer of articular cartilage at the joint surface (Figure 2.10h-i) [70,72-76]. 




Figure 2.10 Endochondral ossification (Reprinted from [76], Copyright 2009, with permission from Elsevier) 
2.1.3.3 Matrix mineralization 
In both processes, osteoblasts play a central role in the production and mineralization 
of bone matrix. In general, body fluids are supersaturated with respect to HA, but the 
mineralization only occurs in the so-FDOOHGµPLQHUDOL]HG WLVVXHV¶7KLV LVPRVW OLNHO\
due to the presence of numerous mineralization inhibitors in the body fluids and 
tissues, including anionic molecules that can chelate calcium, e.g., citrate, ATP, 
pyrophosphate, glycosaminoglycans, and proteins that bind specifically to apatite 
crystals, e.g., osteonectin, OPN, matrix-gla-protein, fetuin, and albumin (Table 2.2). 
These inhibitors prevent de novo precipitation, protect the cells from being engulfed 
in minerals, and also regulate the size and the shape of formed crystals. In bone 
tissues, the inhibitors must be enzymatically degraded before mineralization can be 
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initiated. Matrix vesicles, tiny extracellular organelles originating as cytoplasmic 
blebs from osteoblasts, chondrocytes and odontoblasts, are believed to play an 
important role in initiating the mineralization process. These vesicles are rich in 
calcium-binding phospholipids and enzymes which can degrade the inhibitors, such as 
ATPase, pyrophosphatases, ALP and matrix metalloproteinases. Phospholipids 
sequester calcium, pyrophosphatases and metalloproteinases inactivate local 
inhibitors, while ALP generate phosphate ions, allowing mineralization to process 
[3,77,78]. 
Table 2.2 ECM proteins and cellular enzymes associated with mineralization (Adapted from [77], Copyright 2011, 
with permission from Elsevier)  
Proteins Effect on mineralization 
ECM proteins 




Col I Template 
Dentin matrix protein-1 (DMP1) Nucleator/inhibitor 
Dentin phosphophoryn Nucleator 
Dentin sialoprotein Weak nucleator/inhibitor 
Enamelin Regulator of crystal shape 
Fetuin Inhibitor 
Matrix gla protein (MGP) Inhibitor 







ALP Hydrolyze inhibitors of mineral 
deposition such as pyrophosphates 
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ATPase Hydrolyze ATP; facilitate cellular 
calcium transport 
Matrix metalloproteinases (stromolysin 
MMP3; gelatinase MMP2) 
Degrade matrix molecules that inhibit 
mineralization 
There are several steps in the mineralization process. Firstly, the precursor cells are 
differentiated into mature osteoblasts. Early and late markers of osteoblasts during 
maturational stages are shown in Figure 2.11 [79]. The osteoblasts then secrete 
osteoid, an organic matrix containing Col fibrils. Col fibrils alone are not able to 
initiate primary nucleation in vivo. Instead, the adsorption to Col of bone-specific 
non-collagenous proteins, such as biglycan, BSP and proteolipid, may create 
appropriate sites for nucleation. These proteins bind to and stabilize the initially 
formed HA crystals. The chemical formula for HA is Ca10(PO4)6(OH)2. These crystals 
are deposited in an oriented fashion on a Col template and smaller than 20 nm in size. 
The crystals then spread throughout the Col fibers until they fully fill the entire 
aqueous space [3,77,78].  
 
Figure 2.11 Markers of osteoblasts during the maturational stages (Reprinted from [79], Copyright 2008, with 
permission from Elsevier) 
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The modulation of bone formation is still poorly understood. Growth factors and 
transcription factors important to bone formation are shown in Table 2.3.  
Table 2.3 Growth factors and transcription factors important to bone formation (Adapted from [80,81], Copyright 





FGF Induces bone marrow stromal cell migration, proliferation, 
and differentiation; induces endothelial cell migration, 
proliferation, vasculogenesis, and angiogenesis; increases 
osteoclast precursor cell proliferation; inhibits matrix 
formation and mineralization at high doses 
IGF-I, -II Secreted by the liver; stimulates osteoblast proliferation and 
matrix synthesis; upregulates type I Col production; 
promotes osterix (Osx) expression in osteoblastic cells; 
stimulates osteoclasts 
PDGF-AA, -AB, -BB Synthesized by megakaryocytes, transported in blood by 
platelets; signals cell proliferation and recruit progenitor 
cells by stimulating chemotactic migration; upregulated in 
wound healing and initial fracture repair; inhibits matrix 
(type I Col) apposition; stimulates osteoblasts to produce 
IL-6, which recruits osteoclasts; PDGF-BB and -AB 
increase bone resorption and Col degradation 
TGF-ȕ Secreted by many organs; has an autocrine action on 
osteoblasts; promotes cell migration, proliferation, and 
differentiation; upregulates fibronectin, osteonectin, OPN, 
and type I Col formation; induces Runx2 in vivo; promotes 
orthotopic bone formation; inhibits matrix 
metalloproteinases; modulates bone remodeling; inhibits 
osteoclast progenitor cell proliferation and differentiation; 
may induce apoptosis in mature osteoclasts; induces 
scarring and fibrous tissue formation in non-osseous tissues 
BMP Member of TGF family; concentrated in the organic matrix 
of bone, released after a fracture or during bone resorption; 
autocrine and paracrine action mediated by their kinase 
receptors; induces osteoprogenitor cell migration, 
proliferation, and differentiation; promotes Runx2 
expression in progenitor and osteoblastic cells, and Osx 
expression in osteoblastic cells; inhibits terminal 
differentiation of myogenic and adipogenic cells; does not 
stimulate osteoclast activity; induces orthotopic and 
heterotopic bone formation 
VEGF-A, -B, -E Expressed in several tissues; secreted by osteoblasts and 
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endothelial cells; exerts its role in endochondral ossification 
through its expression and release by hypertrophic 
chondrocytes; required for the formation and maintenance 
of blood vessels; induces endothelial cell growth and 
migration; inhibits endothelial cell apoptosis; important in 
normal and pathological angiogenesis; stimulates 
endothelial cells to produce osteoanabolic growth factors 




protein (LIM-1, -3) 
Upregulates expression of BMPs; induces ectopic bone 
formation 
Runx2/Cbfa1 (I, II, III) Promotes osteogenic differentiation; upregulates OCN 
expression; induces endochondral and intramembranous 
bone formation 
Osx Required for osteogenic differentiation 
Twist Positive regulator of osteoblast differentiation 
Msx2 Inhibits osteoblast differentiation 
2.1.4 Bone modeling and remodeling 
Once bone formed by either intramembranous or endochondral ossification, its shape 
and structure is continuously renovated and modified by modeling and remodeling. 
Bone modeling takes place principally during growth, which refers to alterations in 
the shape of the bone ± changes in length. This process usually ceases when the 
skeleton stops growing, at around age 18-20. In contrast, bone remodeling occurs in 
the adult to maintain skeletal structure. However, bone modeling and remodeling are 
not very different at the molecular level. They both result in the replacement of old 
bone by new bone, which allows the maintenance of mechanical integrity of the 
skeleton [2,57,62,82]. 
The morphological dynamic structure of bone remodeling is the basic multicellular 
unit (BMU), also called bone remodeling unit (BRU) (Figure 2.12) [83]. When the 
bone remodeling is terminated, this unit is called BSU, which refers to the packet in 
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spongy bone or the osteon in compact bone. In the bone remodeling, osteoclasts 
initiate the process by the binding of a receptor activator ± nuclear factor kappa B 
ligand (RANKL) ± to its receptor (RANK) on the surface. Once activated, the cells 
resorb a packet of bone matrix (about 0.05 mm3 in human compact bone). After the 
UHVRUSWLRQ WKHUH LV D µUHYHUVDO¶ SKDVH ZKHUH WKH RVWHRFODVWV XQGHUJR DSRSWRVLV DQG
osteoblasts move into the resorption cavity. The osteoblasts then begin to refill the 
cavity with osteoid and mineralize the matrix [2,57,62,82,83]. Important hormones 
and factors affecting bone remodeling are shown in Table 2.4 [84]. Biochemical 
markers during bone remodeling are shown in Table 2.5 [85]. 
 
Figure 2.12 Bone remodeling unit (Reprinted from [83], Copyright 2012, with permission from Elsevier) 
Table 2.4 Important hormones and factors affecting bone remodeling (Adapted from [84], Copyright 1997, with 
permission from Elsevier) 










High levels stimulate osteoblasts 
causing increased osteoclast 
activity, increased activation 
frequency, and accelerated bone 




Thyroxine (T3) Increase Osteoclasts High concentrations increase 
resorption with differential effects 
on compact and spongy bone; 
compact bone lost preferentially 
Estrogen Decrease Osteoblasts With deficiency, osteoblasts 
stimulated causing increased 
osteoclast activity, increased 
activation frequency, and 
accelerated bone loss 
Testosterone Decrease Osteoblasts With deficiency, osteoblasts 
stimulated causing increased 
osteoclast activity, increased 
activation frequency, and 




Decrease Osteoblasts Deficiency causes increased 
activation frequency but also 
inhibits mineralization of newly 
synthesized osteoid matrix 
Cortisol Increase Progenitors, 
osteoblasts, 
osteoclasts 
Increased concentrations have 
profound effect by both increasing  
bone resorption and inhibiting bone 
formation, leading to accelerated 
bone loss 
Calcitonin Decrease ? Inhibits bone resorption; used 
therapeutically to treated increased 
ERQHORVVHJ3DJHW¶VGLVHDVHDQG
high turnover osteoporosis 
Insulin Decrease Osteoblasts Causes increased IGF-1 synthesis 
in liver, resulting in increased Col 
synthesis by osteoblasts 
Table 2.5 Biochemical markers of bone remodeling (Adapted from [85,86], Copyright 2010 and 2011, with 
permission from Elsevier)  
Markers Specimen Method Remarks 
Markers of bone formation 
Total ALP (t-ALP) Serum Electrophoresis, 
precipitation, 
IRMA, EIA 
Secreted by osteoblasts, but 
also by other cells (e.g. liver, 
gut, kidneys). In children, 




OCN Serum RIA, IRMA, 
ELISA 
Specific product of osteoblasts; 
many immunoreactive forms in 
blood; some may be derived 
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from bone resorption 
C-terminal 
propeptide of type I 
Col (PICP) 
Serum RIA, ELISA Cleaved during the 
extracellular processing of type 
I Col, prior to fibril formation; 
product of proliferating 
osteoblasts and fibroblasts 
N-terminal 
propeptide of type I 
Col (PINP) 
Markers of bone resorption 
Col-related markers 
Hydroxyproline, 




A product of post-translation 
hydroxylation of proline in the 
procollagen chain; present in 






HPLC, ELISA Hydroxylysine in Col is 
glycosylated to varying degrees 




Generated from lysine and 
hydroxylysine during post-
translation modification of Col; 
present in mature Col only; 






telopeptide of type I 
Col (ICTP, CTX-
MMP) 
Serum RIA A product of Type I Col 
degradation; may be derived 
from newly synthesized Col 
Carboxyterminal 
cross-linked 




ELISA, RIA A product of Type I Col 
degradation; isomerization of 
DVSDUW\ , WR ȕ-aspartyl occurs 
with aging of Col molecule 
Aminoterminal 
cross-linked 






A product of Type I Col 
degradation 
Col I alpha 
helicoidal peptide 
(HELP) 
Urine ELISA Degradation fragment derived 
from the helical part of type I 
Col (D1 chain, AA 620-633) 
Non-collagenous proteins 
BSP Serum RIA, ELISA Acidic, phosphorylated 
glycoprotein, synthesized by 
osteoblasts and osteoclastic-
like cells 






Urine ELISA Certain age-modified OCN 
fragments are released during 
osteoclastic bone resorption 
OPN Serum ELISA Synthesis in bone is stimulated 









Isoenzyme identified in both 
the ruffled border of the 
osteoclast membrane and the 
secretions in the resorptive 
space; band 5b predominant in 
osteoclasts 
Cathepsins (e.g., K, 
L) (CathK, CathL) 
Plasma, 
serum 
ELISA Cathepsin K, cysteine protease, 
plays an essential role in 
osteoclast-mediated bone 
matrix degradation by cleaving 
helical and telopeptide regions 
of Type I Col. Cathepsin K and 
L cleave the loop domain of 
TRACP and activate the latent 
enzyme. Cathepsin L has a 
similar function in 
macrophages. Tests for 
measurement of cathepsins in 
blood are presently under 
evaluation 
The remodeling rate is approximately 10% in the adult. Under normal conditions, the 
bone resorption and formation are closely coupled, resulting in no net change in bone 
mass. When bone resorption is impaired in diseases such as osteopetrosis, bone 
becomes fragile and factures occur. In contrast, with aging and osteoporosis, bone 
formation can be incomplete and lead to progressive bone loss [2,57,62,82,83]. 
2.1.5 Bone repair 
Bone repair process closely resembles the pathway of normal embryonic development 
of the skeleton. Most fractures heal by indirect fracture healing through the 
combination of intramembranous and endochondral ossification. However, there are 
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some different aspects from the embryonic development such as inflammation, the 
scarcity of stem/progenitor cells and the increase in mechanical forces in adults [4-6]. 
Bone repair is comprised of four overlapping stages as shown in Figure 2.13 [5]. The 
disruption of blood vessels following damage to the musculoskeletal system activates 
the coagulation cascade and forms hematoma enclosing the fracture area (Figure 
2.13a). The inflammatory response is associated with the release of several growth 
factors and cytokines important to bone repair. New blood vessels are formed from 
pre-existing ones (i.e. angiogenesis). MSCs are recruited to the site and differentiated 
into chondrocytes to produce fibrocartilage (internal callus) following the 
endochondral ossification. Meanwhile, the cells in periosteum undergo proliferation 
following the intramembranous ossification to create an external callus (Figure 
2.13b). The soft callus then becomes mineralized to form a hard callus of woven bone 
(Figure 2.13c). The primary bone formation is subsequently followed by bone 
remodeling (Figure 2.13d). In this stage, the bony callus is replaced and reduced to 
the original size of pre-existing bone by resorption and secondary bone formation [4-
6]. The detail information of these four stages is shown in Table 2.6 [4]. 
 
Figure 2.13 Key stages in bone repair (Reprinted from [5], Copyright 2003, with permission from Elsevier) 
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Table 2.6 Multiple stages of bone repair (Adapted from [4], Copyright 2008, with permission from International & 




Biological processes Expression of signaling molecules and 
their proposed functions 
Inflammation Hematoma IL-1, IL-6, and TNF-D play a role in 
initiating the repair cascade 
Inflammation TGF-ȕ 3'*) DQG %03-2 expression 
increases to initiate callus formation 
Recruitment of MSCs GDF-8 is restricted to day 1, suggesting 








TGF-ȕ-ȕDQG*')-5 peak due to their 
involvement in chondrogenesis and 
endochondral bone formation 
Cell proliferation in 
intramembranous 
ossification 
BMP-5 and -6 rise 
Vascular in-growth Angiopoietins and VEGFs are induced to 
stimulate vascular in growth from vessels 







Phase of most active 
osteogenesis 
 
Bone cell recruitment and 
woven bone formation 
RANKL and MCSF rise in association 
with mineralized cartilage resorption 
Chondrocyte apoptosis and 
matrix proteolysis 
TNF-D rises in association with 
mineralized cartilage resorption. This 
promotes the recruitment of MSCs and 
induces apoptosis of hypertrophic 
chondrocytes 
Cartilage resorption and 
osteoblast recruitment 
BMP-3, -4, -7, and -8 rise in association 
with the resorption of calcified cartilage. 
They promote recruitment of cells in 
osteoblastic lineage 
BMP-5 and -6 remain high during this 
stage, suggesting a regulatory effect on 
both intramembranous and endochondral 
ossification 






Bone remodeling coupled 
with osteoblast activity 
IL-1 and IL-6 rise again in association 
with bone remodeling, whereas RANKL 
and MCSF display diminished levels 
Establishment of marrow Diminished expression of members of the 
TGF-ȕVXSHUIDPLO\ 
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The molecular and cellular processes of bone repair are less understood. Key 
molecules and cells suggested to be involved in bone repair are shown in Table 2.7 
[6]. Related pathways are shown in Figure 2.14 [6]. Many of these factors have been 
tested as new tools for treating bone diseases such as PTHrP/PTH for osteoporosis, 
which is efficient for increasing bone mass; BMP-2 for spinal fusion, bone non-union 
and bone defects, which is efficient for bone repair and regeneration; BMP-7 for 
spinal fusion and bone non-union; Wnt-ȕ-catenin for increasing bone mass; 
RANKL/OPG for osteoporosis; Biophosphonates for osteoporosis, bone necrosis, 
osteogenesis imperfecta and some osteolytic tumors; PDGF for maxillofacial surgery 
and bone defects; and MSCs or osteoblasts for bone defects, osteonecrosis and 
immune rejection [6]. 
Table 2.7 Key molecules and cells involved in bone repair (Adapted from [6], Copyright 2009, with permission 
from Elsevier) 




Elicit inflammation and 
migration 
In vitro inhibit osteoblastic 
differentiation, but in vivo TNFD is 
crucial for bone repair; role of IL-6 is 
controversial (anti- or pro-osteogenic 
probably, depending on soluble IL-6 
receptors) 
SDF1 Chemotactic factor Allows MSCs homing both in vitro and in 
vivo 
TGF-ȕ Mitogenic factor, 
osteogenic factor 
Can induce osteoblast differentiation at 
the early stage of immature cells but can 
also inhibit osteogenesis in committed 
cells 
BMP2 Osteogenic factor Osteochondrogenic factor; might initiate 
bone formation and bone healing and can 
induce expression of other BMPs 
BMP4 Osteogenic factor Osteochondrogenic factor in vivo and in 
vitro 
BMP7 Osteogenic factor Osteogenic factor in vivo and in vitro; 
active on more mature osteoblasts 
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Noggin BMP2, 4, and 7 
specific inhibitor 
Suppresses osteoblastic differentiation 




Mutations induce chondrodysplasia and 
craniosynostosis; can stimulate Sox9; 
might be a negative regulator of postnatal 
bone growth and remodeling 
IGF-I, II Mitogenic factors, 
osteogenic factors 
Stimulate growth plate formation, 
endochondral ossification and bone 
formation by osteoblasts 
VEGF Angiogenic and 
vasculogenic factor 
Most potent angiogenic and vasculogenic 
factor; crucial at the onset of bone 
formation 
PIGF Angiogenic and 
vasculogenic factor 
Induces proliferation and osteogenic 
differentiation of MSCs; crucial for 
vascularization 
PDGF Mitogenic and 
chemotactic factor 
Highly mitogenic factor for MSCs and 
chemotactic for MSCs, osteoblasts and 
perivascular cells 
Wnts Mitogenic and 
osteogenic factors 
Depending on Wnt type, crucial for 
osteoprogenitor proliferation; can also 
inhibit final osteoblast maturation 
DKK1 Inhibitor of Wnt 
signaling 
Strongly inhibits osteogenesis of MSCs 




Pivotal role for growth plate and 
endochondral formation; can inhibit 




Pivotal role for growth plate and 
endochondral formation; can induce or 
inhibit osteogenesis 
OPG Decoy receptor of 
RANKL, inhibition of 
RANKL  
Strongly inhibits bone resorption and has 
a pivotal role in bone remodeling 
RANKL Induces 
osteoclastogenesis 
Strongly stimulates bone resorption and 
has a pivotal role in bone remodeling 
M-CSF Induces 
osteoclastogenesis 





Expressed by enterochromatin cells; 
inhibits bone formation and represses by 
Lrp5 
Intracellular messengers 
MAPKs Transduce osteogenic Crucial for regulation of intracellular 





signaling induced by osteogenic factors 
(still controversial) 
PRK/CREB Transduce osteogenic 
signaling 
Can transducer osteogenic signaling (still 
controversial); possible indirect effect 
ȕ-Catenin Osteogenic transducer 
factor 
Pivotal role in transducing osteogenic 
signal from Wnt and is negatively 
UHJXODWHGE\*6.ȕ 
Runx2 Early osteogenic 
transcription marker 
Master regulator of early osteogenesis 
Osx Late osteogenic 
transcription marker 
Master regulator of late osteogenesis; 
inhibits chondrogenesis 
Dlx5 Osteogenic homeobox 
protein 
Induces osteoblast maturation but inhibits 
osteocyte formation 
Msx2 Osteogenic homeobox 
protein 
Induces proliferation of immature cells; 




Inhibits the differentiation of MSCs and 
committed osteoblastic cells 
Cells 
MSCs Origin of osteoblasts Can form osteoblasts and bone in vivo 
and in vitro 
Osteoblasts Osteogenic 
professional cells 





Multipotential cells Can give rise to bone in vivo and in vitro 
but less effective than bone marrow 
MSCs 




Figure 2.14 Bone remodeling after fracture (Reprinted from [6], Copyright 2009, with permission from Elsevier) 
2.2 Bone grafts and bone graft substitutes 
2.2.1 Clinical need  
As mentioned above, bone is usually able to repair itself without the need for 
intervention. However, in non-union fractures, large bone defects, and revision 
arthroplasty, this spontaneous regeneration can be problematic. In most of these cases, 
bone fails to regenerate itself and bone grafts are required to support the healing [7]. 
After blood, bone is the second most common transplantation tissue [87]. The market 
of bone grafts and bone graft substitutes was valued at $1.9 billion in 2010, and is 
forecast to reach $3.3 billion in 2017, with a Compound Annual Growth Rate 
(CAGR) of 8.3% [8]. Globally, approximately one million bone-grafting procedures 
are performed annually on the pelvis, spine, and other body extremities. Due to an 
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aging population, and increases in the incidences of degenerative intervertebral disc 
diseases, the number of revision orthopaedic surgeries, spinal fusions in private 
healthcare, and the number of seniors seeking an active lifestyle, the market of bone 
grafts and bone graft substitutes is projected to record steady growth [9].  
2.2.2 Bone grafts 
An ideal bone graft should possess three properties namely osteoconduction, 
osteogenesis and osteoinduction ± as mentioned in section 1.1. In addition to these 
important properties, the ideal bone graft should be biocompatible, bioresorbable, 
structurally similar to bone, easy to use and cost-effective. 
To date, the gold standard for bone graft materials is autologous bone graft. 
Autografts are transplants of tissue from one site to another within the same 
individual. Autologous bone has all necessary properties to induce bone growth and 
regeneration: osteoconduction, osteogenic cells and osteoinduction. Additionally, it 
offers excellent success rate, low risk of transmitting disease, and histocompatibility. 
Available autografts include cancellous, vascularized cortical, nonvascularized 
cortical and autologous bone marrow grafts. Due to the presence of spaces within its 
structure, autologous cancellous bone graft has been considered more osteogenic than 
cortical bone graft. Several donor sites are commonly used in orthopaedics, including 
the iliac crest, distal radius, distal tibia and the fibula. Despite those advantages, 
autografts have limitations, including limited availability, donor-site morbidity, 
increased operative time, wound complications and chronic pain. These disadvantages 
can be overcome by the use of allografts [12-17]. 
Allografts can either be collected from cadavers or living donors. The major 
advantages of allograft include its ready availability in various shapes and sizes and 
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avoidance of morbidity. However, allogenic bone has the inherent risks of host-
versus-graft immune response and disease transmission. These concerns are virtually 
eliminated through tissue-processing and sterilization to remove living cells (bone-
forming cells, bacteria and viruses) and antigens. Thus, the processed allograft lacks 
the osteogenic property. Depending on the method used for preparation and 
sterilization, allografts can possess various degrees of osteoinductivity. Fresh frozen 
specimens (stored at below -60oC) may have a moderate degree of osteoinductivity, 
but slightly higher risk of immunologic rejection and disease transmission. 
Meanwhile, freeze-dried (lyophilized) specimens (stored at room temperature) are 
destroyed all osteogenic cells and left only limited osteoinductive capability, but 
offered with lower risk of infection for patient. Allografts can be sterilized with 
ethylene oxide or gamma radiation. Ethylene oxide sterilization is more expensive, 
but it may negatively affect biological activity or mechanical strength of the graft. 
Due to these processes, allografts are primary osteoconductive. They retain variable 
degrees of osteoinduction, but no osteogenesis [12-18]. 
Allogenic bone is available in many forms including DBM, morselized and cancellous 
chips, corticocancellous and cortical grafts, and osteochondral and whole-bone 
segments (Table 2.8) [19]. DBM is produced by acid extraction of allograft to remove 
the mineral components. Urist (1965) discovered that the removal of bone minerals 
exposes more bioactive BMPs [88]. Compared to undemineralized bone grafts, DBM 
is more biologically active, but its mechanical strength is significantly diminished. 
The demineralization process also removes most of the foreign antigens, providing 
DBM as the least immunogenic of allografts. As a result, DBM contains Col and 
various amounts of BMPs and other proteins. It acts as an osteoconductive, and 
possibly as an osteoinductive material. Its osteoinductivity is affected by storage, 
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processing and sterilization methods. DBM also revascularizes quickly and acts as a 
suitable carrier for autologous bone marrow. It has been successfully used to fill bone 
defects and induce bone formation in various clinical conditions in orthopaedic 
surgery and cranio-maxillofacial reconstruction, including benign bone lesions, large 
bone defects and repair of complex fractures. DBM is available as freeze-dried 
powder, crushed granules or chips, and a gel or paste [12-15,17-18,20-21]. 
2.2.3 Bone graft substitutes 
Allografts can be used alone or in combination with other materials such as hydrogel 
carrier, hyaluronate carrier, calcium sulphate, HA/calcium carbonate composite and 
type I Col/sodium alginate, etc. in commercialized products (Table 2.8) [19]. These 
products called allograft-based bone graft substitutes include Grafton®, Opteform®, 
Optecure®, DBX®, Allomatrix®, InterGro®, ProgenixTM and Allomatrix® RCS, etc. In 
spite of the efforts to eliminate disease transmission, allografts and allograft-based 
bone graft substitutes retain the risk of transmission of viral infections [especially 
human immunodeficiency virus (HIV) and hepatitis B and C], malignancy or toxins. 
In addition, they have potential disadvantages of high cost from harvesting, 
processing and conservation, and different potencies between different batches 
because of the wide variety of donors [12-15,17-18,20-21]. 
Table 2.8 Commercially available bone grafts and bone graft substitutes [15,19] 




MTF/Orthofix Allograft of cancellous bone containing 
viable adult stem cells and osteoprogenitor 
cells within the matrix and a demineralized 
bone component 
AllopureTM Wright Medical 
Technology 
Sterile femoral/tibial allograft 

























DBM fibers with demineralized cortical 
cubes, with or without bone marrow aspirate 
Grafton® Gel, 
Plus® Paste 
DBM in a syringe, with or without bone 
marrow aspirate 
Puros® DBM Zimmer DBM putty with allograft chips 
Allograft-based bone graft substitutes 
Optecure® + 
CCC 
Exactech DBM and cortical cancellous chips 
suspended in hydrogel carrier 
Opteform® DBM and cortical cancellous chips 
suspended in gelatin carrier 
OrthoBlast II Integra/IsoTis 
Orthobiologics  
DBM, cancellous bone, Reverse Phase 
Medium 
Allomatrix® Wright Medical 
Technology 
DBM with/without cancellous bone matrix in 
surgical grade calcium sulphate powder 
AlloFuseTM AlloSource Heat sensitive copolymer with DBM 
InterGro® Biomet 
Osteobiologics 
DBM in a lecithin carrier and mixed with 
HA/CC composite granules 
Optecure® Exactech DBM suspended in hydrogel carrier 





DBM, Accell Bone Matrix, Reverse Phase 
Medium 
Accell Evo3TM DBM, Accell Bone Matrix, Reverse Phase 
Medium 
Accell TBM® DBM, Accell Bone Matrix 
DynaGraft II DBM, Reverse Phase Medium 
Optimum 
DBM® 
Life Net Health DBM combined with glycerol carrier 
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Osteofil® DBM Medtronic Spinal 
& Biologics 
DBM in porcine gelatin 
ProgenixTM 
Putty 
DBM in Type I bovine Col and sodium 
alginate  
ProgenixTM Plus DBM in Type I bovine Col and sodium 
alginate with demineralized cortical bone 
chips 
DBX® MTF/Synthes DBM in sodium hyaluronate carrier 
BiosetTM Regeneration 
Technologies 
DBM combined with natural gelatin carrier 





DBM with CaciplexTM technology in 
surgical grade calcium sulphate powder 
Ignite® DBM in surgical grade calcium sulphate 










Zimmer Bovine bone 





rhBMP-2 protein on an absorbable Col 
sponge 
OP-1® Implant Stryker Biotech rhBMP-7 with Type I bone Col 
OP-1® Putty rhBMP-7 with Type I bone Col plus 
carboxymethyl-cellulose (putty additive) 
Calcium sulfate-based bone graft substitutes 
BonePlast® Biomet 
Osteobiologics 





Calceon® 6 Synthes Calcium sulphate 
MIIG® X3 Wright Medical 
Technology 
High strength surgical grade calcium 
sulphate 





75% calcium sulphate and 25% calcium 
phosphate 
Pro-stim® 50% calcium sulphate, 10% calcium 





phosphate and 40% DBM by weight 





Coralline-derived HA/CC composite 
Conduit® TCP 
Granules 
Depuy Spine ȕ-TCP 
OpteMx® Exactech HA/TCP biphasic combination, with or 





KLJKO\SXULILHGȕ-TCP and 20% highly 










Biphasic calcium phosphate and Col 
Vitoss® Orthovita  ȕ-7&3 RU  ȕ-TCP/20% Col, or 
 ȕ-TCP/20% Col/10% bioactive glass; 
with or without bone marrow aspirate 
ChronOS® Synthes ȕ-TCP 
Norian® SRS® Calcium phosphate 
Norian® SRS® 




Zimmer Dibasic calcium phosphate and Type I Col; 
with or without bone marrow aspirate 




Depuy Spine Col matrix mineralized with HA, with or 
without bone marrow aspirate 
CortossTM Orthovita PMMA and glass ceramic particles 
Immix Osteobiologics, 
Smith and Nephew 
PLGA 





NovaBone® NovaBone/MTF Bioactive silicate 
DBM: demineralized bone matrix; CC: calcium carbonate; PCL: SRO\İ-caprolactone); PLGA: Poly(D,L-lactide-
co-glycolide); PMMA: Poly(methylmethacrylate) 
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Instead of depending on natural bone, other bone graft substitutes have been 
developed based on rhBMPs, calcium sulphate, calcium phosphate and polymers 
(Table 2.8) [15,19]. Commercialized products of rhBMP-based bone graft substitutes 
include Infuse® (rhBMP-2 protein on an absorbable Col sponge) and OP-1® (rhBMP-
7 with Type I bone Col) [19]. BMPs are powerful osteoinductive molecules. These 
products are being used in several clinical conditions; including non-unions, open 
fractures, avascular bone necrosis, joint fusions, and critical bone defects. They 
provide a supraphysiological dose (10 ± 1000 folds higher than the concentration of 
native BMPs) over a finite period (60- 240 min). OP-1® provided results comparable 
to bone autograft in intramedullary nailing for tibial non-unions [89]. In posterolateral 
spinal fusions, OP-1® produced fusion rates of 55% compared with 40% of iliac crest 
autograft during the study period [90]. Meanwhile, Infuse® is being increasingly 
employed as an adjunct to accelerate fusion in spinal surgery [91,92]. However, there 
are some disadvantages and side-effects related to using rhBMPs. They are more 
expensive than many other bone graft substitutes and subject to a limited shelf life. 
Additionally, undesired ectopic bone formation can be induced in surrounding tissues 
such as adjacent muscles, nerves, and blood vessels if the carrier is placed incorrectly. 
There is also an issue related to safety of the supraphysiological concentrations of 
rhBMPs to achieve the desired osteoinduction. Some patients have been observed 
with antibody formation and immunological reactions following administration of 
rhBMPs [12,13,15,18,20,21]. 
Calcium sulphate graft material with a patented crystalline structure is described as an 
alpha-hemihydrate. It acts primarily as an osteoconductive bone-void filler for the 
ingrowth of blood vessels and associated fibrogenic and osteogenic cells. Calcium 
sulphate is biocompatible, bioactive and resorbable after 12 weeks. It is completely 
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resorbed as newly formed bone remodels. Commercialized bone graft substitutes 
based on calcium sulphate include BonePlast®, Calceon® 6, Osteoset® and Pro-dense® 
injectable regenerative graft, etc (Table 2.8) [19]. Their potential applications may be 
the filling of bone cysts, benign bone lesions and cavitary or segmental bone defects, 
expansion of grafts used for spinal fusion, and filling of bone graft harvesting sites. 
Their load-bearing applications are questionable due to significant loss of its 
mechanical strength upon its degradation [13-16,20]. 
Calcium phosphate-based bone graft substitutes are similar in composition to the 
mineral phase of native bone. It is available in a variety of forms, including ceramics, 
and cements, etc. The calcium phosphate ceramics mainly consist of HA, tricalcium 
phosphate (TCP) or a biphasic mixture of both (BCP). HA is produced through a 
high-temperature reaction (sintering) and is a highly crystalline form of calcium 
phosphate. Its chemical formula is Ca10(PO4)6(OH)2 with a calcium-to-phosphate 
atomic ratio of 1.67. Due to the chemical composition and crystalline structure similar 
to the native HA in bone, the sintered HA possesses osteoconductive potential and 
excellent biocompatibility. It has been successfully used to coat metal implants to 
increase their osteointegration, or fill bone voids. However, it is slower to resorb than 
the endogenous form, and may remain at the implantation site for many years. The 
sintered HA has good compressive strength, but is weak in tension and shear. It is 
brittle and fracture probe on shock loading. Because of these issues, the sintered HA 
is concerned about slow bone formation, and not commonly used alone as a bone 
graft substitute [13-18,20-21]. It is combined with calcium carbonate or TCP in 
commercialized products such as ProOsteon® 500R, OpteMx® and MasterGraft® 
Granules (Table 2.8) [19].  
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TCP is a random porous ceramic and exists in alpha and beta crystal forms. Like HA, 
the chemical composition and crystallinity of TCP are similar to those of bone 
mineral. However, it is less brittle and has a faster resorption rate than the sintered 
HA. The degradation occurs through the combination of dissolution and osteoclastic 
resorption. Approximately 95% of TCP is resorbed in 26 ± 86 weeks. It undergoes 
partial conversion to HA once it is implanted into the body, leading to an 
unpredictable biodegradation profile. ȕ-TCP is available in porous or solid form as 
either granules or blocks. It is effective for filling bone defects resulting from trauma, 
benign tumors and cysts in orthopaedic and dental applications [13-18,20-21]. 
Commercialized bone graft substitutes bDVHG RQ ȕ-TCP include Conduit® TCP 
Granules, Integra MozaikTM, Vitoss® and ChronOS®, etc (Table 2.8) [19].  
Calcium phosphate cement consists of equimolar amounts tetracalcium phosphate 
(Ca4(PO4)2O) and dicalcium phosphate anhydrous (CaHPO4). These materials are 
then mixed with water to form a paste which can be shaped during surgery to fit bone 
defects. Within 20 min, the cement hardens to allow rapid closure of the wound. HA 
might be formed as one of the products during the hardening reaction. This reaction is 
isothermic and occurs at physiologic pH, thus bone tissue is not damaged during the 
setting reaction. Because of brittleness, calcium phosphate cement is employed for 
non-load-bearing bone defects such as dental and cranio-facial. Similar to calcium 
phosphate ceramics, the calcium phosphate cement is biocompatible and 
osteoconductive. However, compared to the preformed, sintered ceramics; the 
calcium phosphate cement has the advantages of custom-fill defects and increased 
compressive strength. It is also gradually resorbed and replaced with new bone. The 
disadvantage of the cement is the potential of damaging surrounding tissues because it 
can be extruded beyond the fracture boundary [16,18]. Norian® SRS® and CopiOs® 
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are the most popular bone graft substitutes based on the calcium phosphate cement 
(Table 2.8) [19]. 
Polymers can be loosely divided into natural and synthetic polymers, or degradable 
and non-degradable polymers. Some polymers have been used in commercialized 
bone graft substitutes such as Col (Healos®), PMMA (CortossTM), PLGA (Immix), 
PLLA (OPLA) and PCL (Osteoplug, Osteomesh) (Table 2.8) [15]. CortossTM is an 
injectable polymer product indicated for load-bearing sites. Biodegradable polymers 
such as Col, PLGA, PLLA and PCL can be degraded and resorbed by the body, thus a 
second operation to remove them can be avoided. The small polymeric products by 
the degradation may stimulate an inflammatory reaction, but this remains an area of 
debate and investigation [13,15,20]. In Healos®, type I Col fibers are coated with a 
layer of non-sintered HA minerals. Compared to the sintered HA blocks, this powder 
mineral layer is more easily resorbed in vivo. The resorbable and osteoconductive 
Healos® is indicated for spinal fusions [93]. 
Except for allograft- and rhBMP-based bone graft substitutes, the other 
commercialized substitutes ± based on calcium sulphate, calcium phosphate and 
polymer ± at most possess only osteoconductivity. Some of these products are mixed 
with bone marrow aspirate ± such as OpteMx®, Vitoss®, CopiOs® and Healos® - to 
create the graft materials with the osteogenic property. It is still challenging to create 
synthetic bone grafts which can possess all of the osteoconductive, osteogenic and 
osteoinductive properties like autograft, the gold standard, without the use of the 
expensive osteogenic growth factors (e.g., BMPs, FGFs).  
As mentioned above, bone ECM is formed by Col nanofibrils deposited with nano-
HA mineral crystals. However, none of the availably synthetic bone grafts mimics this 
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nanostructure of native bone so far. These commercialized bone graft substitutes are 
all in macro- or micro-structures. Thus, developing biomimetic materials is necessary 
in order to create ideal bone graft substitutes. 
2.3 Stem cells 
2.3.1 Definition and classification 
Stem cells are generically defined DV µLPPDWXUH´ RU XQGLIIHUHQWLDWHG FHOOV WKDW DUH
capable of self-renewal or proliferation as well as differentiation into specific cell 
lineages under appropriate conditions. The classification of stem cells is still evolving. 
Stem cells can be classified into various categories depending on their potency, 
growth stage and place of existence (Table 2.9) [23-30]. The hierarchy of stem cells is 
shown in Figure 2.15 [22]. 
Table 2.9 Classification of stem cells [23-30] 
Methods of 
classification 
Categories Stem cell types 
Potency Totipotent stem 
cells 
Fertilized egg or zygote 
Pluripotent stem 
cells 
Embryonic stem cells, embryonic germ cells 
and embryonic carcinoma/cancer cells 
Multipotent stem 
cells 
Haematopoietic stem cells, bone marrow 
stromal (mesenchymal) stem cells, umbilical 
cord blood stem cells, etc. 
Unipotent stem 
cells 
Dermal stem cells, muscle stem cells, etc. 
Growth stage Embryonic stem cells 
Adult stem cells Haematopoietic stem cells, bone marrow 
stromal (mesenchymal) stem cells, neural 
stem cells, pancreatic stem cells, dermal 
(keratinocyte) stem cells, fetal cord blood 
stem cells, etc. 
Place of 
existence 
Embryonic stem cells 
Fetal stem cells 
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Umbilical cord stem cells 
Adult stem cells Haematopoietic stem cells, bone marrow 
stromal (mesenchymal) stem cells, adipose 
tissue-derived stem cells, etc. 
 
Figure 2.15 Hierarchy of stem cells: (A) Developmental hierarchy, (B) Hierarchy of adult stem cells (Reprinted 
from [22], Copyright 2011, with permission from Elsevier) 
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2.3.2 Stem cells in tissue engineering 
Tissue and organ failure is a major health problem, which can be caused by injury or 
other types of damage. In the US, the treatment of this failure accounts for 
approximately one half of the total annual expenditure in health care. Treatment 
options include transplantation (human or xenotransplantation), surgical repair, 
artificial prostheses, mechanical devices, and in a few cases, drug therapy. However, 
these methods can neither repair nor produce a long-term recovery effect on major 
damage in a truly satisfactory way [94]. 
Over the past 30 years, tissue engineering has emerged as an alternative or 
complementary approach to tissue and organ reconstruction. As firstly stated by 
Langer anG9DFDQWL WLVVXHHQJLQHHULQJ LV ³DQ LQWHUGLVFLSOLQDU\ ILHOG WKDW DSSOLHV WKH
principles of engineering and life sciences toward the development of biological 
VXEVWLWXWHVWKDWUHVWRUHPDLQWDLQRULPSURYHWLVVXHIXQFWLRQRUDZKROHRUJDQ´[95]. A 
distinctive feature of tissue engineering is to regenerate damaged tissues or organs of 
the own patient that remarkably enhance biocompatibility and biofunctionality as well 
as reduce immune rejection. Due to the great advantages, tissue engineering is often 
conceived as an ultimately ideal medical treatment [96]. The worldwide market of 
tissue engineering and regenerative medicine approached $1.5 billion in 2008, and is 
projected to grow at a 16.2% compound annual rate from 2008 through 2013, 
approaching $3.2 billion by 2013 [97]. 
Three basic tools utilized in tissue engineering today are cells, scaffolds, and growth 
factors. Although mature cells isolated from the body can be potentially used for re-
implantation into the same donor to eliminate the immune response, they are not the 
best cell sources for tissue repair. The mature cells are generally differentiated cells, 
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thus they have low proliferative ability. It is, therefore, difficult to generate a 
sufficient number of cells for tissue regeneration. Additionally, there are issues raised 
on accessibility of tissue sites where the mature cells can be harvested. Using stem 
cells can overcome these limitations. Stem cells with self-renewal and variable 
degrees of differentiation abilities offer significant potentials for replacement of 
diseased and damaged tissue areas in the body [23-30]. 
There are two main types of stem cells commonly used in tissue engineering: ESCs 
and MSCs. ESCs are isolated from the inner cell mass of a blastocyst, an early-stage 
embryo consisting of 50 ± 150 cells. They are pluripotent cells that are able to form 
tissues from all embryonic germ layers (endoderm, mesoderm, and ectoderm). ESCs 
can differentiate into cells of all tissue lineages, but not into embryonic annexes like 
zygote. However, using ESCs encounter some problems related to safety issues such 
as ESC rejection and the risk of tumorigenicity as well as ethical and religious issues 
such as the harvesting of donor oocytes and destruction of the blastocyst [23-30]. 
Meanwhile, MSCs can be readily obtained with much less controversy from many 
other sources. Additionally, autologous MSCs surmount immune rejection and 
carcinogenesis [98].  
2.3.3 Mesenchymal stem cells 
MSCs are derived from different adult (bone marrow, adipose tissue, peripheral 
blood) and neonatal tissues (particular parts of the placenta and umbilical cord) 
(Figure 2.16) [99]. They are multipotent cells capable of differentiation into 
mesoderm-derived cell lines such as adipocytes, chondrocytes, osteocytes, myocytes 
and fibroblasts. They are also able to trans-differentiate into cells representative of all 
three embryonic germ layers. Therefore, MSCs have demonstrated the ability to give 
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rise to fat, cartilage, bone, muscle, tendon, skin, hematopoietic-supporting stroma and 
neural tissues [12,18,20,31,99-103]. 
 
Figure 2.16 Sources of MSCs (Reprinted from [99], Copyright 2011, with permission from BioMed Central Ltd.) 
Since MSCs do not have any unique surface markers, the International Society have 
proposed minimal criteria to characterize these cells: (i) the ability to adhere to plastic 
surfaces in culture, (ii) fibroblast-like morphology, (iii) expression of a typical set of 
surface markers such as CD105, CD73 and CD90, (iv) lack of lineage-specific 
markers such as CD34, CD45, CD14 or CD11b, CD79D or CD19, and (v) the 
capacity to differentiate into osteoblasts, chondroblasts and adipocytes in vitro. 
CD146 and STRO-1 are surface markers used to imply self-renewing MSC-like cells 
[12,101]. 
Particular characteristics of MSCs make them interesting for tissue engineering 
purposes (Figure 2.17) [31]. They can be isolated, expanded ex vivo, and used in an 
autologous fashion which can avoid the problem of finding a compatible donor. 
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Moreover, several evidences have showed that MSCs may not be subject to allogenic 
rejection in human and animal models. However, this phenomenon, called 
immunoprivileged profile, is still controversial and needs to be further investigated.  
In bone tissue engineering, bone marrow aspirate containing MSCs is applied to 
enhance bone growth and repair. Since the number of MSCs in bone marrow aspirates 
is very low, one proposal is to concentrate them by a closed centrifugation system 
prior to implantation with bone graft substitutes. MSCs can be also isolated from bone 
marrow and expanded ex vivo before homing to the body. Another proposal is to 
expand and then differentiate MSCs in vitro before implantation. A medium with the 
presence of osteogenic stimuli including Dex ȕ-glycerophosphate ȕ-GP) and 
ascorbic acid are usually applied to differentiate MSCs into osteoblasts in vitro 
[12,18,20,31,99-103]. 




Figure 2.17 MSCs: isolation, multipotential differentiation and other favorable characteristics (Reprinted from 
[31], Copyright 2010, with permission from Elsevier) 
2.4 Stem cell response to biomaterial topography 
In the body, almost all tissue cells reside in a 3D environment where various stimuli 
cues in the surrounding fluid and ECM provide the guidance for cellular responses. 
There are different cues which can regulate stem cell fate: (i) Chemical cues (through 
soluble supplements added into the environment); (ii) Topographical cues (surface 
geometry, size effect and dimensionality); (iii) Mechanical cues (various stress stimuli 
applied to substrate and/or cell construct); and (iv) Electrical or electromagnetic cues 
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(through application of electrical or electromagnetic currents/fields to stimulate 
substrate and/or cell construct) (Figure 2.18A). 
Currently, the most common method used to control the differentiation ability of stem 
cells is the chemical treatment such as the supply of cytokines and growth factors. 
However, it would be better to induce the stem cell differentiation without those 
soluble factors because of their noticeable disadvantages: (i) generally derived from 
animal sources, (ii) expensive, (iii) difficult to control the optimal concentration for an 
efficient differentiation without side effects, and (iv) not fully understood mechanism 
[104].  
In this section, we focus on analyzing the influence of topographical cues on 
controlling stem cell fate and guiding stem cell differentiation. Tissue-specific cell 
differentiation and its mechanism is a key question in cell biology [32]. The 
topography may play an important role in tissue-specific development through 
mechanotransductive pathways. Some studies showed that the interaction of 
topography with stem cells were enhanced in comparison with terminally 
differentiated cells [33,34]. The exquisite sensitivity of the stem cells to their 
microenvironment has provided further evidence with the importance of 
topographical environment to tissue-specific differentiation. 
As shown in Figure 2.18B, topographical cues include surface geometry (smooth/flat, 
groove/ridge, pit/pore, and disordered/ordered structure), size (from macro-, micro- to 
nanoscale), and dimensionality (2D vs. 3D). Understanding these issues plays an 
important role in designing suitable scaffolds for tissue regeneration. 




Figure 2.18 (A) Various cues regulating stem cell fates: chemical, topographical, chemical and electrical or 
electromagnetic cues; and (B) There domains of topographical cues: surface geometry, size and dimensionality. 
2.4.1 Surface geometry 
With numerous numbers of biomaterials applied in research and medical treatment up 
to now, many types of surface geometry have been recognized. The substrate 
geometry has significantly affected the morphology and orientation of stem cells. 
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Compared to substrates patterned with hexagonal posts, the ones with square posts 
were shown to be more influential in directing the orientation of MSCs [105]. Several 
studies have shown that on substrates with aligned patterns (nano-grooves, micro-
grooves and aligned nanofibers), MSCs were elongated and aligned along the patterns 
as indicated by focal adhesions and actin cytoskeleton network [106-114]. 
Meanwhile, MSCs on non-aligned patterns presented different morphologies such as a 
square-localized distribution of D-tubulin/actin fibers on nano-grid patterns [109], a 
random orientation and clump formation on unpatterned and 5Pm-deep micro-pitted 
films [110], and spreading on a flat surface [111]. Using biocompatible shape-
memory surfaces, Le et al. demonstrated a switch of MSCs morphology from a highly 
aligned to a stellate shape in response to a surface transformation between a channel 
array and a planar surface [115]. Not only cell body shapes, but the nuclei of MSCs 
were also dramatically changed in interaction with the nano-grooves [116]. The nuclei 
were aligned with the cytoskeleton and elongated parallel to the nano-grafting. By 
observing dynamic behaviours of living MSCs, Fujita et al. indicated that the 
retracting phase of cell protrusions played an important role in cell alignment [107]. 
Cell protrusions perpendicular to the nano-grooves demonstrated a trend towards 
retraction more rapid than those parallel to the pattern. Meanwhile, the filopodia 
probing phase did not cause significant influence on cell alignment. 
Choosing suitable surface geometry has been reported to regulate the differentiation 
ability of stem cells in the presence of soluble differentiation inducers. Compared to 
MSCs on smooth scaffolds (TCPS plates, smooth surfaces, and 3D smooth scaffolds), 
the cells on unsmooth scaffolds such as micro-patterned pNIPAM films (channels 
with 10Pm groove width, 2Pm ridge width and 20Pm depth) [35], 3D texture PDMS 
scaffolds with 10Pm diameter/height posts [41], and PCL nanofibers [42] showed 
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higher osteogenic differentiation ability through higher specific ALP activity, OPN 
and OCN expressions, and calcium phosphate mineralization. Similarly, highly 
porous nanofibrous PLLA was shown to be an excellent candidate scaffold for 
osteochondral defect repair (cartilage/bone composite) [117]. The calcium deposition 
and the gene expression of early chondrogenic commitment marker Sox-9 were 
higher on these scaffolds than on smooth films. Aligned nanofibrous meshes were 
demonstrated to increase the differentiation abilities of stem cells in comparison with 
random nanofibrous meshes. The extent of mineralization of MSCs was enhanced in 
the osteogenic differentiation [113]. Additionally, in the neuronal differentiation of 
MSCs or neuron stem cells under the presence of nerve growth factor (NGF) or 
retinoic acid, aligned nanofibrous meshes obviously increased the elongation along 
the major fibrous axis as well as the expression of neuronal markers (such as 
microtubule-associated  protein 2 (MAP2)) [32,118].  
Surface geometry has not only regulated the differentiation in the presence of soluble 
differentiation supplements, but also has been able to direct the differentiation of stem 
cells without those factors.  The importance of topography to directing the osteogenic 
differentiation of MSCs was obviously shown in the study of Grazino et al. [38]. 
MSCs cultured on substrates enriched with pits or microcavities (80-120Pm in 
diameter and 40-100Pm in depth) expressed higher ALP activity as well as released 
larger amounts of BMP-2 and VEGF into the culture medium than on the smooth 
scaffolds. When transplanted into rats, this type of scaffold elicited superior bone 
formation. In another study, Jang et al. showed that micro-grooved surfaces preferred 
the MSC differentiation into smooth muscle-like cells, whereas flat substrates 
provided a suitable environment for the differentiation into osteo-related cells [119]. 
The neuronal differentiation was able to be induced by nanostructured scaffolds [104]. 
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The 350-nm ridge/groove patterned arrays alone could effectively and rapidly induce 
the neuronal differentiation of ESCs without any soluble inducers. The cells were 
positive for neuronal markers such as Tuj1, HuC/D and MAP2 on the 5th day.  
To clarify the role of surface geometry in directing osteogenic differentiation, MSCs 
cultured on nanoscale topographies (pitted surfaces and raised islands) were compared 
with the cells treated with Dex [120]. Interestingly, the efficiency of bone formation 
on the nano-topographies was similar to that with Dex. Additionally, unlike treated 
with Dex, the cells on the nanoscale substrates did not suppress the angiogenesis 
which is important to supplying nutrients to new tissues. As such, by altering the 
matrix shape, a similar cellular response to chemical stimulation can be achieved, 
maybe by a different mechanism. MSCs treated with Dex performed wide-ranging 
and unspecific actions including a large number of canonical and functional pathways 
stimulated. Meanwhile, the nanotopography was more selective in the canonical 
pathways affected. Dalby et al. also showed that the nanoscale disorder of PMMA 
embossed with 120-nm-diameter, 100-nm-deep nanopits over 1 cm2 stimulate MSCs 
to produce bone minerals in vitro in the absence of osteogenic inducers [121]. This 
approach had a similar efficiency to that of the cells cultured in osteogenic media, but 
in a distinct differentiation profile. 
In the neuronal differentiation, interestingly, MSCs cultured on aligned 
nanofibers/nano-graftings without NGF/retinoic acid also indicated much higher 
elongation levels than random nanofibers/unpatterned surfaces with those chemical 
cues [122]. In addition, without the soluble cues, the aligned nanofibers was shown to 
be sufficient to drive the activation of canonical Wnt signaling which is crucial for the 
neurogenesis of stem cells [118]. These evidences demonstrated that the 
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topographical cues were important to allowing stem cells to differentiate into neuron 
cells. 
The ability of surface geometry to dictate selective differentiation may be derived 
from its influence on cell morphology. MSCs cultured on hydrogels with lamellar or 
hexagonal surface wrinkles in the same media (1:1 adipogenic induction: osteogenic 
media) exhibited different morphologies [123]. The cells on the lamellar wrinkles 
spread following the shape of the pattern, whereas the cells on the hexagonal wrinkles 
remained rounded with low spreading. As a result, the osteogenic differentiation was 
observed on the lamellar pattern, while the adipogenic differentiation was obtained on 
the hexagonal pattern. 
The changes in the gene expression of stem cells on a specific topography leading to 
targeted differentiation might be caused by nuclear deformation and focal contacts 
[123,124]. It has been hypothesized that stem cells can recognize several focal 
adhesion points on the surface. The changes in focal adhesions can lead to changes in 
cytoskeletal organization [125]. In recent years, there have been increasing evidences 
which indicate filopodia (or microspikes) as a crucial factor to contact guidance 
[108,126]. Filopodia are driven by actin cytoskeleton and forming integrin-containing 
adhesions. The cells use filopodia in response to nanotopography for the specific 
activation of adhesion and cytoskeleton-related pathways [34]. The guidance of 
filopodia by nanotopography may alter mechanical forces within the cells which can 
affect the interphase nucleus organization and genomic regulation [127,128]. Further 
studies should be done to clarify the intermediate steps connecting intracellular 
structural changes and signaling pathways in response to external topographical cues. 




In addition to topographical properties which play an important role in cellular 
functions, the topographical size also affects stem cell fate. The morphology of stem 
cells has been shown to be controlled by the size of the topography. In comparison 
with MSCs on conventional coarse grained surface, the cells on refine grained surface 
enhanced the attachment and spreading in the initial stages (up to 24 hr) [129]. MSCs 
cultured on nanofibrous scaffolds also attached and spread more rapidly than on 
microfibrous PCL [50]. On microfibers, MSCs were more globular with less cell 
spreading, whereas the cells on nanofibers were significantly flattened and spread. 
Similarly, neuron stem cells on random nanofibrous matrix with 283 nm diameter 
stretched multi-directionally, whereas the cells on larger fibers (749 and 1452 nm) 
extended along a single fibrous axis [130].  
In the nanoscale of less than 100 nm, when the diameters of vertically oriented TiO2 
nanotubes increased from 15 to 100nm, the morphology of MSCs cultured in the 
medium with or without osteogenic supplements was dramatically changed [131,132]. 
With the diameters smaller than 30nm, the cells were somewhat flat and rounded, and 
they became progressively elongated as the diameters were increased to 50nm or 
beyond. Extraordinary elongation was found on the nanotubes with 70 and 100nm 
diameters. 
2.4.2.1 Influence on stem cell differentiation in the presence of soluble 
differentiation inducers 
The topographical size has shown its role in modulating the differentiation of stem 
cells in the presence of soluble differentiation agents. HA granules calcified from red 
algae, varying in grain sizes (10-100, 200-500 and 600-1000Pm), were found to affect 
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the osteogenic potential of MSCs [36]. The cells grown on the smallest grain size had 
significantly higher ALP activity than on the others. In the presence of retinoic acid, 
MSCs cultured on nano-grafting of 350nm width showed higher expression of 
neuronal markers than on micro-patterns [122]. 
Normally, the influence of size on stem cell behaviours is non-linear. Titania surfaces 
with different grain sizes (50, 200 and 1500nm) were used to culture MSCs in the Ost 
medium (containing Dex, ascorbic acid and glycerol phosphate) [133]. Almost no 
osteogenic differentiation was detected on 50nm substrates.  Meanwhile, on the 
200nm grain size titania, the cells differentiated earlier with greater extent than on 
either 50 or 1500nm substrates, as evidenced by ALP activity and calcium content. 
Similarly, it was also shown that nanofibers  with 480nm diameter yielded the highest 
fraction of Tuj1+ cells for the neuronal differentiation of neuron stem cells compared 
to nanofibers with the diameters of 260 and 930nm [32].  
Many studies have shown the influence of porosity on the differentiation of stem 
cells. The cells cultured on HA ceramics in the presence of Dex after 2 weeks showed 
higher ALP activity and OCN protein than those without Dex, and osteogenic ability 
increased with increasing porosity (from 30% to 70%) [134]. The higher osteogenic 
abilities were observed on the higher porosity constructs might be due to their high 
pore interconnection. In other studies, the significantly higher chondrogenic 
differentiation was also found on scaffolds with larger pore sizes (370-400Pm 
compared to 90-320 Pm, microscale compared to nanoscale) [135,136]. One possible 
reason was that the higher permeability of oxygen into the scaffolds resulted in higher 
oxygen tension which can increase the chondrogenesis in vitro. Additionally, the 
larger pore sizes could promote cell aggregation and cell-cell contact which are 
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necessary for chondrogenesis. Although some other studies showed that the porosity 
(25-75%) and pore size (150-710Pm) did not affect the osteogenic differentiation of 
MSCs, suitable values of those factors are significantly important because their roles 
in facilitating blood vessel development for oxygen/nutrients supplies and tissue 
ingrowth in vivo [137,138]. 
2.4.2.2 Influence on stem cell differentiation in the absence of soluble 
differentiation inducers 
In the absence of soluble differentiation inducers, topographical size has played an 
important role in directing stem cells to a certain targeted lineage. The grooved 
topographies of identical groove depths with different widths (10, 25 and 100Pm) 
were used to investigate the influence of groove width on osteogenic differentiation of 
MSCs [39]. 100Pm grooved/ridge arrays were found to induce the up-regulation of 
genes related to skeletal development and increase osteospecific function, which were 
not indicated by 10Pm grooved/ridge arrays. Similarly, on 100Pm-wide grooved 
substrates, STRO-1+ skeletal stem cells were stimulated to differentiation into 
osteoblasts through the up-regulation of osteospecific genes, Ets and Stat1[139]. On 
the contrary, the cells on the 10Pm-wide grooved substrates induced the upregulation 
of peroxisome proliferator-activated receptor J (PPARJ) which acts sequentially to 
trigger the differentiation into adipocytes. The ability of topographical size to control 
the differentiation of stem cells may be explained through a phenomenon called 
contact guidance. Reducing cellular spreading and focal adhesion formation 10Pm-
wide grooved substrates on may induce the adipocyte differentiation; while increasing 
cell spreading on 100Pm-wide grooved substrates may induce the osteogenic function 
[139]. 
Chapter 2 ² Literature Review  
 67 
 
MSCs on nanopillar surfaces (approximately 20nm in diameter) had up-regulated 
osteogenic specific matrix components compared to micropillar surfaces [43]. The 
role of nanotopography in controlling stem cell fate has been discussed in many 
previous literatures [140,141]. The nanofibers were more effective in promoting cell 
spreading might be due to the fact that integrins on the cell surface engaged with 
proper adhesion proteins on the matrix and transformed to a spread configuration 
[142-144]. Another possibility was that the protein conformation on the nanofibers 
might be more favorable for cell-matrix interaction [50]. Additionally, the large-
surface-to-volume ratio of nanostructures could promote the adsorption of serum 
proteins, provide more binding sites for receptors, and thus enhance cellular functions 
[47]. It was also claimed that the disordered nanotopography of random circular 
nanostructures induced changes in the adhesion formations and cell morphology 
affecting cytoskeleton tension and mechanotransductive pathways which could induce 
and direct the osteogenic differentiation of osteoprogenitor cells [121]. 
The changes in cell morphology might be a reason resulting in the significant 
induction of osteogenic differentiation MSCs on vertically oriented TiO2 nanotubes 
with 100nm diameter [132]. The cells on these tubes were extraordinarily more 
elongated than on 30nm-diameter nanotubes. This elongated morphology might cause 
cellular cytoskeletal tension and stress on MSCs. Another explanation was that on the 
larger diameters, because of the reduced cell adhesion and proliferation, much less 
ECM aggregates were induced. As a result, the cells were forced to elongate and 
stretch to search for protein aggregates and thus guided/forced to specifically 
differentiate into osteoblast cells. It was shown that when the stem cells were stressed, 
the osteogenic differentiation was enhanced [121,145,146]. This suggested 
mechanism agreed to the general notion that when the stem cells were busy with the 
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adhesion and proliferation, their functions were expected to be reduced [147,148], and 
when the stem cells were stressed, they had a tendency to differentiate to a specific 
lineage to accommodate the stress. 
The oppose results and a different proposed mechanism was shown in the study of 
Park et al. [131]. It was hypothesized that the maximum cellular activity on 15nm-
diameter nanotubes might be due to the fact that this scale is comparable to the 
integrin size [131,149]. Using electron micrographic imaging of individual integrin 
molecules, the predicted size of surface occupancy by the head of an integrin 
heterodimer was about 10nm in diameter [150]. Cell-matrix interactions are mostly 
mediated by integrin. The adhesion of cells to ECM causes clustering of integrins into 
focal adhesion complexes, and consequently activates intracellular signaling cascades 
into the nucleus and cytoskeleton [151,152]. As such, the 15nm spacing would allow 
or force the integrin clustering into the possible closet packing which could lead to 
optimum integrin activation. The dramatically reduced cellular activity on 100nm 
nanotubes might be caused by the prevention of integrin clustering and focal adhesion 
complex formation [131]. These were different from the findings of Oh et al. [132]. 
However, it is noted that the medium used for culturing MSCs in these two studies 
were different. Park et al. supplemented osteogenic inducers in the medium, whereas 
a normal medium without any osteogenic inducer was used by Oh et al. As such, the 
presence of osteogenic inducers might cause different responses of MSCs to nanotube 
diameters. Further studies should be done to investigate this phenomenon.  
2.4.3 Dimensionality  
Up to now, most studies have been performed on 2D scaffolds such as TCPS plates or 
other 2D substrates because of their convenient handling and analyzing [153,154]. 
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However, almost all tissue cells reside in a 3D environment in the body. The lack of 
structural cues in 2D cultures have forced cells to adapt to flat surfaces which can 
cause alterations and reduce cellular functions [154-157]. So, developing 3D scaffold 
and studying cellular responses to the 3D culture play key roles in tissue engineering. 
ESCs and MSCs could be expanded and maintained in their undifferentiated state in 
3D scaffolds for at least 20 days without subculturing as indicated by surface markers 
[158-160]. While MSCs grown on 2D surfaces (TCPS plates) had a higher initial rate 
and stopped their proliferation as the confluence reached (approximately on day 15), 
the cells in porous 3D polyethylene terephthalate (PET) matrix grew at a stable and 
lower rate, but lasted for a longer time and reached a higher final cell number 
[160,161]. Other 3D scaffolds also demonstrated greater cell numbers than TCPS 
plates [138,162-164]. During cell culture, MSCs formed connections with 
surrounding porous matrix leading to 3D aggregates [165]. A bioreactor perfusion 
system has been often used to culture 3D scaffolds for promoting the culture of stem 
cells. The attachment and proliferation of cardiac stem cells in 3D Col-PGA 
(nanoscale in fibrous diameter and microscale in pore size) were significantly 
enhanced by the bioreactor system compared to 3D static and 2D systems [166]. 
After 3 weeks of culture in the Ost medium, ESCs in 3D porous PLGA had 
significantly higher expressions of ALP and OCN than those on TCPS plates coated 
with gelatin (2D control) [37]. The constructs were subsequently implanted in rabbits 
and the new bone formation was detected at the implantation site after 4 weeks. In the 
3D self-assembling peptide scaffold, ESCs also significantly promoted the 
differentiation into osteoblast-like cells in comparison with 2D scaffolds (TCPS 
plates) as evidenced by higher levels of ALP, Col I marker, OPN and calcium 
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phosphate deposits [167]. Similarly, culturing MSCs in a 3D fibrous network formed 
by self-assembly of peptide-amphiphile (PA) molecules led to higher expressions of 
ALP and OCN than on TCPS plates [162,163]. In the presence of TGF-ȕFRPSDUHG
to ESCs grown on TCPS plates coated with gelatin (2D substrates), the cells in 
poly(ethylene glycol)-based (PEG) hydrogels upregulated the expression of cartilage-
relevant markers [168]. In these 3D scaffolds, decreasing levels of ectodermal and 
endodermal cell lineage markers suggested that the ability of ESCs to differentiate 
into different lineages might be limited after the chondrogenic differentiation. 3D Col-
coated-PLGA scaffolds were used for the hepatocyte differentiation of MSCs [169]. 
Most hepatocyte-specific markers [albumin (ALB), D-fetoprotein, cytokeratin 18, 
hepatocyte nuclear factor 4D, and cytochrome P450] of MSCs cultured in the 3D 
scaffolds were expressed one week earlier than those on TCPS plates. As such, the 3D 
Col-coated-PLGA scaffolds provided a suitable environment for the hepatocyte of 
MSCs. Many other studies have shown the importance of 3D scaffolds to improving 
the differentiation of ESCs into hepatocytes [170-172]. 3D fibrous matrices were also 
used for the hematopoietic differentiation of ESCs [158]. The cells in the 3D matrix 
had higher expression of c-kit, a cell surface marker of hematopoietic progenitor, 
suggesting a better-directed hematopoietic differentiation than those on TCPS plates. 
3D MSCs/biphasic calcium phosphate (BCP) constructs were formed after a few days 
of culturing MSCs with BCP particles (140-200Pm) [40]. In proliferative medium, the 
3D constructs expressed much more BSP and BMP-2 than the cells on TCPS plates. 
As such, BCP particles alone could induce the osteogenic differentiation of MSCs 
which is useful for in vivo conditions. However, the osteogenic ability of the 3D 
constructs was slightly lower than 2D cultures in the Ost medium8VLQJSRURXVȕ-
TCP matrix helped to significantly increase the osteogenic potential of adipose-
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derived stem cells (ASCs) [173]. The cells cultured in this 3D scaffold in proliferative 
medium had considerably higher ALP, OPN and OCN expression than on TCPS 
plates in differentiation meGLXP$VVXFKȕ-TCP matrices showed their efficiency in 
triggering the differentiation of ASCs towards osteoblastic lineage without the need 
for differentiative media.  
Due to larger surface provided by the interconnected pores and the 3D nature of the 
constructs, 3D scaffolds had a more significant growth potential than 2D surfaces, 
which is important to long-term culture of stem cells [138,160]. A 3D culture system 
had many advantages over conventional 2D system. This architecture closely mimics 
tissue architecture in vivo. Also, in comparison with 2D environments, 3D 
environments provide another dimension for cell adhesion and external mechanical 
inputs. The enhancement in cell adhesion remarkably affects cell contraction, integrin 
ligation and related intracellular signals [174,175]. 3D matrices also provide an 
optimal template for cell-cell communication and cell migration within a 3D space 
[37]. Cell-cell and cell-matrix interactions are important to regulating many cell 
signaling pathways to efficiently promote tissue development [176]. As such, 
engineered 3D structures might give appropriate structured patterns  to cells leading to 
the correct ECM organization and the increase of their proliferation and 
differentiation abilities [177,178]. 
To guide tissue growth in well-defined configurations, it is necessary to fabricate 3D 
scaffolds with hierarchical geometrical resolutions. With well-designed, this structure 
can promote particular biological responses solely through selective physical stimuli 
without destabilizing surrounding delicate biochemical environment, and 
consequently can enhance and direct specific cell behaviours and tissue growth [41]. 
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3D scaffolds with bi-modal pore size distributions (small and large pore sizes) might 
also be ideal scaffolds for tissue engineering with enhanced cellular responses and 
vascularization [179,180].  
Taken together, different aspects of biomaterial topography including surface 
geometry, size and dimensionality showed their significant importance to controlling 
stem cell behaviours such as morphology, proliferation and differentiation. The 
biomaterial topography not only can modulate the cell differentiation in the presence 
of soluble differentiation agents, but also can induce the differentiation in the absence 
of those factors. As such, understanding the responses of stem cells to biomaterial 
WRSRJUDSK\FDQSURYLGHDYDOXDEOHJXLGDQFHWRGHVLJQ³VPDUW´ELRPDWHULDOVZKLFKDUH
able to direct the tissue-specific differentiation for stem cells. Based on the above 
findings, the development of unsmooth scaffolds (especially aligned patterns) with 3D 
nanostructure might bring novel impacts on directing stem cells fate due to the 
integration of the advantages of unsmooth pattern, nanostructure and 3D environment. 
2.5 Fabrication techniques of nanofibers 
As mentioned above, nanostructure is important to controlling stem cell behaviours. 
Among nanostructures, nanofibers are in much interest as they mimic the structure of 
Col fibrils in native ECM. With the development of nanotechnology, during the past 
two decades, there have been a significantly increasing number of studies on 
nanofibers and their applications. The International Standards Organization (ISO) 
considers nanomaterials to be materials that are typically but not exclusively below 
100 nm in at least one dimension. However, in informal nonwovens, textile, and other 
engineered fibers industries, it has been well accepted that nanofibers are fibers with 
diameters smaller than 1000 nm [181]. In 1992, carbon nanofibers were discovered to 
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grow spontaneously by deposition from carbon vapour [182]. After that, many other 
techniques have been developed to fabricate nanofibers such as electrospinning, self-
assembly, phase separation, interfacial polymerization, rapidly-initiated 
polymerization, template- or patterned assisted growth, vapor-liquid-solid growth and 
hydrothermal synthesis, etc. Among them, electrospinning [51,52], self-assembly 
[53,54] and phase separation [55,56] are the most common techniques to fabricate 
polymeric nanofibers for biomedical applications. 
2.5.1 Electrospinning 
Electrospinning is a technique using electrostatic forces to fabricate nanofibers. When 
a high voltage is applied to the droplet of a solution, the molecules of the solution 
becomes charged and an electrostatic repulsion occurs, which counteracts the surface 
tension of the droplet. When the high voltage increases to a critical point, a jet of the 
solution is erupted from the surface. As the solvent evaporates, further stretching of 
the charged jet under the electrostatic forces will push it into a bending instability 
stage. The elongation and thinning of the charged jet due to this instability lead to the 
formation of continuous fibers with diameters in the nano-scale. Based on this 
principle, different electrospinning setups as well as different types of collectors have 
been designed to create various nanofibrous architectures [51,52]. A typical 
electrospinning setup is shown in Figure 2.19. Figures 2.20A ± D indicate some 
examples of different nanofibrous patterns fabricated by electrospinning. 




Figure 2.19 Typical electrospinning setup 
 
Figure 2.20 Representative  SEM images of nanofibers fabricated by different techniques: (A) Random nanofibers 
fabricated by electrospinning, (B) Aligned nanofibers fabricated by electrospinning (Adapted from [183], 
Copyright 2009, with permission from Springer), (C) Porous nanofibers fabricated by electrospinning (Adapted 
from [184], Copyright 2001, with permission from John Wiley and Sons), (D) Nanofibrous yarn fabricated by 
electrospinning, (E) Nanofibers fabricated by self-assembly (Adapted from [185], Copyright 2008, with 
permission from Elsevier), and (F) Nanofibers fabricated by thermally induced liquid ± liquid phase separation 
(Adapted from [186], Copyright 2007, with permission from Elsevier) 
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Properties such as the surface tension, viscosity and density of net charges of the 
polymeric jet highly influenced the morphology of the fibers. Solution concentration 
is considered a major factor that affects the fiber size, and fiber diameter increase with 
increasing solution concentration [187]. The morphology of fibers has a strong 
correlation to solution viscosity as well the solution concentration and temperature 
[188]. Lower diameter fibers were prepared by electrospinning of PLA with tetraethyl 
benzylammonium chloride (TEBAC), whereby TEBAC increased the surface tension 
and electrical conductivity of the solution. Electrically induced double layer in 
combination with the polyelectrolytic nature of solution was also anticipated as a 
method for formation of high aspect ratio polyamide-6 nanofibers with diameters as 
small as 9-28 nm [189]. In many cases, randomly oriented fibers are deposited on a 
flat collector plate forming a non-woven mat of fibers. Another approach commonly 
applied is using a spinneret containing two needles to produce composite nanofibers 
[190]. Moreover, many different types of molecules can be incorporated into the 
fibers and a wide range of polymers are electrospun in varying fiber diameters 
ranging from <100 nm to micrometer levels using electrospinning. Controlled fiber 
deposition techniques are also applied for the fabrication of aligned nanofibers, on a 
rotation drum or a rotating rim. Using a collector designed of two conductive strips 
separated by a void gap of desired width, uniaxially aligned nanofibers were produced 
too. The alignment of the fibers could induce cell elongation and reorganize the 
cytoskeletal structures that regulate the cell adhesion and morphology. However, 
electrospinning has limitations of low productivity, as solutions are usually fed at a 
low rate so as to produce fibers of low diameter. 
Various structural variations of the nanofibers include careful design of core-shell 
nanofibers, porous surface scaffolds or even multilayered fiber structures. Electrospun 
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nanofibers of these architectures can act as drug delivery reservoirs for controlled and 
timely release of drugs, proteins, antioxidants and other molecules to the site of tissue 
UHSDLU7KHXVHRIPROWHQSRO\PHUVWRSURGXFHHOHFWURVSXQPDWV LQWURGXFHGDVµmelt 
HOHFWURVSLQQLQJ¶LVDQHQYLURQPHQWDOO\EHQLJQSURFHVVVLQFHLW LPSOLHVDVROYHQWIUHH
approach [191]. Cellular infiltration within the electrospun scaffold remains a great 
challenge and methods such as cell electrospraying are also concurrently performed 
during the fabrication of a vascular conduit [192]. 
Benefits of electrospinning technique are plenty, but challenges of obtaining a three 
dimensional scaffold by electrospinning still remains a field of exploration. 
Nanofibrous and microfibrous 3D scaffolds of desired shape and size are more 
preferred as implantable materials compared to the electrospun 2D scaffolds. 
Compared to electrospinning, the major advantage of self assembly is that it can 
produce fine nanofibers smaller than 10 nm and these nanofibers could be applied as 
injectable scaffolds for tissue regeneration. Pore sizes of 5-200 nm are insufficient for 
cell migration and proliferation [193]. In this respective, electrospinning has a 
drawback of incapability to control the pore size and porous structure of the scaffolds. 
The challenge to integrate nanofibers into useful devices requires well-controlled 
orient, size, and other target characteristics of the nanofibers.  
2.5.2 Self assembly 
Self assembly is a bottom-up process in which small molecules spontaneously 
assemble into well-ordered nanofibers (Figure 2.20E) [185]. The formation of this 
structure is induced by many interactions, including chiral dipole± dipole interactions, 
S-S stacking, hydrogen bonds, nonspecific van der Waals interactions, hydrophobic 
forces, electrostatic interactions, and repulsive steric forces [53]. Normally, the basic 
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molecules to fabricate nanofibers using this technique are PAs. They consist of a 
dialkyl chain moiety (hydrophobic component/tail group) attached to an N-alpha 
amino group of a peptide chain (hydrophilic component/head group) [54]. The 
peptides can be self-assembled by many reagents such as acid, divalent ion, and 
covalent capture, etc [53]. 
Bioactive sequences were introduced within PA with formation of the triple helix 
structure by Malkar et al. and it demonstrated much similarity to the native self-
assembled triple helix of the ECM [194]. The self assembly of PAs into nanofibers 
was developed by engineering of the peptide head group of the PA by the controlling 
the pH of the solution [195]. In such a way, nanofibers of 5-8 nm in diameter with 
several micron lengths were developed by these researchers and it was investigated 
for mineralization potential, with application as primary building block for bone 
regeneration. With advances in this field, even the osteogenic differentiation of MSCs 
was possible in self-assembled PA nanofibers containing RGD peptide sequences 
[162]. Other methods for formation of self-assembled PAs include divalent ion 
induced self-assembly and drying on surface induced self-assembly [53]. Moreover, 
PAs can be self assembled reversibly into nanofibers and hence it could be applied for 
versatile material fabrications. It produced nanofibers in high yield with low 
polydispersity, enabling further exploration of this method for dHYHORSLQJ µVPDUW¶
biomaterial scaffolds for effective tissue regeneration.  
2.5.3 Phase separation 
Thermally induced phase separation was commonly employed during the early days 
to produce porous polymeric scaffolds (Figure 2.20F) [186].  The method was 
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biodegradable polymers by Ma et al. (1999) [55]. Scaffolds with porous structure and 
interconnected spaces are greatly suitable for implantations, mainly because the 
continuous fibrous network provide interconnecting mechanical support for cell 
attachment, proliferation and migration [196]. There are five basic steps in this 
technique: i) polymer dissolution, ii) phase separation and gelation, iii) solvent 
extraction from the gel with water, iv) freezing, and v) freeze-drying under vacuum. 
The selection of proper solvent is considered as one of the most critical steps of 
nanofibrous structure formation during this process. The formation of the nanofibrous 
structure is postulated to be caused by spinodal liquid±liquid phase separation of the 
polymer solutions and consequential crystallization of the polymer rich phase. The 
method does not require specialized instruments and it also allows for batch to batch 
consistency, while the architecture and scaffold properties can be controlled easily by 
varying the polymer concentration, gelation temperature/time, solvent, and freezing 
temperature [55,56]. Macroporosity was another feature that could be obtained within 
these scaffolds by incorporating porogens such as salt or sugars into the polymer 
solution during the phase separation process [55]. Such 3D macroporous structures 
are advantageous to the cells to absorb nutrients, receive signals and to discard 
wastes. The presence of both nano and macro structures at the nanofiber level provide 
additional benefits to cell distribution and response [56]. 
Table 2.10 summarizes the advantages and disadvantages of the fabrication methods 
mentioned above. 
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Electrospinning x Nanofibers are long and 
continuous. 
x Nanofibrous diameters are quite 
uniform, and it is able to fabricate 
a wide range of diameters 
x Flexibility in material selection 
x Able to create various architectures 
x Able to form bulk structure 
x Small pore size 
x Difficult to produce 
uniform fibers with 
diameters less than 50nm 
Self-assembly x Easy to modify and functionalize 
nanofibers 
x Difficult to obtain bulk 
structure 
x Low mechanical strength 
x Limited in material 
selection 
x Only can fabricate random 




x Easy to form bulk structure 
x Large pore size with well-defined 
structure 
x Limited in material 
selection 
x Only can fabricate random 
and short nanofibers 
2.6 The importance of nanofibers in tissue engineering 
2.6.1 Current challenges in tissue engineering 
Although tissue-engineered products have been applied to patients, their clinical 
applications are still very limited. There are many challenges to overcome before the 
translation of scientific discoveries into treatments for millions of patients: (a) risk of 
rejection [197,198], (b) vascularization of tissue-engineered constructs [94,197,198], 
(c) lack of proper mechanical properties [96], (d) scaffolds able to degrade in response 
to remodeling progress [197], (e) quality control of materials [94], (f) fundamental 
understanding of tissue differentiation mechanisms [94], (g) enhancement of 
production scale [198], (h) storage and preservation of tissue constructs [197,198], (i) 
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translation of successful animal studies to humans [197] and (j) lack of verifiable 
clinical data [198]. Among them, the risk of rejection of tissue-engineered constructs 
is a major challenge today. The inflammatory response can lead into fibrous capsule 
development which will inhibit tissue remodeling by limiting nutrient transport and 
angiogenesis [199]. The importance of nanofibers to reducing the inflammatory 
response and inducing fast regeneration of native tissues will be demonstrated in the 
following sections. 
2.6.2 Novel characteristics of nanofibers in medical applications 
Collagens are the most abundant protein in the ECM of many tissues in the body such 
as the bone, skin and nerve, etc. They are present as nanofibrillar proteins with 
diameters in the range of 50 ± 500 nm. ECM has several functions such as providing 
biomechanical strength to the tissue, serving as a biological scaffold for cells to 
adhere/migrate, serving as an anchor for several proteins and regulating the phenotype 
of cells [200]. Among existing biomaterial structures, nanofibrous scaffolds can create 
cellular environments mimicking the nanoscale structure with complexity of the 
ECM. As opposed to flat surfaces, the attachment of various cell types such as the 
smooth muscle cells, adipose stem cells and fibroblasts was at a rate of 50-150% 
higher on the nanofibers (in 15 min - 8 hr period) [201-203]. It has been hypothesized 
WKDW WKH ERG\ FDQ UHFRJQL]H WKH ELRPLPHWLF QDQRILEURXV VFDIIROGV DV ³VHOI´ DQG
therefore, all of the intercellular and intracellular responses can be mimicked which 
help to stimulate the healing and the regeneration of tissues and organs [44-46]. 
Smartly designed tissue engineered scaffolds are even capable of promoting an 
organized deposition of ECM products from the resident cells. In a study carried out 
by Li et al., chondrocytes seeded on electrospun fibers of 500 - 900 nm in diameter 
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produced double the amount of glycosoaminoglycan in 28 days compared to the cells 
on microfibers with the diameter of 15 µm in culture [204]. 
In addition, the topography of nanofibers can lead into changes in focal contacts 
through a phenomenon called contact guidance [47]. At the cell-matrix interface, the 
focal adhesions play an important role in linking the ECM on the outside to the actin 
cytoskeleton on the inside. The adhesion of cells to ECM causes clustering of 
integrins into focal adhesion complexes, and consequently activates intracellular 
signaling cascades into the nucleus and cytoskeleton [151,152]. Thus, the changes in 
focal adhesions can cause changes in cytoskeletal organization and integrin-
containing adhesions [125]. These components are known to drive filopodia (or 
microspikes) in response to nanotopography for the specific activation of 
cytoskeleton- and focal adhesion-related signaling pathways [205]. The elongation of 
focal adhesion plaque is associated with the cytoskeletal strengthening as well as the 
recruitment of focal adhesion-associated signaling molecules [206]. The guidance of 
filopodia by nanotopography may alter mechanical forces within the cells which can 
affect the interphase nucleus organization and genomic regulation [127,128]. 
Moreover, due to their large surface-area-to-volume ratio, nanofibers provide more 
binding sites to cell membrane receptors, promote the adsorption of serum proteins 
and change the profile of adsorbed proteins [47,48]. The adsorption of serum 
fibronectin and vitronectin, which are known to mediate cell-matrix interactions, are 
improved significantly with nanofibrous structures [49]. As such, changes in the 
amount or type of adsorbed serum proteins may provide cells with a better niche to 
enhance cellular functions. In addition, the conformation of cellular proteins on the 
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nanofibers may expose additional cryptic binding sites and be more favorable for cell-
matrix interactions [47,50]. 
The overall advantage of nanofibers over other micro- or macro-sized fibers is 
demonstrated in Figure 2.21. 
 
Figure 2.21 The advantage of nanofibers over micro- or macro-fibers. Due to high surface-to-volume ratio, 
nanofibers provide more binding sites for cell membrane receptors resulting in activating more related signaling 
pathways, and consequently faster tissue regeneration. 
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2.6.3 In vivo response to nanofibers 
To achieve a desired tissue/organ reconstruction, biomaterials should possess 
following properties: good biocompatibility, proper biodegradation, high cellular 
infiltration, high vascularization, ability to induce angiogenesis. In an in vivo 
condition, cells in distances of > 200 Pm from a blood vessel will suffer from hypoxia 
and limitation of other nutrients since this is the maximum diffusion distance [207]. 
So, angiogenesis and rapid vascularization of implants are essential for cell survival 
[208]. 
2.6.3.1 Biocompatibility and biodegradation 
A biodegradable scaffold is a material capable of degraded enzymatic hydrolysis, 
whereby non-toxic alcohols, acids or low molecular weight products are easily 
eliminated from the body. Meanwhile, a biocompatible scaffold is a material which 
elicits little or no immune response in the body and well-integrated with the targeted 
tissue/organ. To reduce the immune response, scaffolds should have non-
thrombogenic blood compatible surfaces, and should be in harmony with the cells and 
environment. The antithrombogenic properties can be induced by 
hydrophilic/hydrophobic micro domains on the material surfaces. The 
biocompatibility not only depends on the type of the polymer and functional groups, 
but also on the structure of the scaffold surface. 
Compared to thin films, nanofibrous meshes minimized host immune responses with 
the thickness of fibrous capsule decreased approximately 6 times [209]. Similarly, 
fibrous capsule was significantly reduced on nanofibrous scaffolds compared to 
microfibrous ones [210]. Electrospun polyhydroxyalkanoate (PHA) copolymers 
showed excellent biocompatibility during the course of the subcutaneous 
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implantation, with no fibrous encapsulation, mild inflammatory responses and the 
presence of thin connective tissue surrounding the scaffolds [211]. When modified 
with heparin, silk fibroin nanofibrous scaffold did not induce any neutrophil and 
lymphocyte which indicated the minor inflammation as well as no significant 
rejection of this type of scaffold [212]. Excellent biocompatibility in vivo with minor 
inflammatory reactions and biodegradation after 3 months of implantation was 
demonstrated by bi-layer PLLA/silk fibroin ± gelatin nanofibrous meshes [213]. 
Multi-layered PCL/Col nanofibrous constructs also showed good integration with 
surrounding tissues and neovascularization when implanted into nude mice [214]. 
2.6.3.2 Cell migration and infiltration 
Infiltration of cells through the polymeric scaffold is a crucial factor while utilizing 
nanofibrous scaffolds for tissue regeneration and nanofibrous structure could 
encourage migratory and remodeling behaviour in comparison to smooth surface. 
Optimally designed pore size and high porosity of electrospun scaffolds provide 
sufficient space for cell migration and it enables the exchange of nutrients between 
the scaffold and the environment.  
Periosteal cells were infiltrated when PCL nanofibers were implanted under rabbit 
periosteum with the infiltration extent increased from day 1 to day 7 [215]. A hybrid 
scaffold of electrospun poly(ester urethane)urea (PEUU) and an ECM derived 
scaffold resulted in a large cellular infiltrate compared to the PEUU alone [216]. In rat 
dermal replacement model, electrospun PLGA nanofibers achieved good cellular 
penetration, with no adverse inflammatory response and no capsule formation [217]. 
However, in a cylindrical shape with a inside diameter of 2 mm and a wall thickness 
of 200±250 Pm for the implantation into the interstitial space of the rat vastus lateralis 
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muscle, only electrospun scaffolds made from Col showed good infiltration by 
interstitial and endothelial cells and the formation of functional blood vessels within 7 
days [218]. Meanwhile, implants made from gelatin, PGA, PLA and PLGA were not 
infiltrated to any great extent and induced fibrosis. The difference might be derived 
from the chemical nature of Col which promoted cell migration and capillary 
formation. Compared to random nanofibers, aligned nanofibers were shown to 
increase cell infiltration, guide matrix organization and elicit a thinner fibrous capsule 
[209,219,220]. Increasing scaffold porosity also promoted cellular infiltration and 
angiogenesis [221]. In general, electrospun nanofibers have limited cell infiltration 
because of their small pore sizes. It could restrict the delivery of nutrients to the cells 
and waste disposal, and constrains vascularization. To overcome this problem, the 
electrospinning technique was combined with photopatterning to create multiscale 
porous scaffolds [180]. Another solution was the use of ice crystals as porogens to 
fabricate cryogenic electrospun scaffolds with large pore sizes [222]. This technique 
improved cell infiltration and vascularization compared to conventional electrospun 
scaffolds. In addition, layers of micro and nanofibers have been proposed [223], while 
methods such as salt leaching and introduction of sacrificial polymers such as PEO 
were moderately successful in fabricating stable fibers with larger pore sizes suitable 
for cell infiltration [224]. Recruitment of endothelial progenitor cells, SMCs and 
myocytes progenitor cells was achieved in vivo in a peptide nanofiber-assembled 
myocardium and the nanofibrous substrates enhanced vascularization and tissue 
regeneration [225]. Electrospun scaffolds fabricated as three dimensional structures 
VLPLODU WR D µFRWWRQ EDOO¶ PLJKW RYHUFRPH WKH FXUUHQW FKDOOHQJHV DQG KDYH JUHDW
potential in a range of tissue engineering applications. 
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2.6.3.3 Vascularization and angiogenesis 
Vascularization is the development of proliferating capillaries, while angiogenesis is 
the formation of new vessels. Angiogenesis is one of the major processes required for 
functional tissue formation. To induce the angiogenesis, nanofibers have been 
QRUPDOO\FRPELQHGZLWKLQGXFHUV,QPLFHVXSUDPROHFXODUQDQR¿EHUVIRUPHGE\VHOI-
assembly of a heparin-binding PA and heparin sulphate-like glycosaminoglycans 
revealed excellent biocompatibility and developed a new vascularized tissue which 
demonstrated an angiogenesis-promoting potential of this material [208]. When 
injected into rats, IKVAV (Isoleucine-Lysine-Valine-Alanine-Valine)-containing 
peptide nanofibers were able to induce angiogenesis as shown by formed capillary 
vessels with complete walls [226]. Chemokines induced by PDGF released from 
nanofibers enhanced the angiogenesis in vivo [227]. 
Subcutaneous injection of hepatocyte growth factor (HGF) incorporated with self 
assembled PA nanofibers to mouse sub-cutis was carried out by Hosseinkhani et al., 
and 3 weeks post-evaluation maintained their biological activities and showed 
enhanced vascularization [228]. However, robust strategies for complete integration 
and vascularization of the engineered tissue with the host tissue are apparently lacking 
after implantation of the bio-engineered grafts. Clinical studies to deliver 
vasculogenic growth factors in myocardial and peripheral limb ischemia are in its 
preliminary stages [229]. 
Taken together, with chemical and physical modifications, nanofibers have shown 
their great in vivo characteristics in biocompatibility, biodegradation, cell infiltration, 
vascularization and angiogenesis. These properties would help to accelerate their 
success in targeted applications in medical treatment. The studies of in vivo response 
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to nanofibers are significantly important and have to be taken into a serious 
consideration before the studies of functional applications (bone, cartilage, skin, 
nerve, heart, etc.) are performed, especially when a new material is introduced. The 
results of biocompatibility, biodegradation, cell infiltration, vascularisation, and 
angiogenesis studies will provide a in-depth profile of responses of in vivo 
environments (animals/humans) so that researchers can modify their scaffolds 
accordingly. The most important properties of nanofibers have to be considered 
before in vivo studies are biocompatibility, biodegradation and pore sizes. The 
biocompatibility and biodegradation normally can be determined by the chemical 
components of nanofibers.  The nanofibers should possess a suitable biodegradable 
property for tissue regeneration, but it also has to maintain an appropriate mechanical 
property to serve as a scaffold for cellular growth and differentiation. The pore size is 
a key factor of nanofibrous scaffolds which determines cell migration, infiltration and 
vascularization. To achieve a complete cell migration, infiltration and vascularization, 
the nanofibrous scaffolds should have a pore size of 100 - 200Pm. 
2.6.4 Clinical trials 
To our best knowledge, up to now, there have been few published reports on clinical 
trials of nanofibers as listed in Table 2.11. It might be due to the fact that many 
challenges as shown above are needed to be solved before moving up with clinical 
trials. For example, immense challenge remains in finding the accurate path that guide 
the axons to their target and in establishing the microenvironment to facilitate neurite 
outgrowth while utilizing nerve graft for clinical trials. Most of the trials have focused 
on skin regeneration - the easiest application, including the treatments of cutaneous 
leishmaniasis [230,231] and diabetic ulcers [232,233]. Phase III clinical trial of nitric 
oxide releasing nanofibrous patch (| ȝPRO12FP2/day for 20 days) for cutaneous 
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leishmaniasis treatment was completed [231]. Previous pre-clinical studies and 
clinical trials of this material showed that the multilayer transdermal nanofibrous 
patch fabricated by electrospinning provided a continuous and stable nitric oxide 
release when administered topically without adverse events [230]. In the phase III, 
three months after the treatment starts, although the cure rate of the nanofibrous patch 
was only 37.1% compared to 94.8% of intramuscular meglumine antimoniate 
(Glucantime, 20 mg/kg/day for 20 days), the patients treated with the nanofibers 
showed a significantly lower frequency of adverse events as well as a decreased 
variation in serum markers. Phase III clinical trial of this material for diabetic ulcer 
treatment is on-going [232]. Bioactive borate glass nanofibers are also under clinical 
trials to treat diabetic ulcers [233]. The result of phase II with twelve patients 
demonstrated that the material helped to heal venous stasis wounds in eight of the 
patients who had suffered from diabetes and not responded to other treatments. The 
nanofibers supported the migration of epidermal cells and facilitated the healing 
process. This study has been expanded and phase III clinical trial will be performed 
soon. In addition, nanofibers have been performed with clinical trials for anti-
adhesion application [234]. The biodegradable nanofibrous membrane helped body 
tissues be prevented from sticking together as they heal. Further results will be 
obtained from the phase III clinical trial. Although there are not many clinical trials, 
with novel results of nanofibers as shown in pre-clinical trials, we believe that a large 
number of human trials on nanofibers with various applications are coming soon. 
Table 2.11 Clinical trials using nanofibers 
Nanofiber-based scaffolds Applications Status References 







Nitric oxide releasing Diabetic ulcers On-going Phase [232] 
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nanofibrous patch III 
Bioactive borate glass 
nanofibers 
Diabetic ulcers Completed Phase 
II 
[233] 
Nanofibrous mesh Anti-adhesion Completed Phase 
II 
[234] 
2.7 Nanofiber-based scaffolds as bone graft substitutes 
Nanofiber-based scaffolds have demonstrated their substantial support in bone tissue 
engineering in several animal studies (Table 2.12). Electrospinning, self assembly and 
phase separation are three common methods to fabricate nanofibers for biological 
applications. Among them, electrospinning has been shown to be the most frequently 
used method. It could be due to the flexibility in material selection and scaffold 
architectures of this method. 
Table 2.12 Animal studies using nanofiber-based scaffolds 
Animal models Fabrication 
methods 
Nanofiber-based scaffolds 
Mouse Subcutaneous Electrospinning PLLA/nano-HA [235]; 
PEOT/PBT/calcium phosphate/MSC 
[236]; PCL/gelatin/nano-
HA/differentiated DPSC [237] 
  Self assembly Self-assembling PA/differentiated 
DPSC [238] 
  Phase separation PLLA/differentiated hAFSC [239] 
 Intraperitoneal Solid-phase 
procedures 
P-15 peptide/ABM/MSC [240] 
 Tibia Electrospinning PLGA/HA/BMP-2 plasmid [241,242] 




Rat Subcutaneous Electrospinning PCL/HS/differentiated MSC [245] 
  Self assembly Self-assembling PA/bFGF combined 
with Col/PGA [246] 
  Phase separation PLLA nanofibers immobilized with 
rhBMP-7 containing PLGA 
nanospheres [186] 
 Abdominal Electrospinning  PCL/differentiated MSC [247] 




 Femur Electrospinning PCL/Irradiated RGD-modified 
alginate/rhBMP-2 [248,249] 
  Self assembly Self-assembling PA with 
phosphoserine residues [250]; Self-
assembling PA/Ti [185] 
 Calvaria Electrospinning PCL nanofibrous mesh/PLGA 
membrane [251]; PLLA/DBP [252]; 
PCL/BG [253]; PCL/simvastatin 
[254]; Col/nBG/bFGF [255] 
  Phase separation PLLA [256] 
Rabbit Tibia Electrospinning PLLA [257] 
 Calvaria Electrospinning Chitosan [258]; 6LON¿EURLQ[259]; 
Silica gel [260]; SiO2±CaO gel [261]; 
PLGA/TCP [262] 
 Sterna Electrospinning PLLA/differentiated MSC [263,264] 
Cells - AFSC: amniotic fluid-derived stem cell; DPSC: dental pulp stem cell. 
Materials - ABM: anorganic bone material; DBP: demineralized bone powder; HS: glycosaminoglycan heparin 
sulphate; nBG: nano-bioactive glass; P-15 peptide: cell-binding domain of type I Col; PA: Peptide-Amphiphile; 
PBT: poly(buthylene terephthalate); PCL: poly(H-caprolactone); PEOT: poly(ethylene oxide terephthalate); PGA: 
poly(glycolic acid); PLGA: poly(lactic-co-glycolic acid); RGD: Arginine-Glycine-Aspartic Acid; Ti: titanium. 
The treatment of bone defects in mouse, rat or rabbit models have been successfully 
done using pure nanofibers made from synthetic/natural polymers such as PLLA 
[256,257], PCL [251], chitosan [258] DQG VLON ¿EURLQ [259]; or inorganic matrices 
such as bioactive glass (BG) [253] and silica gel [260]. Woo et al. showed significant 
advantages of PLLA nanofibrous scaffolds over PLLA solid-walled scaffolds in 
critical-size calvarial defects [256]. The nanofibrous implants produced substantially 
more new bone minerals, abundant Col deposition, and strong expressions of Runx2 
and BSP compared to the solid-walled implants. Especially, electrospun nanofibrous 
scaffolds have been beneficial to be employed as guided bone regeneration (GBR) 
membranes [251,257-259]. GBR is a standard procedure which uses membranes to 
protect bone defects from the ingrowth of surrounding fibrous connective tissues, and 
thus promote bone healing. The nano- to micro- pore size of nanofibrous membranes 
was shown to be efficient in preventing from fibrous connective tissue invasion, but 
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allowing growth factors, nutrients and oxygen to be penetrated into the defects, which 
led to faster bone regeneration. Not only organic matrices, nanofibers made from BG 
or silica gel also indicated good osteoconductivity in the treatment of calvarial defects 
[253,260]. 
In addition to using the pure nanofibers, nanofibers have been usually combined with 
growth factors or other osteogenic inducers such as BMPs [186,243,248,249], bFGF 
[246,255], ALP [244], demineralized bone powder (DBP) [252], HA [235,241,242] 
and TCP [262], etc. to further improve bone regeneration. Nanofibers provided a 
sustained and prolonged release of the growth factors to bone defects. The presence of 
BMP-2 in nanofiber-based scaffolds resulted in consistent bony bridging for the repair 
of critically-sized segmental bone defects [248]. Not only growth factors, but 
nanofibers also significantly contributed to bone formation. Although both scaffolds 
contain bFGF, only the scaffold with the presence of nanofibers produced a 
homogeneous bone formation [246]. In addition to growth factors, inorganic 
substances such as HA and TCP were demonstrated to be very efficient in promoting 
or even inducing bone regeneration when combined with nanofibers 
[235,241,242,262]. Self-assembling PA with phosphoserine residues showed a greater 
bone formation in rat femur than the untreated group (Figure 3) [250]. 




Figure 2.22 Representative PCT images depicting the difference in bone formation observed in rat femurs 
implanted self-assembling PA/phosphoserine residues within the defect (A-C) versus those left untreated (D-F). 
The defect with nanofibers showed greater bone formation at 4 weeks after implantation (Reprinted from [250], 
Copyright 2010, with permission from Elsevier) 
When injury or other types of damage occur in the body, stem cells are hypothesized 
to migrate to the injured sites and combine with local cells in the repair response. 
Thus, recently, stem cells have been usually incorporated into scaffolds to speed up 
tissue regeneration. The incorporation of MSCs [236,240,245,247,263,264], amniotic 
fluid-derived stem cells (AFSCs) [239] and dental pulp stem cell (DPSCs) [237,238], 
etc. into nanofibrous scaffolds helped to accelerate bone regeneration. The 
cell/scaffold composite indicated obvious in vivo hard tissue formation with a 
surrounded thin fibrous tissue capsule, and without any sign of undesired tissue 
ingrowth [237,238]. 
2.8 Summary 
Except for allograft- and rhBMP-based bone graft substitutes, the other 
commercialized substitutes ± based on calcium sulphate, calcium phosphate and 
polymer ± at most possess only osteoconductivity. Although bone ECM is formed by 
Col nanofibrils deposited with nano-HA mineral crystals, none of the availably 
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synthetic bone grafts mimics this nanostructure of native bone. These commercialized 
bone graft substitutes are all in macro- or micro-structures. Stem cells have been 
shown to be affected by biomaterial topographical cues such as surface geometry, size 
and dimensionality. Therefore, it is possible to control stem cell behaviours by 
designing proper biomimetic scaffolds. Among available methods to fabricate 
biomimetic nanofibers, electrospinning is the most popular one due to its flexibility in 
material selection and product architectures. Previous animal studies have 
demonstrated the efficacy of nanofiber-based scaffolds in bone tissue engineering. 
(Note: Some of the text and figures in this chapter have been published and reprinted 
from the following publications: (1) CRC Press. Luong TH Nguyen, Susan Liao, 
Casey K Chan and Seeram Ramakrishna. Stem Cell Response to Biomaterial 
Topography. In: Murugan Ramalingam, Seeram Ramakrishna and Serena Best, 
editors. Biomaterials and Stem Cells in Regenerative Medicine, p. 299-326, Copyright 
2012, with permission from Taylor & Francis. (2) Macromol. Mater. Eng. Luong TH 
Nguyen, Shilin Chen, Naveen Kumar Elumalai, Yun Zong, Chellappan Vijila, 
Suleyman I Allakhverdiev and Seeram Ramakrishna. Novel Biological, Chemical and 
Electronic Characteristics of Nanofibers, DOI: 10.1002/mame.201200143, Copyright 
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Chapter 3  
 The Importance of Nanofibrous Structures 
3.1 Introduction 
Adult MSCs are multi-potent cells primarily derived from bone marrow, and several 
other tissues such as brain, thymus, lungs, spleen, pancreas, liver, kidney and muscle. 
In the adult, these cells are hypothesized to migrate to the injured sites and combine 
with local cells in the repair response. MSCs possess a great therapeutic potential due 
to their ability to self-renew and differentiate into various lineages. However, the 
population of adult MSCs extracted from tissues/organs is very low. In bone marrow, 
they account for about 0.001% to 0.01% as indicated by Friedenstein et al. (1982) 
[265], or a frequency of 1 in 3.4 u 104 cells as reported by Wexler et al. (2003) [266]. 
In order to get a sufficient cell number for use in research and autologous therapeutic 
applications, a technique of serial monolayer subcultures on a plastic surface is often 
used because of its simplicity and economy.  
Nevertheless, cell behaviours may be affected significantly during long-term culture 
(serial passage) on the smooth surfaces. Bonab et al. (2006) showed that from the 
moment in vitro culture starts, MSCs began to lose their stem cell characteristics 
[267]. Rubin (1997) supposed that the constant decrease of growth rate during serial 
subculture might represent a decay of cell function [268]. Not only cell proliferation, 
differentiation potential has been changed dramatically by prolonged culture. In vitro 
and in vivo osteogenic differentiation abilities of human MSCs gradually reduced with 
serial subcultures (from passage 1 to passage 10) [267,269,270]. For other 
differentiation abilities, a study of Crisostomo et al. (2006) showed that there was no 
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improvement in functional recovery in hearts pre-treated with MSCs of passage 5, 
whereas MSCs of passage 10 caused worse myocardial function than controls [271]. 
In the neuronal differentiation in vitro, Khoo et al. (2008) found that human MSCs 
could maintain a stable phenotype during the first 6 ± 8 passages, but not for late 
passage cultures (passage 11 ± 12) [272].  
Changes in culture conditions have been studied to maintain cellular characteristics 
for prolonged cultures on the plastic surfaces. Pal et al. (2009) indicated that the 
medium in the presence of 10% FBS and growth factors (bFGF, epidermal growth 
factor (EGF), and TFG-ȕ) can be used to retain the differentiation ability of human 
MSCs and ASCs up to 25 passages [273,274]. Other chemicals such as TMJ disc 
proteins (aggrecan, Type I Col, Type II Col, or decorin) and Col I/aggrecan have been 
used to recover the adverse changes by serial subculture of temporomandibular joint 
(TMJ) disc cells and meniscal fibrochondrocytes, respectively [275,276]. In addition, 
encapsulating chondrocytes in alginate hydrogel at 5% oxygen (reduced oxygen 
tension) helped key differentiated phenotypic markers be restored (comparable to 
primary chondrocytes) as passaged [277]. Moreover, the differentiated functions of 
chondrocytes could be restored by treating the cells which were subcultured up to 
passage 2 for multiplication in monolayer with staurosporin, a protein kinase C 
inhibitor [278]. 
As such, choosing suitable culture conditions to maintain human MSCs characteristics 
or reverse any changes caused by extensive subculture is one of the prerequisites of 
autologous cell therapeutics. However, the above studies only focused on changing 
chemical cues in culture environment. The objective of this study was to demonstrate 
the role of topographical cues in recovering the adverse effects of long-term culture. 
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Additionally, studying the influence of extended culture on the osteogenic 
differentiation potential of human MSCs on a certain bone graft, not conventional 
plastic surface, is extremely important, because the scaffold itself will be used to seed 
human MSCs, which were isolated from the patient and expanded in vitro, before 
implanting back to the body.  
Our hypothesis in this study was that biomimetic nanofibrous scaffolds would help to 
increase the osteogenic differentiation of MSCs and recover the lost in cellular 
osteogenic differentiation during the serial passage, comparing to conventional 
smooth plastic surfaces (TCPS plates). Here, human MSCs from passage 2 to passage 
8 were cultured on both PLLA nanofibers and TCPS plates in the Ost medium to 
investigate the influences of prolonged culture as well as the nanofibrous structure on 
osteogenic differentiation function of the stem cells. 
3.2 Materials and methods 
Fabrication of electrospun nanofibers: PLLA (300,000 Da, Polysciences, Inc., 
Warrington, PA, USA, Cat.18582) was dissolved in 1,1,1,3,3-hexafluoro-2-propanol 
(HFP, Sigma-Aldrich, St. Louis, MO, USA, Cat.105228) with the concentration of 3 
wt%. This polymer solution was loaded into a syringe (Becton Dickinson, Franklin 
Lakes, NJ, USA) connected with a BD 27G½ needle (Becton Dickinson). The feed 
rate was kept constantly at 1.2 mL/h by a KD Scientific syringe pump (Holliston, 
MA, USA). A metal plate covered by a sheet of aluminum foil and 15mm cover slips 
on top was placed at a distance of 12 cm from the needle. A high voltage (12kV) was 
applied between the needle and the metal plate by a direct current high-voltage power 
supply (Gamma High Voltage Research, Ormond Beach, Florida, USA). The 
humidity and room temperature were kept at 48 r 2% and 25 r 1oC, respectively, for 
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the electrospinning process. After electrospinning, nanofibrous scaffolds produced on 
the cover slips were vacuum dried overnight to remove any remaining solvent. 
Growth of human MSCs: human MSCs (Lonza Walkersville, Walkersville, MD, 
USA, Cat.PT-2501) purchased were cryopreserved cells at passage 2 and then 
FXOWXUHG LQ0LQLPXP(VVHQWLDO0HGLXP0(0Į0HGLXP;D-MEM medium, 
Invitrogen, Carlsbad, CA, USA, Cat.12561) supplemented with 10% fetal bovine 
serum (FBS, Invitrogen, Cat.10082), 100 U/mL penicillin (Sigma-Aldrich, 
Cat.P7794) and 100 Pg/mL streptomycin (Sigma-Aldrich, Cat.S9137) in tissue culture 
flasks at 37°C in a humidified atmosphere of 5% CO2. When the cells reached near 
confluence (80±90%), they were detached by trypsin/EDTA (Cell Applications, San 
Diego, CA, USA, Cat.070-100) and then subcultured into the next passage. All cells 
used in this study were from a single donor, a healthy male at the age of 21 years old, 
and were kept in continuous cultures without any re-cryopreservation until they 
reached predetermined passages. 
Osteogenic differentiation of human MSCs: human MSCs at different passages 
(passage 2, passage 4, passage 6 and passage 8) were detached and seeded on the 
PLLA nanofibrous scaffolds with the density of 104 cells per cm2 in Ost medium. The 
cells were also seeded on TCPS plates as controls. The Ost medium was the growth 
PHGLXP VXSSOHPHQWHG ZLWK  P0 ȕ-GP (Sigma-Aldrich, Cat.G9891), 50 µM 
ascorbate-2-phosphate (AsP) (Sigma-Aldrich, Cat.A8960) and 100 nM Dex (Sigma-
Aldrich, Cat.D4902). The components and concentrations of cell culture and 
osteogenic media followed the protocol used in previous literatures [279,280]. The 
medium was changed every three days. 
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Before using, the scaffolds were sterilized under UV light for 30 min and pre-wetted 
in 70% ethanol for 5 min. Subsequently, they were washed three times with phosphate 
buffered saline (PBS, Invitrogen, Cat.70011) and once with the cell culture medium. 
SEM: The morphology of PLLA nanofibers and human MSCs were observed by 
SEM. The samples were fixed in 2.5% glutaraldehyde (Sigma-Aldrich, Cat.G5882) 
and followed by dehydration in sequentially increasing ethanol solutions with 10 min 
for each concentration (50%, 80%, 90%, 95% and 100%). The samples were then 
dried in vacuum overnight, gold sputtered with a JEOL JFC-1600 Auto Fine Coater 
(JEOL, Tokyo, Japan) at 10mA for 90s, and observed under SEM (FEI Quanta 200F, 
Hillsboro, Oregon, USA). The mineralized nodules were identified and analyzed by 
the SEM equipped with an Oxford INCA Energy Dispersive X-ray (EDX) 
Spectrometer. 
Cell proliferation: The number of living cells was estimated by Cell-7LWHU 
Aqueous One Solution Cell Proliferation Assay (Promega, Madison, WI, USA, 
Cat.G3581), a colorimetric assay using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] at determined time 
points. Briefly, a reaction mixture of the CellTiter 96® AQueous One Solution 
Reagent and D-MEM medium with the ratio of 1:5 was prepared. The Ost medium 
was aspirated and 500PL of the mixture was added into each well. The wells were 
subsequently incubated for 4 hr at 37°C in a humidified, 5% CO2 atmosphere. The 
absorbance at 490 nm was then measured using a 96-well plate with FLUOstar 
OPTIMA microplate reader (BMG LABTECH GmbH, Ortenberg, Germany). A 
calibration curve of human MSCs was established to estimate the number of living 
cells from the absorbance index. 
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ALP activity: ALP activity was determined by a colorimetric method using 
Phosphatase Substrate Kit (Pierce, Rockford, IL, USA, Cat.37620) which contains p-
nitrophenyl phosphate (PNPP) as a substrate. Briefly, after aspirating the medium 
from culture wells and rinsing with PBS, 400 PL of PNPP solution, which was 
prepared by dissolving two PNPP Tablets in 2 mL of Diethanolamine Substrate 
Buffer and 8 mL of de-ionized (DI) water, was added into each well. After 30 min 
incubated at room temperature, the reaction was stopped by adding 200 PL of 2 N 
NaOH into each well. The absorbance at 405 nm was recorded using the 96-well plate 
reader. The activity of the ALP was inferred from the millimolar absorptivity of the 
SURGXFWȡ-Nitrophenol), which is 18.75 mM-1.cm-1, and the results were normalized 
with the total cell number. 
Calcium content: In predetermined time intervals, the samples were collected and 
washed three times with PBS. To extract calcium, each well was added with 500 PL 
of 0.5 M acetic acid (Sigma-Aldrich, Cat.318590) and incubated in an orbital shaker 
overnight at 37oC. Subsequently, the calcium content in the supernatants was assayed 
by a colorimetric assay using o-cresolphthalein complexone (Calcium Colorimetric 
Assay Kit, Biovision, Mountain View, CA, USA, Cat.K380-250). Briefly, each 50 PL 
of the supernatants was mixed with 90 ȝ/RIWKH&KURPRJHQLF5HDJHQWDQG ȝ/RI
the Calcium Assay Buffer, respectively. They were then incubated for 15 min at room 
temperature, and the optical density (OD) at 575 nm was determined using the 96-
well plate reader. The calcium amount was calculated from the calibration curve 
constructed according to the instruction of the manufacturer. 
Alizarin red S staining: Alizarin red S (ARS) staining was used to observe the 
mineralization of the ECM. After aspirating the medium, the samples were rinsed 
Chapter 3 - The Importance of Nanofibrous Structures 
 100 
 
three times with DI water and fixed in iced cold 70% ethanol for 1hr at 4oC. The fixed 
samples were subsequently rinsed three times with DI water and stained with 1.36% 
ARS (Sigma-Aldrich, Cat.A5533) for 1hr at room temperature. The wells were 
washed three times with DI water and images were taken using an inverted optical 
microscope (Leica DC300 F, Leica Microsystems GmbH, Wetzlar, Germany). 
Actin Cytoskeleton and Focal Adhesion staining: Actin cytoskeleton and focal 
adhesion were stained using Actin Cytoskeleton and Focal Adhesion Staining Kit 
(Invitrogen, Cat. FAK100) as described by the manufacture. Briefly, after 4 days of 
culture, the samples were collected and fixed in 4% formaldehyde for 1hr. These 
samples were then incubated with the primary antibody (Anti-Vinculin) for 1 hour at 
room temperature. After washing, the cells were incubated with the second antibody 
(Gt x Ms, FITC-conjugated) and TRITC-conjugated Phalloidin simultaneously for 30-
60 min at room temperature. Finally, they were incubated with 4´,6-diamidino-2-
phenylindole, dilactate (DAPI, Invitrogen, Cat.D3571) for 30 min at room 
temperature, and viewed under Laser Scanning Confocal Microscope (Olympus 
FluoView FV1000, Olympus, Center Valley, PA, USA). 
Real time Reverse transcription polymerase chain reaction (Real time RT-PCR): 
Total RNA of the cells was extracted and purified using RNeasy® Plus Mini Kit 
(Qiagen, Valencia, CA, USA, Cat. 74134). The RNA samples were next reverse-
transcribed into first-strand cDNA using the oligo(dT) method described by the 
PDQXIDFWXUHU¶V NLW 6XSHU6FULSWTM First-Strand Synthesis System for RT-PCR, 
Invitrogen, Cat.11904-018). The cDNA was subsequently run real time PCR with 
SYBR (Applied Biosystems, Carlsbad, CA, USA, Cat. 4368706) to analyze the gene 
expression. A real-WLPHWKHUPDOF\FOHUL42SWLFDO6\VWHP%LR-Rad Laboratories, 
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Hercules, CA, USA) was used to analyze the expression of OPN, OCN, BSP and 
Wingless-type MMTV integration site family, member 5A (WNT5A) (Table 1). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was chosen as a house 
keeping gene to normalize gene expression using ''CT method. PCR reaction 
conditions were 2 min at 50oC, 10 min at 95oC, and then 45 cycles at 95oC for 15 s, 
and 1 min at 60oC. 
Table 3.1 Designed primers for real time ± PCR 
Gene )RUZDUGSULPHUV¶o ¶ 5HYHUVHSULPHUV¶o ¶ 
OPN ATGTGATTGATAGTCAGGAA GTCTACAACCAGCATATCT 
OCN ACCGAGACACCATGAGAG TCTTCACTACCTCGCTGC 
BSP CGAGCCTATGAAGATGAG GTGGTGGTAGTAATTCTGA 
WNT5A ATATTAAGCCCAGGAGTTG TAGCGACCACCAAGAATT 
GAPDH CATGAGAAGTATGACAACAG ATGAGTCCTTCCACGATA 
Statistical analysis: The results given are representative of three independent 
experiments. Data were analyzed by means of one-factor analysis of variance 
(ANOVA) or multifactor ANOVA using STATGRAPHICS Centurion XV (Statpoint 
Technologies, Warrenton, VA, USA). The statistics were completed correctly to study 
differences in cell proliferation and differentiation of different passages and different 
substrates. 
3.3 Results 
3.3.1 Nanofibrous morphology 
Figure 3.1 showed the uniform and smooth nanofibers of PLLA with the average 
diameter of 501 r 63 (nm) fabricated using the electrospinning technique. 




Figure 3.1 SEM image of electrospun PLLA nanofibers. The uniform and smooth nanofibers of PLLA with the 
average diameter of 501 r 63 (nm) were fabricated. 
3.3.2 Cell morphology 
The morphology of human MSCs after 4 days cultured on PLLA nanofibers and 
TCPS plates were indicated by F-actin staining (Figure 3.2). In addition, focal 
adhesions in the cell-matrix interface were stained simultaneously (Figure 3.2). The 
cell morphology and focal adhesion plaque on the nanofibrous scaffolds had much 
more elongated shapes than those on the smooth surfaces. 
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Figure 3.2 Actin Cytoskeleton and Focal Adhesion staining of human MSCs at passage 4 cultured on the PLLA 
nanofibrous scaffolds and TCPS plates (control) in the Ost medium after 4 days. The cell morphology and focal 
adhesion plaque on the PLLA nanofibers had much more elongated shapes than those on the TCPS plates. 
3.3.3 Cell proliferation 
The proliferation of differentiated human MSCs at different passages (from 2 to 8) on 
the PLLA nanofibers and TCPS plates (control) in the Ost medium was shown in 
Figure 3.3. From the 14th day to the 28th day, human MSCs grew continuously on both 
the nanofibrous scaffolds and the controls. For both cases of nanofibrous PLLA and 
TCPS plates, the early passage cultures (passage 2 and passage 4) proliferated 
significantly better than the late passage cultures (passage 6 and passage 8) (p < 0.05). 
Compared to the controls, the scaffolds caused the considerable decline in the growth 
ability of human MSCs (p < 0.05). Noted that after 21 days of culture, due to over 
confluence of the cells on the nanofibrous scaffolds and TCPS plates, differentiated 
human MSCs may be detached from the surfaces and reduced the cell number 
measured in comparison with their true proliferation abilities. 




Figure 3.3 Cell proliferation of human MSCs at different passages (passage 2, passage 4, passage 6 and passage 8) 
cultured on the PLLA nanofibrous scaffolds and TCPS plates (control) in the Ost medium after 14, 21 and 28 days. 
Significant difference of investigated groups was denoted as * (p < 0.05). For the cells on the PLLA nanofibers, 
cell proliferation of passage 6 was significantly higher than passage 8. There was no significant difference in 
proliferation between passage 2 and passage 4, and the cell proliferation of these passages were considerably 
higher than passage 6 and passage 8. For the cells on TCPS plates, there was no significant difference in cell 
proliferation between passage 2 and passage 4, between passage 6 and passage 8. The proliferation of the cells at 
passage 2 and passage 4 were significantly higher than passage 6 and passage 8. Comparing two groups of PLLA 
and TCPS, the cell proliferation on TCPS plates was significantly higher. 
3.3.4 Alkaline phosphatase activity 
ALP activity is an early marker of osteogenic differentiation of human MSCs. It 
increases but then decreases when the culture becomes well-mineralized. ALP activity 
of MSCs cultured in osteogenic conditions usually peaks after 14 ± 21 days, 
depending on cell sources and culture conditions.  Our preliminary investigations also 
showed that ALP activity of differentiated human MSCs reached the maximum level 
on the 14th day (data not shown). Therefore, in this study, ALP activity was measured 
at time points of the 14th and the 21st days. ALP activity at different passages on both 
PLLA and TCPS (Figure 3.4) was obtained by dividing the initial values by the 
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number of viable cells. Similar to the cell proliferation, a considerable decrease in 
ALP activity was also observed with subculture (p < 0.05). Human MSCs of passage 
2 cultured on PLLA nanofibers and TCPS plates showed significant higher values of 
ALP activity than the other passages. In respect of evaluating PLLA and the control, 
the nanofibers significantly enhanced the ALP activity of differentiated human MSCs 
(p < 0.05).  
 
Figure 3.4 ALP activity of human MSCs at different passages (passage 2, passage 4, passage 6 and passage 8) 
cultured on the PLLA nanofibrous scaffolds and TCPS plates (control) in the Ost medium after 14 and 21 days. 
The ALP activity was normalized by the number of viable cells. Significant difference of investigated groups was 
denoted as * (p < 0.05). For the cells on the PLLA nanofibers, ALP activity of passage 2 was significantly higher 
than passage 4. There was no significant difference in ALP activity between passage 6 and passage 8, and ALP 
activity of these passages were considerably lower than passage 2 and passage 4. For the cells on TCPS plates, 
there was no significant difference in ALP activity between passage 4 and passage 6.  ALP activity of these 
passages was significantly lower than passage 2, and higher than passage 8. Comparing two groups of PLLA and 
TCPS, ALP activity of differentiated human MSCs on the nanofibrous scaffolds was significantly higher. 
3.3.5 Matrix mineralization 
Calcium deposition on both the nanofibrous PLLA and TCPS plates of differentiated 
human MSCs was shown in Figure 3.5. A decreasing trend of the calcium content was 
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indicated as the number of passage was increased (p < 0.05). On the nanofibers, there 
was no significant difference in the amount of calcium produced between human 
MSCs of passage 2 and passage 4. Meanwhile, the calcium amount on TCPS plates of 
passage 4 was considerably lower than passage 2. The cells on the PLLA nanofibers 
had considerably higher calcium amounts than the control (p < 0.05). 
 
Figure 3.5 Calcium deposition on the PLLA nanofibrous scaffolds and TCPS plates (control) after 21 and 28 days 
of culture with human MSCs. The calcium content was normalized by the number of viable cells. Significant 
difference of investigated groups was denoted as * (p < 0.05). For the cells on the PLLA nanofibers, the calcium 
amount produced by passage 6 was significantly higher than passage 8. There was no significant difference in 
calcium amount between passage 2 and passage 4, and these passages produced significantly more calcium 
deposition than passage 8. For the cells on TCPS plates, the calcium amount produced by passage 2 was 
significantly higher than passage 4. There was no significant difference in calcium amount between passage 6 and 
passage 8, and calcium amount of these passages was significantly lower than passage 2. Comparing two groups of 
PLLA and TCPS, the amount of calcium deposition on the nanofibrous scaffolds was significantly higher. 
The mineralization of the ECM on the PLLA scaffolds was also illustrated by ARS 
staining in Figure 3.6. The calcium deposition was stained with orange-red spots, and 
the amount of calcium produced is proportional to the color intensity. This staining 
reflected the total calcium deposited on the scaffold surface, not the calcium 
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deposition per cell as shown in Figure 3.5. The early passages (passage 2 and passage 
4) performed remarkably higher calcium amounts than the late passages (passage 6 
and passage 8). 
 
Figure 3.6 ARS staining of human MSCs differentiated on the PLLA nanofibrous scaffolds in the Ost medium on 
the 21st and the 28th days. The early passages (passage 2 and passage 4) performed remarkably higher calcium 
amounts than the late passages (passage 6 and passage 8). 
The bone nodule formation of human MSCs at passage 4 on both PLLA nanofibers 
and TCPS plates were observed under SEM (Figure 3.7). The presence of inorganic 
atoms in the bone nodules, Ca and P, with the Ca/P ratio of approximately 1.45 was 
confirmed by the EDX Spectrometer. For each test sample, the number of bone 
nodules in 5 predetermined square areas at the magnification of 4000X (top, center, 
bottom, left and right portions of the sample) was counted based on the SEM/EDX 
images. The cells on the nanofibrous structure produced much more bone nodules, 
approximately 4 times higher, than the ones on the control. 




Figure 3.7 SEM images of bone nodules (indicated by arrows) produced by human MSCs of passage 4 on the 
PLLA nanofibers and TCPS plates (control) in the Ost medium after 21 days of culture. The cells on the 
nanofibrous structure produced much more bone nodules than on the control. 
3.3.6 Osteoblastic gene expression 
The differences in expression of osteoblastic genes (OPN, OCN, BSP and WNT5A) 
of differentiated human MSCs at passage 4 on the PLLA nanofibers and the control 
were illustrated in Figure 3.8. There was no considerable difference in the OPN 
expression of differentiated human MSCs on PLLA and TCPS (p < 0.05) (Figure 
3.8a). Meanwhile, differentiating human MSCs on the scaffolds made OCN 
expression reduced in comparison with differentiating the cells on the TCPS surfaces 
(p < 0.05) (Figure 3.8b). In contrast to OCN, the expression of BSP was extremely 
higher for the human MSCs differentiated on the PLLA scaffolds than on the control 
(p < 0.05) (Figure 3.8c). The level of BSP expression of the cells on PLLA was 10 a 
12 times higher than on TCPS in both investigated time points (14th day and 21st day). 
Additionally, the WNT5A expression of human MSCs on PLLA was significantly 
higher than the cells on TCPS (p < 0.05) (Figure 3.8d). For both days (14th and 21st 
day), the level of WNT5A expression was about 1.5 times higher for the cells on 
nanofibrous scaffolds.  




Figure 3.8 Normalized gene expression of human MSCs at passage 4 cultured on the PLLA nanofibrous scaffolds 
and TCPS plates (control) in the Ost medium after 14 and 21 days: (a) OPN, (b) OCN, (c) BSP and (d) WNT5A. 
Significant difference of investigated groups was denoted as * (p < 0.05). In Figure a, there was no significant 
difference in OPN expression between PLLA and TCPS. In Figure b, OCN expression of human MSCs on the 
PLLA nanofibers was considerably lower than on the TCPS plates. In Figures c and d, the expression levels of 
BSP and WNT5A of the cells on the nanofibers were significantly higher than on the controls. 
3.4 Discussion 
MSCs have offered great potentials in bone tissue engineering because of their ability 
to differentiate into osteoblastic lineage as well as the ease of isolation processes. 
However, these cells need to be expanded to achieve enough cell number for 
therapeutic applications. In vitro serial passage on conventional smooth surfaces 
(TCPS) may affect adversely cellular characteristics [267-269]. To recover these 
changes, we focused on using scaffolds with topographies mimicking the native 
ECM. The nanofibers were fabricated using the electrospinning technique had the 
average diameter of approximately 500nm (Figure 3.1) which is similar to the 
diameter of type I Col fibers, a major component of the ECM. 
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3.4.1 The effects of serial passage 
The cell proliferation assay showed significant effects of serial passages (from 
passage 2 to passage 8) on the growth of human MSCs (Figure 3.3). On both TCPS 
plates and the nanofibers, the number of viable cells decreased considerably during 
serial subculture. Some previous studies have also reported the decline of the 
proliferation ability when cells were subcultured repeatedly. In one study to 
investigate effects of long-term serial passage on human MSCs in neuronal 
differentiation medium, Khoo et al. (2008) found that the late passage cultures 
(passage 11 ± passage 12) lost the abilities of proliferation and symmetric division 
[272]. In addition, human bone marrow stromal cells tended to decline the 
proliferation considerably in the osteogenic induction medium when the passage 
number increased from 1 to 5 [270]. Contrary, some other studies have showed that 
the cell proliferation was not affected, and even enhanced during serial passage.  
From passage 1 to passage 10, there was no statistical difference in the proliferation 
of human MSCs [267]. Meanwhile, the proliferation ability of human ESCs was 
accelerated as the passage number increased [281]. One possible reason for this 
phenomenon was that the adaption of the stem cells to culture conditions shortened 
the cell-doubling time. In our case, the decline in cell growth of late passages may be 
owing to certain genetic mutation causing the loss of proliferative ability. 
Serial passage not only affected the cell proliferation, but also affected the osteogenic 
differentiation ability of human MSCs.  The osteogenic differentiation ability declined 
with subculturing as shown by ALP activity (Figure 3.4) and calcium deposition 
(Figures 3.5 and 3.6). This decline occurred to human MSCs cultured on both the 
nanofibrous scaffolds and the controls (TCPS plates). Some previous researches into 
the osteogenic differentiation of MSCs on the plastic surfaces indicated that MSCs 
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only possess full capacity of differentiation into matured osteoblasts at passage 0 
(extracted from the body) [282]. After that, at passages as early as passage 1 or 
passage 2, MSCs started to reduce their osteogenic differentiation ability [283]. Not 
only in vitro studies, did MSCs also seem to lose their osteogenic potential in vivo 
with repeated passages [284].  
Taken together, our results indicated adverse influences of prolonged in vitro 
subculture on both proliferation and differentiation potentials of human MSCs when 
they were differentiated on either PLLA nanofibrous scaffolds or conventional TCPS 
plates. These influences of serial passage might be representative of cellular aging and 
senescence [285,286]. Certain changes in DNA repair, cell cycle regulation or energy 
metabolism might cause imbalance or impairment of cellular functions [287]. In 
addition, undesirable influences might be due to the fact that the monolayer 
subculture system used was lacking in a true 3D ECM environment [288]. 
3.4.2 The role of electrospun nanofibers 
Because of severe effects caused by prolonged subculture in vitro, changes in culture 
conditions have been studied to maintain or recover cellular characteristics on the 
plastic surfaces. Growth factors such as EGF, bFGF, and TGF-ȕ KDYH EHHQ
supplemented into the culture medium to retain the differentiation ability of MSCs 
[273,274]. In addition, to partially recover the adverse changes in the differentiation 
function of chondrocytes by serial subculture, some strategies have been proposed 
such as coating the culture surfaces with proteins (aggrecan, Type I Col, Type II Col, 
or decorin), encapsulating the cells in alginate hydrogel at 5% oxygen (reduced 
oxygen tension), or treating the cells with staurosporin, a protein kinase C inhibitor 
[275-278]. However, these studies only focused on changing chemical cues in culture 
Chapter 3 - The Importance of Nanofibrous Structures 
 112 
 
environment. Here, we demonstrated the role of topographical cues in recovering the 
adverse effects of long-term culture. The scaffolds with nanofibrous structure 
mimicking the ECM structure were used to differentiate MSCs into mature 
osteoblasts in the osteogenic medium. 
The PLLA nanofibrous scaffold demonstrated its osteoconductivity as evident by 
spreading cells on day 4 (Figure 3.2), continuous cell growth during 28 days (Figure 
3.3) and a scaffold surface almost fully covered by the cells on day 21 (Figure 3.7). 
However, the cell numbers on the PLLA nanofibers were considerably lower than 
those on the conventional TCPS plates. It was well-accepted that when stem cells 
were busy with differentiation, their proliferation could be reduced [147]. It could be 
explained that in the Ost medium, the MSCs were induced to differentiate into 
osteoblastic cells. In response to the medium, the signals/interactions/reactions 
towards the osteogenic differentiation pathway of MSCs were accelerated. The 
nanofibers might help to further accelerate this process in comparison with the TCPS 
plate. Once the MSCs were differentiated into osteoblasts, their proliferation was 
decreased. And once they became fully differentiated, they ceased proliferation. 
Over a time course of osteogenic differentiation of MSCs, there are expressions of 
different osteoblastic markers which reflect the maturation and the mineralization of 
the ECM. ALP activity is an early marker of osteogenic differentiation of human 
MSCs. It increases but then decreases when the culture becomes well-mineralized. 
ALP is necessary for mineralization process by hydrolyzing organic phosphate to 
inorganic phosphate which results in precipitation of HA. With the onset of 
mineralization, OPN becomes induced. OPN, also known as BSP-1 due to its high 
sialic acid content, are bone-specific ECM proteins important to the regulation of 
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matrix mineralization and resorption. It binds strongly to HA and modulates crystal 
growth. OPN appears prior to BSP and OCN which can be detected in mature 
osteoblasts. BSP, known as BSP-2, is a major non-collagenous protein and highly 
specific in mineralizing tissues. In bone matrix mineralization, the highest BSP 
concentration is mostly found in bone areas newly synthesized or remodeled. BSP is 
also a nucleator of HA crystals in bone. OCN is a specific marker for the late stage of 
osteogenic differentiation, and plays an important role in regulating bone formation 
and mineralization. It binds tightly and modulates the growth of HA crystals [289].  
Our results showed that there was no significant difference in the expression level of 
OPN between the cells on the PLLA nanofibers and on TCPS plates (Figure 3.8a). 
Meanwhile, OCN expression on the PLLA scaffolds was considerably lower than 
conventional TCPS plates (Figure 3.8b). OCN is widely used as a specific marker of 
late osteoblastic expression because it seems only expressed by mature osteoblasts. 
The binding of OCN to HA could block growth sites of HA and inhibit further crystal 
growth. So, the role of OCN is not to initiate, but to regulate the bone mineralization. 
In contrast, ALP is required for precipitation of HA, and BSP exhibits a high 
nucleation activity which plays an important role in initiation of the mineralization 
process [290]. ALP activity was considerably higher for the PLLA scaffolds with all 
passages (Figure 3.4). Additionally, BSP had an impressive expression level, about 10 
a 12 times higher than the cells on conventional TCPS plates (Figure 3.8c). Also, 
WNT5A, a growth factor which strongly stimulates osteogenic differentiation of 
MSCs, was up-regulated on our scaffolds in comparison with the smooth TCPS plates 
(Figure 3.8d). As such, the significantly higher expression of ALP, BSP, and WNT5A 
in combination with the lower expression of OCN led to extremely higher calcium 
deposition on the nanofibrous scaffolds than on TCPS plates (Figure 3.5). At the same 
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passage, calcium amounts produced per cell on PLLA nanofibers were approximately 
8 times higher on the 21st day and approximately 4 times higher on the 28th day than 
the controls. Also, the number of bone nodules was approximately 4 times higher 
after 21 days of culture (Figure 3.7). Although there has not been a certain level of in 
vitro calcium deposition which is required for bone regeneration, the ability to 
produce a high calcium deposition is a good evidence for the potential of nanofibrous 
scaffolds in vivo.  
These findings indicated great advantages of nanofibrous scaffolds in osteogenic 
differentiation of human MSCs. Due to the scaffold structure mimicking the ECM 
structure, the nanofibrous scaffolds have been supposed to provide a 
microenvironment as well as play a role more similar to the native ECM in vivo than 
traditional smooth surfaces. The large surface-area-to-volume ratio of nanofibers 
promoted the adsorption of serum proteins and changed the profile of adsorbed 
proteins compared to the solid-walled scaffolds [48]. The adsorption of serum 
fibronectin and vitronectin, which are known to mediate cell-matrix interactions, were 
improved significantly with nanofibrous structures [49]. In addition, the enhancement 
in fibronectin adsorption might accelerate the differentiation of stem cells into 
osteogenic lineages [291] due to increased integrin-fibronectin interactions [292]. As 
such, changes in the amount or type of adsorbed serum proteins may provide stem 
cells with a better niche to direct the differentiation of the cells to a particular lineage. 
In our study, the morphology of human MSCs cultured on the nanofibers was 
different from the cells on the smooth surfaces (TCPS plates) as indicated by F-actin 
staining in Figure 3.2. The cells seeded on the nanofibrous scaffolds had a more 
elongated shape after 4 days of culture. The changes in cytoskeletal organization 
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might derive from the changes in focal adhesions [108]. At the cell-matrix interface, 
the focal adhesions play an important role in linking the ECM on the outside to the 
actin cytoskeleton on the inside. In addition to affecting cytoskeletal organization, the 
changes in focal adhesions also affect the mechanism of focal adhesion-activated 
signaling pathways [205]. Here, the focal adhesion plaque of human MSCs on the 
nanofibrous surfaces was much more elongated than the one on the control surfaces 
(Figure 3.2). This elongation is associated with the cytoskeletal strengthening as well 
as the recruitment of focal adhesion-associated signaling molecules [293]. Salasznyk 
et al. (2007) showed the important role of the focal adhesion kinase signaling 
pathway, one of the focal adhesion-activated signaling pathways, in regulating the 
osteogenic differentiation of human MSCs [206]. Therefore, we proposed that much 
more elongation of focal adhesions on the nanofibers might increase the activation of 
the focal adhesion kinase signaling pathway which led to the higher osteogenic 
differentiation of human MSCs on nanofibrous scaffolds.  
In this study, human MSCs were subcultured on the smooth plastic surfaces of tissue 
culture flasks until they reached the predetermined passages (passage 2, passage 4, 
passage 6 and passage 8). The cells of these passages were then seeded on the PLLA 
nanofibers and the smooth TCPS plates as control. Serial subculture on plastic 
surfaces was shown to cause adverse effects to cellular behaviours. One of the aims of 
this study was to demonstrate whether differentiating human MSCs on nanofibrous 
scaffolds led to recovering their osteogenic functions or not. The meaning of 
³UHFRYHU\´KHUHZDVWKDWWKHRVWHRJHQLFDELOLWLHVRIhuman MSCs with later passages 
cultured on the nanofibers was higher than or similar to human MSCs with earlier 
passages cultured on the control. Our results showed that the ALP activity and 
calcium amount produced by human MSCs on the PLLA nanofibers were 
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considerably higher than or not statistically different from those of human MSCs at 
the earlier passage cultured on the smooth surfaces. Concretely, ALP activities of 
human MSCs at passage 4, passage 6 and passage 8 cultured on the nanofibrous 
scaffolds were higher than or similar to those of human MSCs at passage 2, passage 4 
and passage 6, respectively, seeded on the conventional TCPS plates. In addition, the 
calcium amounts of human MSCs at passage 4, passage 6 and passage 8 cultured on 
the nanofibers were significantly higher than those of human MSCs at passage 2, 
passage 4 and passage 6, respectively, seeded on the smooth surfaces. As such, 
although serial subculture decreased the osteogenic ability of human MSCs seeded on 
both the nanofibrous scaffolds and the conventional smooth surfaces, the adverse 
changes were regained by differentiating human MSCs on the nanofibrous scaffolds. 
However, the nanofibers only recovered partially, not fully, osteogenic functions of 
human MSCs because serial passage still caused decrease for those functions on 
nanofibrous scaffolds. As such, to get a better cell source with fully maintained 
cellular characteristics for seeding on scaffolds and implanting in the body, instead of 
using traditional tissue culture flasks, an alternative method using the surfaces coated 
with nanofibers should be developed to subculture human MSCs in vitro. 
In the body, cells reside in an environment where the presentation of chemical, 
topographical, mechanical and electrical stimuli cues in the surrounding fluid and 
ECM provides the guidance for cellular responses. This study and previous studies 
have shown that topographical and chemical cues have their abilities in recovering 
undesirable changes in the osteogenic functions of human MSCs caused by serial 
passage. Similarly, mechanical and electrical stimuli cues may be expected to do the 
VDPHUROH6XEVWUDWHVWLIIQHVVDFWVDVD³SDVVLYH´PHFKDQLFDOFXHDQGKDVEHHQVKRZQ
as one of key factors that influence stem cell behaviours [294,295]. Because the 
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stiffness of nanofibers is different from TCPS plates, in addition to the 
nanotopography of nanofibers, their stiffness may play a part in supporting the 
osteogenic differentiation of human MSCs in comparison with TCPS. Recently, one 
study of Yim et al. (2010) demonstrated that nanotopography affected more 
dominantly the organization of the cytoskeleton and focal adhesions of human MSCs 
than the stiffness did [108]. Additionally, nanotopography may possess great 
advantages due to the large surface-area-to-volume ratio as discussed above. As such, 
we supposed that the factor mainly contributed to the role of nanofibers in this study 
was the nanotopography rather than the stiffness. However, further studies should be 
performed to identify whether the substrate stiffness plays an important role in 
recovering the gradually lost to differentiate over prolonged culture or not. The 
difference in surface chemistry of PLLA and polystyrene (of the culture plate) might 
also contribute to the difference in the differentiation abilities of the MSCs. However, 
both of them are biologically inert synthetic polymers, thus they would not make 
significant effects on the cellular activities. 
%RQHLVRQHRIWKHERG\¶VWLVVXHVFDSDEOHRIUHFDSLWXODWLQJWKHLULQLWLDOGHYHORSPHQWDO
processes and thus undergoing regeneration to a stage of repair, allowing full healing 
under some circumstances. Treatment of large bone defects is a great challenge to 
reconstructive surgery because defects above a critical size usually become scarred 
rather than regenerated. Using suitable scaffolds supplemented with a large number of 
autologous stem cells (MSCs) has been postulated as a gold strategy for the treatment 
of those defects. Greater bone regeneration can be obtained due to recreating an 
embryonic environment in injured adult tissues [296]. In order to get a sufficient cell 
number for the treatment, MSCs are usually expanded in vitro through serial 
subculture on plastic surfaces. The larger cell number needs to be obtained, the more 
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serial subculture need to be done. However, the more serial subculture is performed, 
the worse cellular behaviours are. Therefore, scaffolds capable of recovering 
undesirable changes of osteogenic functions caused by long-term culture are 
extremely important to clinical treatments. Human MSCs of earlier than or exact 
passage 2 are supposed to be the best for bone treatment. Due to great advantages of 
the nanofibrous scaffolds, based on our results, human MSCs up to passage 4 could be 
considered for seeding on the nanofibers to treat large bone defects because there was 
no significant difference in cell proliferation and calcium deposition of passage 4 in 
comparison with passage 2 (Figure 3.3 and Figure 3.5). 
3.5 Conclusion 
In order to achieve enough cell number for the treatment of bone defects, MSCs are 
usually expanded in vitro through serial subculture on plastic surfaces. However, cell 
behaviours have been shown to be severely affected during serial passage on the 
smooth surfaces. To maintain or recover cellular characteristics for prolonged cultures 
on the plastic surfaces, changing chemical cues in the culture environment has been 
performed in previous studies. In this study, we demonstrated the role of 
topographical cues in recovering the adverse effects of long-term culture. The PLLA 
electrospun nanofibrous scaffolds showed their great advantages over the smooth 
TCPS plates due to mimicking the structure of ECM as well as its large surface-area-
to-volume ratio. Our results indicated that although the cell proliferation of human 
MSCs on the PLLA nanofibers was considerably lower, their osteogenic ability was 
significantly higher than the TCPS plates which was proved by higher values of ALP 
activity, the gene expression of BSP and WNT5A, and calcium deposition. The cells 
seeded on the nanofibrous scaffolds had a more elongated shape than those on the 
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smooth TCPS which might also lead to higher osteogenic differentiation of human 
MSCs on the nanofibers. However, serial passage still decreased the osteogenic 
abilities of human MSCs cultured on nanofibrous scaffolds. As such, the nanofibrous 
structures partially recovered the loss in osteogenic differentiation ability of human 
MSCs caused by serial subculture on conventional smooth surfaces. In addition, the 
biodegradable PLLA nanofibers were shown to have the osteoconductivity by 
supporting the growth of human MSCs and their differentiated cells. 
(Note: Most of the text and results in this chapter have been published and reprinted 
from Nanomedicine 6(6). Luong TH Nguyen, Susan Liao, Seeram Ramakrishna and 
Casey K Chan. Role of Nanofibrous Structure in Osteogenic Differentiation of 
Human Mesenchymal Stem Cells with Serial Passage, 961-974, Copyright 2011, with 
permission from Future Medicine) 
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Chapter 4  
Dexamethasone-loaded Nanofibers as Osteoinductive Bone 
Graft Substitutes 
4.1 Introduction 
Dex is a synthetic steroidal anti-inflammatory drug which has been shown to induce 
osteogenic differentiation of MSCs in combination with AsP and E-GP [279]. Dex is 
known to induce expression of osteoblastic markers such as ALP, OCN, OPN, BMP, 
Type I Col, and BSP, and stimulate MSCs to form bone nodules [297-300]. However, 
the molecular mechanism of these effects has not been fully understood. Dex was 
supposed to be bound to albumin [301] and induced higher expression of glutamine 
synthetase, an important enzyme for bone cells [302]. In another study, Jaiswal R.K. 
et al. (2000) showed that the Mitogen-activated Protein Kinase (MAPK) pathway was 
activated by osteogenic supplements to differentiate human MSCs into osteocytes 
[303]. In addition, up-regulating of FHL2, a member of LIM protein superfamily, 
induced by Dex may be a reason for osteogenic differentiation of MSCs [304]. 
Dex-loaded scaffolds have been employed to enhance osteogenic differentiation of 
stem cells. Kim H. et al. (2003, 2005) fabricated porous PLGA scaffolds containing 
AsP and Dex using the solvent-casting, particulate-leaching technique for in vitro and 
in vivo studies [305,306]. MSCs cultured on these scaffolds expressed higher ALP 
activity and calcium deposition than control scaffolds. Nevertheless, this fabricating 
method has the disadvantage of losing Dex during the process of leaching out the salt. 
The reason is that the composite of PLGA/Dex/salt had to be immersed in DI water 
for 10 hr with gentle stirring; meanwhile, Dex loaded in this scaffold was released 
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quickly in the initial incubation time. In another study, Charles R. N. et al. (2005) 
encapsulated human MSCs in PEG-based hydrogel scaffold and induced osteogenic 
differentiation of these cells by covalently linked Dex to the hydrogel [307]. Because 
Dex was bound to the hydrogel by chemical bonds, Dex was released gradually from 
the scaffold without burst release. In this case, Dex was released as Dex conjugates 
instead of free Dex, so their side effects still need to be further investigated.  
With novel characteristic of nanofibers as mentioned in section 2.6.2, loading Dex 
into nanofibrous scaffolds can bring significant advances for osteogenic 
differentiation of human MSCs. Our aim in this study was to develop an effective 
osteoconductive and osteoinductive scaffold for bone treatment. Dex was loaded into 
PLLA nanofibers with the concentration of 0.333 wt% using electrospinning 
technique. The release profile of Dex from the nanofibers was investigated. 
Additionally, human MSCs were cultured on these scaffolds as well as PLLA 
nanofibers without Dex in both growth medium and the Ost-Dex medium to evaluate 
the importance of released Dex to the osteogenic differentiation of human MSCs.  
4.2 Materials and methods 
Fabrication of electrospun nanofibers: 3 wt% of PLLA (300,000 Da) was prepared 
by dissolving and stirring overnight in HFP. To fabricate scaffolds loaded with Dex, 
20 min before electrospinning, Dex was added into the PLLA solutions with the 
concentration of 0.333 wt% to PLLA.  
The electrospinning setup and operation parameters were the same to those mentioned 
in section 3.2. The mass of scaffold on the coverslip was 1.067 r 0.180 mg (n = 9). 
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Water contact angle: The hydrophobicity of PLLA and Dex-loaded PLLA scaffolds 
was evaluated by sessile drop water contact angle measurement with VCA Optima 
Surface Analysis system (AST products, Billerica, MA, USA) using 0.5 ȝ/',ZDWHU
droplets. 
Tensile testing: The tensile property of PLLA and Dex-loaded PLLA nanofibers was 
characterized using a tensile tester (Instron Micro Tensile Tester 5848, MA, USA). 
The thickness of rectangular membranes (10 mm width, 20 mm length) was measured 
using a micrometer (Mitutoyo America Corporation, Aurora, IL, USA) before testing. 
Each sample was subjected to a load of 2.5 N with a deforming speed of 5 mm/min. 
The data were recorded at a sampling rate of 100 +]<RXQJ¶VPRGXOXVLVWKHVORSHof 
the linear portion of a stress-strain curve. 
In vitro release study of Dex from PLLA scaffolds: 12 scaffolds were placed into 
each 15 mL polypropylene tube containing 6 mL of PBS with 0.2% Tween 20 
(Sigma-Aldrich, Cat.P9416). The tubes were next incubated at 37oC with orbital 
shaking rate at 100 rpm. At predetermined time points, aliquots of 1 mL were 
withdrawn and the same volume of PBS with Tween were replaced into the tubes. 
The samples were measured at 242 nm using UV-Vis. spectrometer (UniCam UV 300 
spectrophotometer, Thermo Spectronic, Rochester, NY, USA).  
Growth of human MSCs: this procedure is the same to that mentioned in section 3.2. 
Osteogenic differentiation of human MSCs: human MSCs were cultured until 
passage 4, detached and seeded on PLLA and Dex-loaded PLLA scaffolds in 24-well 
plates with the density of 104 cells per cm2. Two different types of media used to 
culture human MSCs on both PLLA and Dex-loaded PLLA nanofibers were growth 
medium and Ost-Dex medium. The cells were also seeded on the PLLA scaffolds in a 
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standard Ost medium (mentioned in section 3.2) as a positive control. The Ost-Dex 
medium was the Ost medium with the absence of Dex. An amount of medium used 
was 0.5 mL per well and changed every three days. At predetermined time points, the 
samples were collected. Cell morphology, cell proliferation, ALP activity, 
osteoblastic gene expression, and matrix mineralization were then examined to 
identify the influence of Dex released from PLLA nanofibers on the osteogenic 
differentiation of human MSCs. 
Before seeding the cells, the scaffolds were treated under UV light for 30 min for the 
purpose of sterilization. Subsequently, they were pre-wetted in 70% ethanol for 5 min 
and followed by rinsing thrice in PBS and once in growth medium. 
 SEM: this method is the same to that mentioned in section 3.2. 
Actin Cytoskeleton and Focal Adhesion staining: this method is the same to that 
mentioned in section 3.2. 
Cell proliferation: this method is the same to that mentioned in section 3.2. 
ALP activity: this method is the same to that mentioned in section 3.2.  
Gene expression: this method is the same to that mentioned in section 3.2. Designed 
primers of ALP, OCN, BSP and core-binding factor alpha 1 (Cbfa1) and GAPDH are 
shown in Table 4.1.  
Calcium content: this method is the same to that mentioned in section 3.2.  
Alizarin red S staining: this method is the same to that mentioned in section 3.2. 
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Table 4.1 Designed primers for real time ± PCR 
Gene )RUZDUGSULPHUV¶o ¶ 5HYHUVHSULPHUV¶o ¶ 
ALP CTGATGTGGAGTATGAGAGT AGTGGGAGTGCTTGTATC 
OCN CAGCGAGGTAGTGAAGAG GATGTGGTCAGCCAACTC 
BSP GGCTACGATGGCTATGAT ACCTTCCTGAGTTGAACTT 
Cbfa1 AGCTTGATGACTCTAAACCTA GGTCTGTAATCTGACTCTGT 
GAPDH TGACAACAGCCTCAAGAT GTCCTTCCACGATACCAA 
Statistical analysis: The results given were representative of three independent 
experiments. Data were analyzed by means of one-factor ANOVA or multifactor 
ANOVA using STATGRAPHICS Centurion XV. 
4.3 Results  
4.3.1 Characterization of nanofibers 
With or without Dex loaded, uniform and smooth nanofibers were produced using 
electrospinning technique (Figure 4.1). According to the result of fibrous diameters 
shown in Table 4.2, there was no significant difference in diameter between PLLA 
nanofibers and PLLA nanofibers loaded with 0.333% Dex (p < 0.05). The 
hydrophobicity test (as measured by water contact angle) shown in Table 4.2 also 
indicated that with this concentration of Dex loaded, the hydrophobicity of the 
scaffolds was not significantly changed (p < 0.05). However, blending Dex into 
PLLA scaffolds increased the tensile property of the nanofibers as shown by tensile 
stress-strain curves in Figure 4.2 and VLJQLILFDQWO\KLJKHU<RXQJ¶VPRGXOXVWKDQSXUH
PLLA nanofibers in Table 4.2 (p < 0.05). 




Figure 4.1 The SEM images of the nanofibrous scaffolds at 4000X magnification: A) PLLA, and B) Dex-loaded 
PLLA. 
Table 4.2 The material characterization of PLLA and Dex-loaded PLLA nanofibrous scaffolds 








PLLA 501 r 63 144 r 2 69 r 3 
Dex-loaded PLLA 530 r 100 143 r 2 91 r 5* 
Each value represents mean and standard deviation of three independent samples. Significant difference in 
<RXQJ¶VPRGXOXVRI'H[-loaded PLLA scaffolds from PLLA scaffolds was denoted as * (p < 0.05) 
 
Figure 4.2 Tensile stress-strain curves of PLLA and Dex-loaded PLLA scaffolds 
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4.3.2 In vitro release study of Dex from PLLA scaffolds 
The release profile of Dex from the nanofibrous PLLA scaffolds was shown in Figure 
4.3. The curve showed an initial burst release of Dex during first 12 hr. At this time 
point, the accumulative released Dex concentration was 1218.301 Pg/L. This 
accumulative amount hold 17% of total Dex loaded in each scaffold. Especially, 
PLLA nanofibers loaded with 0.333% Dex indicated a continuous release for over 2 
months. After 2 months, approximately 68% of total initial loaded Dex was released 
from PLLA scaffolds. 
 
Figure 4.3 Sustained release profile of Dex-loaded PLLA nanofibrous scaffolds for over 2 months. 
4.3.3 Cell morphology 
The morphologies of human MSCs after 14 days of culture on PLLA and Dex-loaded 
PLLA scaffolds, in growth and Ost-Dex media were illustrated in Figure 4.4. In both 
media, human MSCs on PLLA scaffolds loaded with Dex became cuboidal in shape, 
which was different from fibroblast-like spindle shapes of human MSCs on PLLA 
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scaffolds without Dex. The osteoblastic cell morphology was obviously observed in 
the case of culturing human MSCs on the scaffolds supplemented with 0.333% Dex 
and in Ost-Dex medium. 
 
Figure 4.4 Actin Cytoskeleton and Focal Adhesion staining of human MSCs cultured in different conditions after 
14 days: (A) PLLA scaffolds in the growth medium, (B) Dex-loaded PLLA scaffolds in the growth medium, (C) 
PLLA scaffolds in the Ost-Dex medium, and (D) Dex-loaded PLLA scaffolds in the Ost-Dex medium. 
4.3.4 Cell proliferation 
Figure 4.5 showed the proliferation of human MSCs on different scaffolds after 7, 14, 
21 and 28 days cultured in growth and Ost-Dex media. In both media, compared to 
PLLA nanofibers, the number of viable cells on the Dex-loaded nanofibers was 
considerably higher (p < 0.05). Meanwhile, the cells in the control case (PLLA 
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nanofibers in the Ost medium) were less proliferative than the rest. In all investigated 
cases, human MSCs were continuously proliferated during 28 days of culture.  
 
Figure 4.5 Cell proliferation of human MSCs cultured on PLLA and Dex-loaded PLLA scaffolds in the growth and 
Ost-Dex media at different time points (7, 14, 21 and 28 days). Significant difference of investigated groups was 
denoted as * (p < 0.05). The cells were also cultured on the PLLA nanofibers in the Ost medium as a control. 
4.3.5 Alkaline phosphatase activity 
ALP is an early marker of osteogenic differentiation of human MSCs. ALP activity of 
human MSCs seeded on different scaffolds and media were indicated in Figure 4.6. 
The human MSCs cultured on Dex-loaded PLLA nanofibers had significantly higher 
ALP activity than human MSCs cultured on the scaffolds without Dex in both growth 
and the Ost-Dex media (p < 0.05). ALP activities of the human MSCs on the scaffolds 
loaded with Dex quickly enhanced after 7 days of culture, achieved a maximal value 
on the 14th day, and decreased afterwards. Meanwhile, ALP activity of the cells on the 
PLLA nanofibers cultured in the growth medium was extremely low on the 7th day, 
and no significant change during the following days. The cells on PLLA nanofibers 
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exposed to the Ost-Dex medium also showed a remarkably low ALP activity on the 7th 
day, but this value was considerably increased after 14 days of culture, and then 
slightly increased on the 21st day. The cells achieved the highest ALP activity when 
cultured on the PLLA scaffolds in the Ost medium (positive control). 
 
Figure 4.6 ALP activity of human MSCs cultured on PLLA and Dex-loaded PLLA scaffolds in the growth and 
Ost-Dex media at different time points (7, 14 and 21 days). The ALP activity was normalized by the number of 
viable cells. Significant difference of investigated groups was denoted as * (p < 0.05). The cells were also cultured 
on the PLLA nanofibers in the Ost medium as a positive control. 
4.3.6 Osteoblastic gene expression 
The expressions of osteoblastic genes (ALP, OCN, BSP and Cbfa1) of human MSCs 
in different conditions after 14 and 21 days of culture were shown in Figure 4.7. 
Influence of different types of scaffolds and media on the profile of ALP expression 
was similar to their influence on ALP activity (p < 0.05) (Figure 4.7A). Contrary to 
ALP, the cells cultured on Dex-loaded PLLA nanofibers expressed lower levels of 
OCN compared to the scaffolds without Dex, in both media (p < 0.05) (Figure 4.7B).  
There was a tendency towards increased expression of OCN from day 14 to day 21.  
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There was almost no expression of BSP secreted by human MSCs on both types of 
scaffolds in the growth medium (Figure 4.7C). Meanwhile, strong BSP expression 
was observed for the cells cultured in Ost-Dex medium. In this medium, on the 14th 
day, there was a significantly higher in BSP expression of human MSCs on Dex-
loaded PLLA nanofibers than the cells on nanofibers without Dex (p < 0.05). The 
expression of the cells on the scaffolds loaded with Dex demonstrated a trend towards 
decrease on the 21st day. On the contrary, human MSCs on the PLLA scaffolds 
increased BSP expression from day 14 to day 21. In both media, the expression levels 
of Cbfa1 had no considerable difference between two types of scaffolds (p < 0.05) 
(Figure 4.7D). 
 
Figure 4.7 Normalized gene expression of human MSCs cultured on PLLA and Dex-loaded PLLA scaffolds in the 
growth and Ost-Dex media after 14 and 21 days: (A) ALP, (B) OCN, (C) BSP, and (D) Cbfa1. Significant difference 
of investigated groups was denoted as * (p < 0.05). 
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4.3.7 Matrix mineralization 
The results of calcium deposition on the scaffolds with/without Dex after 14, 21 and 
28 days of culture with human MSCs in the growth/Ost-Dex medium were illustrated in 
Figure 4.8. In the Ost-Dex medium, the calcium deposited on the PLLA scaffolds 
loaded with 0.333% Dex was significantly higher than on the PLLA nanofibers 
without Dex (p < 0.05). The calcium amounts produced per cell were approximately 5 
times and 2 times higher on the 21st day and the 28th day, respectively. In contrast to 
the Ost-Dex medium, human MSCs cultured in the growth medium on the scaffolds 
with or without Dex showed extremely low calcium contents after 28 days of culture. 
Noticeably, the cells on Dex-loaded PLLA nanofibers showed a trend towards 
increased calcium amount on the 28th day cultured in the growth medium. Meanwhile, 
as a positive control, the cells on the PLLA scaffolds in the Ost medium showed the 
highest calcium deposition. 
 
Chapter 4 ² Osteoinductive Dex-loaded Nanofibers 
 132 
 
Figure 4.8 Calcium deposition on PLLA and Dex-loaded PLLA scaffolds in the growth and Ost-Dex media after 21 
and 28 days of culture with human MSCs. The calcium content was normalized by the number of viable cells. 
Significant difference of investigated groups was denoted as * (p < 0.05). The cells were also cultured on the 
PLLA nanofibers in the Ost medium as a positive control. 
The ARS staining was performed for the cells cultured on both types of scaffolds in 
the Ost-Dex medium on the 28th day to observe the calcium deposition of the ECM 
(Figure 4.9). Agreed with the quantitative result shown in Figure 4.8, orange-red spots 
were obviously viewed on the Dex-loaded PLLA scaffolds (Figure 4.9B). Meanwhile, 
the calcium deposition on the PLLA scaffolds without Dex was undetectable using 
ARS staining (Figure 4.9A).  
 
Figure 4.9 ARS staining of human MSCs cultured on different scaffolds in the Ost-Dex medim after 28 days: (A) 
PLLA, and (B) Dex-loaded PLLA. The scale bar is 100Pm. 
The mineralization of the ECM was also analyzed by SEM-EDX (Figure 4.10). The 
SEM images of the cells/Dex 0.333% scaffolds on the 21st day showed the formation 
of large number of bone minerals on the cellular surfaces (Figure 4.10A). The bone 
nodules were also clearly observed by SEM (Figure 4.10B). The Ca/P ratio of the 
mineral determined by EDX was 1.42 r 0.03 (n = 3), similar to its ratio in the natural 
HA (Figure 4.10C). 




Figure 4.10 SEM images of human MSCs cultured on the Dex-loaded PLLA scaffolds in the Ost-Dex medium after 
21 days. Bone minerals were produced on the cellular surfaces: (A) 4000X magnification, (B) 16000X 
magnification, and (C) The Ca/P ratio of the bone nodules was 1.42 r 0.03 (n = 3) as analyzed by EDX. 
4.4 Discussion 
Electrospun nanofibers possess many advantages for a novel drug delivery system. 
They offer the site-specific drug delivery by implanting the scaffolds containing drugs 
directly into the defects. Additionally, the drugs can be incorporated into polymeric 
carriers more conveniently than other complicated encapsulation processes. Also, the 
therapeutic compound ± scaffold complexes can be delivered using different target 
geometries by fabricating and cutting into desired shapes [308,309]. There was one 
study by Martin et al. (2010) demonstrated loading Dex into nanofibrous scaffolds 
using electrospinning technique [310]. The authors incorporated 15 wt% Dex into 
poly(H-caprolactone) (PCL) to induce osteogenic differentiation of human MSCs. Dex 
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released from these scaffolds enhanced significantly matrix mineralization. However, 
the fibers fabricated with this concentration were not drastically uniform. Many of 
them were microfibers and broken. In addition to affecting nanofibrous morphology, 
this high Dex concentration might cause side effects on long-term cellular activity. 
In our study, a remarkable lower concentration of Dex, 0.333 wt%, was used to 
develop osteoinductive nanofibrous scaffolds. In addition, a different biodegradable 
polymer, PLLA, was chosen because the degradation through nonenzymatical 
hydrolyzation in vivo into lower molecular weight PLLA was found to increase the 
differentiation of mouse osteoblast-like cells [311].  
4.4.1 Physical properties of nanofibrous scaffolds 
The results of characterization study (Figure 4.1 and Table 4.2) indicated that loading 
with 0.333 wt% Dex into PLLA nanofibers did not affect their morphology as well as 
hydrophobicity. With or without Dex loaded, the fibers produced were continuous, 
smooth and uniform. Their fibrous diameters were also not influenced by adding Dex. 
Although Fourier transform infrared spectroscopy (FTIR) and X-ray photoelectron 
spectroscopy (XPS) were used to identify the presence of Dex in the Dex-loaded 
PLLA nanofibers through the presence of specific peaks in the spectra, it was 
unsuccessful since the Dex amount was too low to be detected (data not shown). 
However, the presence of Dex was demonstrated in an indirect way, through tensile 
properties of nanofibers. Tensile strength and <RXQJ¶VPRGXOXVRI'H[-loaded PLLA 
scaffolds was significantly higher than pure PLLA scaffolds (Figure 4.2 and Table 
4.2). As such, blending Dex into PLLA was not merely a mix, but there might be 
interactions between the drug and the polymer which helped to increase the tensile 
strength. Lin et al. also showed that the tensile strength of the piroxicam-loaded film 
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was significantly higher than the drug-free film [312]. There might be an existence of 
intermolecular hydrogen bonding between Dex and PLLA. In addition, due to the 
nano size of the fibers, Van der Waals force which could be responsible for the 
adhesion of the nanofibers and the drug molecules [313-315]. This adhesion was also 
enhanced by hydrophobic interactions between hydrophobic molecules, Dex and 
PLLA. These interactions could help to retard the initial burst release of Dex from 
PLLA nanofibers and keep the drug longer inside the nanofibers. In addition, the 
enhanced tensile property (from 69 to 91MPa) would be a benefit for the Dex-loaded 
scaffold to become a bone graft material.  
4.4.2 In vitro release study of Dex from PLLA scaffolds 
After 12 hr of the incubation, it was calculated that approximately 17% of total initial 
loaded Dex was released from PLLA nanofibrous scaffolds. This initial quick release 
may derive from the diffusion of drugs distributed at or close to the surface of 
nanofibers. The paracetanol molecules dispersed close to the polymer film surface 
also induced an initial burst in the initial incubation time [309]. With 0.333% Dex 
blended, the ratio of burst release of our scaffolds was similar to Dex-loaded porous 
PLGA scaffolds [306]. In addition, this ratio was much lower than many other types 
of scaffolds ± a significant advantage of loading Dex into nanofibrous scaffolds. 
Using supercritical fluid impregnation process to incorporate Dex into freeze-dried 
chitosan scaffolds, this process resulted in the drug being released extremely quickly 
[316]. Nearly 90% of the drug was released just after 2 hr, and the rest was released 
over the next 6 hr. This was due to the fact that the high swellability of the chitosan 
scaffold facilitated the drug diffusion. Drugs that are loaded onto scaffolds post 
fabrication by surface adsorption are easily eluded in comparison with drugs that are 
loaded by blending it with the polymer prior to scaffold fabrication as in the case of 
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our Dex/PLLA system. Furthermore, PLLA, because of its hydrophobicity, has less 
swellability. Therefore, the drug release from Dex-loaded PLLA was retarded due to 
its less swellability. Although conjugating Dex to polymers such as 
poly(hydroxypropyl methacrylamide) (HPMA) and PEG by chemical synthesis can 
cause the drug to be released without an initial burst release due to the strong covalent 
bonds; in this situation, most of the Dex released were Dex conjugates and not free 
Dex [307,317,318]. So, the bioactivity and potential side effects need to be examined 
further. Moreover, very slow release of Dex from these scaffolds might delay the 
differentiation as there was not enough Dex at the early stage to initiate the 
differentiation process. 
As discussed above, the interactions between Dex and PLLA could help to slow down 
the initial quick release as well as maintain the drug in the nanofibers for a long 
period of time. On the other hand, the large surface area to volume ratio of the 
nanofibers increases the release rate of the drug molecules [308]. As such, the release 
rate of Dex from the nanofibers is a complex combination of many opposing factors. 
When Dex was blended with PLLA before electrospinning, it was assumed that 
because of their good compatibility, Dex was mixed and entrapped evenly at 
molecular level throughout the PLLA nanofibers. That could be one of the reasons 
why the initial release ratio of Dex from PLLA scaffolds was significantly lower than 
other scaffolds. Maretschek et al. (2008) also proposed that incorporating lipophilic 
molecules into polymeric matrix usually led the homogenous dispersion of the drugs 
inside the fibers. Meanwhile, hydrophilic molecules are normally located at the 
surface and induce a very high burst release [319]. The study of Kim H. et al. (2003) 
also showed the extremely high burst release of AsP ± a hydrophilic molecule, up to 
70.2%, compared with just 11.1% of Dex ± a lipophilic molecule from the porous 
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PLGA scaffolds loaded with 320Pg and 3300Pg of Dex and AsP, respectively, per 
gram of PLGA [306].  
In the study of Martin et al. (2010), although Dex was also loaded into a polymeric 
matrix by blending it with PCL prior to electrospinning, approximately 50% of initial 
loaded Dex was quickly released from the fibers after 12 hr of incubation with the 
initial concentration of 15 wt% Dex to PCL [310]. This burst release ratio was 
remarkably higher than our corresponded ratio, 17%. One possible explanation was 
that mixing such a large amount of the drug as demonstrated in that study interfered 
with the distribution of Dex in the polymer solution as well as the solution 
conductivity. These factors affected the electrospinning jet which might lead to an 
unequal distribution of Dex in the fibers, with most of the drugs located at or close to 
the surface. Additionally, those factors also induced the fibrous morphology to 
become notably uneven as a mixture of nanofibers and microfibers shown in SEM 
images of that study. Also, many fibers were obviously broken. This discontinuity of 
the fibers might be one more reason which accelerated the Dex release from the PCL 
fibers.  
Jaiswal et al. (1997) used media containing 1 to 1000nM Dex to optimize the 
osteogenic differentiation of human MSCs, and 100nM Dex was found to be the 
optimal concentration for the expression of osteogenic markers and the formation of 
mineralized ECM [279]. Based on the release curve of 15 wt% 'H[DQGWKHVFDIIROG¶V
PDVVLQ0DUWLQ¶VVWXG\LWZDVFDOFXODWHGWKDWDIWHUhr, approximately 112.5mg of 
Dex was released from one PCL sheet used for cell culture [310]. Meanwhile, in the 
standard Ost medium, with the concentration of 100nM Dex, it is approximately 
0.02Pg Dex supplemented into the medium every three days. As such, within first 12 
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hr, the PCL nanofibers released an amount of roughly 5 million times higher than the 
standard condition. The initial incubation time is a critical period for cells to get stable 
in the medium. So, that tremendously high concentration might seriously interfere 
with cellular properties. In the following days, Dex was also released with thousands 
of times higher than the standard. Such extremely high concentrations not only wasted 
Dex, but also may cause adverse effects on in vitro cell proliferation and 
differentiation, or glucocorticoid-induced osteoporosis as shown clinically [320,321]. 
In our study, within 12 hr of the initial incubation time, Dex released from one 15 
mm-diameter PLLA nanofibrous mesh was 0.61 Pg, which was approximately 30 
times higher than the standard Ost medium. Figure 4.3 also indicated a sustained Dex 
release for over 2 months. Except for the burst release, in the rest of the profile, it was 
estimated that about 0.02 a 0.2Pg Dex was stably released every three days which 
was close to the standard concentration. This ideal release was the main reason why 
we chose the concentration of 0.333 wt% for loading Dex into nanofibrous PLLA.  
It was supposed that there were many stages of the Dex release from nanofibers. 
Firstly, the drugs distributed at or close to the nanofibrous surface were quickly 
diffused in the initial incubation time. Subsequently, the inner drugs were released by 
the influence of two mechanisms: the molecular diffusion of the drug out of the fibers 
due to a concentration gradient and the macromolecular relaxation due to the water 
uptake into the polymeric scaffolds [322]. In addition, the pores left after the initial 
diffusion were also important for further release of the drugs from the inner parts of 
the fibers. For long-term culture, matrix degradation may contribute to the release of 
Dex from the biodegradable polymer. The degradation rate of PLLA is over 24 
months [323], so it may take at least two years to release all Dex molecules into the 
surrounding tissue in vivo. In modeling the release profile over a period of 2 months, 
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we did not take into account the degradation of the bioactivity of Dex over a 
prolonged period of time. 
Taken together, loading 0.333 wt% Dex into nanofibrous PLLA using electrospinning 
technique demonstrated substantial benefits. The ratio of burst release in the first 12 
hr, 17%, was much lower than many other types of scaffolds. Moreover, Dex-loaded 
PLLA nanofibers showed a sustained release profile for over 2 months with 
concentrations close to the concentration of Dex in the standard Ost medium. Dex not 
only initiates the differentiation of MSCs at early stage, it also directs the cells toward 
mature osteoblasts at late stages. So, the sustained release of Dex from these scaffolds 
was critical to achieve maximal osteogenic differentiation of human MSCs by 
providing a sustained osteoinductive environment surrounding the cells. 
4.4.3 Dex-loaded PLLA nanofibers as osteoinductive scaffolds 
For both types of media, nanofibrous PLLA scaffolds loaded with 0.333 wt% Dex 
showed significant advantages compared to the nanofibers without Dex. The 
Dex/PLLA scaffolds had slightly higher cell proliferation and significantly higher 
ALP activity ± an early marker of osteogenic differentiation (Figure 4.5 and Figure 
4.6). ALP is necessary for mineralization process by hydrolyzing organic phosphate 
to inorganic phosphate which results in precipitation of HA. In addition, human MSCs 
on these scaffolds became more cuboidal in shape, which is an important signal of 
differentiation into osteoblastic cells (Figure 4.4). OCN is a specific marker for the 
late stage of osteogenic differentiation, and plays an important role in regulating bone 
formation and mineralization. It binds tightly and modulates the growth of HA 
crystals [289]. Although the expression level of OCN was lower for Dex/PLLA 
scaffolds; in fact, all normalized values (normalized by the expression of human 
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MSCs on tissue culture polystyrene plates in the growth medium) shown in Figure 
4.7B, about 1 a 4, were much lower than the ones expected in a bone matrix. It might 
be due to the fact that the cells needed vitamin D to accelerate the synthesis of OCN 
[279,298], which was not supplemented in the media of this study. Additionally, it is 
necessarily noticed that OCN is widely used as a specific marker of late osteoblastic 
expression because it seems only expressed by mature osteoblasts. The binding of 
OCN to HA could block growth sites of HA and inhibit further crystal growth. So, the 
role of OCN is not to initiate, but to regulate the bone mineralization. On the contrary, 
ALP is required for precipitation of HA. As such, Dex released from the PLLA 
nanofibers enhanced cell proliferation and differentiation of human MSCs which was 
proved by the cuboidal shape and the increased ALP activity. 
In addition to the common advantages of Dex-loaded PLLA scaffolds in comparison 
with pure PLLA scaffolds as shown in both media, human MSCs cultured on the 
former indicated distinct advantages over the latter in the Ost-Dex medium. On the 14th 
day, the expression of BSP ± a late marker of osteogenic differentiation - was 
considerably higher for the cells differentiated on the Dex/PLLA scaffolds (Figure 
4.7C). BSP, known as BSP-2, is a major non-collagenous protein and highly specific 
in mineralizing tissues. BSP exhibits a high nucleation activity which plays an 
important role in initiation of the mineralization process [290]. It is also interesting to 
note that in this medium, the cells on the scaffolds blended with Dex approached 
maximum levels in the expression of ALP and BSP after 14 days of culture and 
decreased afterwards. Meanwhile, the cells on the scaffolds alone demonstrated a 
continuous increase during 21 days. These findings suggested that the Dex-loaded 
PLLA scaffolds might accelerated the differentiation of human MSCs towards mature 
osteoblasts. Together with the osteoblastic morphology as shown in Figure 4.4D, it 
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could be said that in the Ost-Dex medium, Dex released from the PLLA nanofibers 
successfully differentiated human MSCs into osteoblasts after culturing for 14 days. 
Without Dex, the cells on the pure nanofibers in the Ost-Dex medium might also have 
the ability to differentiate, but the speed of this process was remarkably low. 
Importantly, in the Ost-Dex medium, the cells on Dex-loaded PLLA nanofibers also 
indicated a strong matrix mineralization. A large amount of calcium was deposited on 
these scaffolds compared to the scaffolds without Dex as shown by calcium content 
on the 21st and the 28th days and ARS staining on the 28th day (Figure 4.8 and Figure 
4.9). In addition, the SEM images showed the formation of many HA-like 
minerals/bone nodules on the cellular surfaces of Dex-loaded scaffolds after 21 days 
cultured (Figure 4.10). Meanwhile, a small amount of calcium was produced on the 
scaffolds without Dex, but it was too low to be detected by ARS staining. As such, in 
the Ost-Dex medium, human MSCs cultured on Dex-loaded PLLA scaffolds strongly 
differentiated into mature osteoblasts and significantly produced bone minerals on the 
cellular surface. 
Although Dex-loaded PLLA scaffolds showed their advantages over the scaffolds 
without Dex in the growth medium, it was insufficient to differentiate human MSCs 
into mature osteoblasts. BSP expression was extremely low for both types of scaffolds 
in this medium (Figure 4.7C). Similarly, the expression levels of Cbfa1 were 
considerably lower than the Ost-Dex medium. In addition, there was almost no calcium 
produced in the growth medium, although there was a trend towards a slight increase 
in calcium amount on the 28th day for the scaffolds loaded with Dex (Figure 4.8). This 
finding demonstrated that not only Dex, other components in the Ost medium ȕ-GP 
and AsP) also played an important role in osteogenic differentiation of human MSCs. 
ȕ-GP was considered as a source of phosphate ions in vitro and necessary for 
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mineralization [279,324]. Anderson RE (1984) has showed that ascorbic acid is 
essential to enhance ALP activity in cultures of osteoblast-like cells [325]. However, 
because this chemical is unstable in solution at 37oC and neutral pH, AsP, a stable 
analogue and has similar bioactivity in cell culture, has been used instead [326]. 
Therefore, for scaffolds loaded with Dex, it is crucial to culture human MSCs in the 
Ost-Dex medium to differentiate the cells in vitro. The study of Martin et al. (2010) 
also indicated that human MSCs cultured on PCL nanofibers loaded with 15 wt% Dex 
were fully differentiated only in the Ost-Dex medium [310]. For in vivo studies, organic 
phosphates and ascorbic acid can be supplied through nutrients in blood vessel 
system.  
The cell culture results throughout this article demonstrated strong effects of the Dex-
loaded PLLA nanofibers on the osteogenic differentiation of human MSCs. In 
addition to the osteoinductivity, the Dex-loaded PLLA scaffold demonstrated its 
osteoconductivity as evident by spreading cells on day 14 (Figure 4.4), continuous 
cell growth during 28 days (Figure 4.5) and a scaffold surface almost fully covered by 
the cells on day 21 (Figure 4.10). However, their osteoinduction efficiency was still 
lower than the cells cultured in the Ost medium containing 100nM Dex (positive 
control) as shown by lower ALP activity and calcium deposition (Figure 4.6 and 
Figure 4.8), although the in vitro release profile indicated the similarity of 
accumulative Dex concentrations to this standard concentration. It might be due to the 
fact that the in vitro release was performed in a dynamic condition (shaking) to mimic 
the in vivo condition, whereas the cell culture study was performed in a static 
condition. Therefore, the release profile of Dex in the cell culture study might be 
different from the in vitro release study. Further dynamic cell culture study should be 
done to indicate the efficiency of these Dex-loaded PLLA nanofibers.  
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Taken together, in the Ost-Dex medium, PLLA nanofibers loaded with 0.333 wt% Dex 
strongly differentiated human MSCs into mature osteoblasts with a large amount of 
bone minerals produced. In addition, these scaffolds slightly increased the 
proliferation of human MSCs. AdGLWLRQDOO\ȕ-GP and AsP showed their importance 
to osteogenic differentiation of human MSCs. These findings also demonstrated that 
Dex still maintained its bioactivity in spite of the use of HFP solvent and the 
electrospinning process. As such, our PLLA nanofibers can be an effective carrier for 
the delivery of Dex and act as an osteoinductive scaffold for the differentiation of 
human MSCs. 
4.5 Conclusion 
The nanofibrous PLLA scaffolds loaded with 0.333 wt% Dex increased the tensile 
strength of the nanofibers and indicated a sustained release profile for over 2 months 
with accumulative concentrations every three days close to the concentration used in 
the standard Ost medium. This release provided a sustained osteoinductive 
environment surrounding human MSCs. Consequently, the cells cultured in the Ost-
Dex medium on the Dex-loaded PLLA nanofibers were strongly differentiated into 
mature osteoblasts with high levels of ALP activity, BSP expression and matrix 
mineralization as well as the formation of osteoblastic morphology. The 
osteoconductivity of the Dex-loaded PLLA scaffold was also proven by the spreading 
and continuous growth of human MSCs and their differentiated cells during 28 days 
of in vitro culture.  In addition WKH SUHVHQFH RI ȕ-GP and AsP was shown to be 
important to the osteogenic differentiation.  
(Note: Most of the text and results in this chapter have been published and reprinted 
from Journal of Biomaterials Science, Polymer Edition 23(14). Luong TH Nguyen, 
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Susan Liao, Casey K Chan and Seeram Ramakrishna. Electrospun Poly(L-lactic acid) 
Nanofibres Loaded with Dexamethasone to Induce Osteogenic Differentiation of 
Human Mesenchymal Stem Cells, 1771-1791, Copyright 2012, with permission from 
Taylor & Francis) 
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Chapter 5  
Osteoinductive Biomimetic Nanocomposites  
5.1 Introduction 
Osteogenic differentiation of bone-marrow stromal cells on plastic tissue culture 
plates has conventionally been achieved in media supplemented with osteogenic 
solutes, which can be chemicals (such as Dex, AsP, and ȕ-GP) [279] or growth factors 
(for example, BMPs [327], bFGF [328], or TGF-ȕ [329]). Modulating stem-cell 
behaviour by using the physical properties of the substrate has emerged as a preferred 
approach over using chemical treatments [120], as osteogenic solutes are generally 
unstable and expensive, and it is difficult to control the differentiation process without 
unwanted effects. For example, it has been demonstrated that in the absence of Dex, 
flow perfusion can induce osteoblastic differentiation of bone-marrow stromal cells 
cultured on titanium microfibrous scaffolds [330]. In a separate study [146], 
reprogramming of the osteogenic lineage during the first week in cell culture was 
achieved through the addition of soluble factors; after several weeks in culture on stiff 
matrices of 25-40 kPa, MSCs had committed to an osteoblastic lineage. These results 
are in agreement with another study [330], in which MSCs typically responded to 
metal implants by producing, over long time-scales, bone rather than soft tissues. 
Also, substrate topographies ² such as grooves, ridges, pits, pores, tubes or pillars ² 
with appropriate sizes were shown to induce osteogenic differentiation of stem cells 
[43,120,132,139]. Ectopic bone formation (that is, bone formation at a site other than 
the natural one) was achieved using an injectable calcium phosphate hydrogel with 
undifferentiated MSCs [331]. These studies suggested that it might be possible to 
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induce differentiation without osteogenic supplements by providing suitable 
substrates or scaffolds and other environmental stimuli. However, conflicting views 
still exist regarding the effects of these biomaterials on the direct differentiation of 
MSCs in the absence of osteogenic supplements. 
In general, the ECM complex, with their several nanocues, mediates the cell shape, 
provides a local environment, and binds to soluble factors. Therefore, scaffolds with 
nanocues, such as nanofiber features, have been intensively applied to tissue 
regeneration. Cell adhesion to nanofibers was found to occur quickly, within one hour 
or less, and the adhesive efficacy was significantly improved by coating the 
nanofibers with small adhesive molecules [332,333]. The large surface area of the 
nanofibrous scaffolds could provide adequate binding sites for serum proteins in the 
cell culture medium and for cell membrane receptors, which in turn could support 
sustainable proliferation. Nanofibers also promote multiple lineage commitments of 
the MSCs in concert with soluble factors in the medium [334,335]. Unlike hydrogels, 
which prevent changes in cell morphology, nanofibrous scaffolds with high porosities 
provide space for cell extension and cell migration, both of which are crucial for bone 
repair.  
The most distinctive difference between hard and soft tissues in terms of ECM 
components concerns the presence or absence of nano-HA, which provides the high 
mechanical strength required to protect organs and tissues. Nano-HA strongly binds 
fibronectin and vitronectin, which are ligands for the integrin family of cell-adhesion 
receptors [336]. Integrins are thought to be important in mediating the adhesion of 
MSCs and osteoblasts. In addition, the differentiation of osteoblasts on nanofibrous 
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scaffolds with HA is enhanced compared with that on scaffolds without HA [337-
339]. 
In the present study, we have investigated the specific microenvironmental cues that 
are necessary to induce osteogenic differentiation of MSCs. In particular, these cues 
included nanofibrous topography and nano-HA particles. We hypothesized that the 
biomimetic scaffolds with a sustainable local supply of Ca/P ions would effectively 
induce osteogenic differentiation of stem cells without the need for osteogenic solutes. 
The biomimetic scaffolds with distinct nanotopographies and with components 
similar to the ECM of native bone could serve as control systems for osteogenic 
differentiation. The osteoinductivity was determined by culturing human MSCs on the 
biomimetic nanocomposite scaffolds in media without soluble osteogenic 
supplements. The cells cultured on these scaffolds in Ost medium were used as 
controls. In addition, the osteoinductivity of the scaffolds was assessed using 
subcutaneous implantation in a nude-mouse model. 
5.2 Materials and methods 
Materials: Nanocomposites were made based on the previously published two-step 
electrospinning and mineralization procedure [184]. Nanofibers of pure PLLA 
(300,000 Da) or blended PLLA and type I Col (Atelocollagen, Koken, Tokyo, Japan) 
with a weight ratio of 80:20, at the concentration of 3 wt% in HFP were fabricated by 
electrospinning with the procedures as mentioned in section 3.2.  All nanofibers were 
collected on coverslips of 15-mm diameter for cell culture studies. 
The nanofibrous scaffolds were mineralizeG XVLQJ WKH PRGL¿HG DOWHUQDWH-soaking 
method (Ca/P soaking) [340]. The scaffolds were immersed in a 0.5 M calcium-
Chapter 5 - Osteoinductive Biomimetic Nanocomposites 
 148 
 
chloride solution (Sigma-Aldrich) for 10 min. After being rinsed with DI water for 1 
min, the scaffolds were immersed in a 0.3 M solution of disodium phosphate (Merck, 
Whitehouse Station, NJ, USA) for 10 min. After being rinsed with DI water for 1-2 
min, the mineralized scaffolds were subsequently freeze-dried for 24 hr. Scaffolds 
treated by artificial mineralization were defined as PLLA/HA and PLLA/Col/HA.  
Material characterization: The fiber morphology of the all scaffolds was examined 
XVLQJ ¿HOG-emission scanning electron microscopy (FESEM) with an accelerating 
YROWDJHRIN97KHDYHUDJH¿EUHGLDPHWHURf the scaffolds (n=20) were determined 
from the FESEM micrographs using image-analysis software (Image J1.41, National 
Institutes of Health, Bethesda, MD, USA  7KH K\GURSKLOLFLW\ RI WKH QDQR¿EHUV
before and after mineralization, was measured according to the sessile-drop contact-
angle measurement using a VCA Optima Surface Analysis System. To quantify the 
DPRXQWRI+$RQWKH¿EUHVWKHUPRJUDYLPHWU\DQDO\VLV7*$7$,QVWUXPHQWV7*$
2050 Thermogravimetric Analyzer, Tokyo, Japan) was employed. The specimens 
(n=3±5) were heated to 1000°C at a rate of 10°C/min in air. The specific surface area 
of the substrates was studied using the Brunauer±Emmett±Teller (BET) Analyzer 
(NOVA-3000 Ver 6.07, Quantachrome Instruments, Boynton Beach, FL, USA). The 
scaffolds (n>5) were degassed at room temperature for one day before measurements 
were taken. 
Cell Culture: Human MSCs were cultured until passage 6 with the procedures as 
mentioned in section 3.2. Ten thousand cells were seeded onto each of the scaffolds in 
the growth medium. The cells on the scaffolds were also cultured in the Ost medium 
as positive controls.  
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Cell viability and proliferation: the cell viability and proliferation were evaluated at 
determined time points during the cell culture (days 4, 7, 10, 16 and 22), using a MTS 
assay as mentioned in section 3.2. 
Alkaline phosphatase activity: ALP activity was detected using the Phosphatase 
Substrate Kit as mentioned in section 3.2, at predetermined time intervals (4, 7, 10, 16 
and 22 days). 
Gene expression: MSCs on the scaffolds after 10, 16 and 22 days of culture were 
examined for gene expression using the commercialized kits as mentioned in section 
3.2. Designed primers of OCN, OPN, Cbfa1 and GAPDH are shown in Table 5.1. 
Table 5.1 Designed primers for real-time PCR 
Gene )RUZDUGSULPHUV¶o ¶ Reverse primers (¶o ¶ 
OCN ACCGAGACACCATGAGAG TCTTCACTACCTCGCTGC 
OPN ATGTGATTGATAGTCAGGAA GTCTACAACCAGCATATCT 
Cbfa1 CACTCACTACCACACCTACC ATCCTGACGAAGTGCCATAG 
GAPDH CATGAGAAGTATGACAACAG ATGAGTCCTTCCACGATA 
Observation of cell morphology and bone minerals: After 10 days and 16 days of 
seeding the human MSCs, the medium was removed, and the samples were analyzed 
by SEM-EDX method as mentioned in section 3.2. 
Quantification of calcium deposition: The samples collected at days 10, 16 and 22 
were rinsed with PBS and subsequently processed for calcium quantification using the 
colorimetric assay as mentioned in section 3.2. For the mineralized scaffolds, the 
amount of calcium was subtracted from the original HA amount. 
Immunohistochemical staining: At predetermined time points, the medium was 
removed from the samples, and the cells were fixed in 4% paraformaldehyde for 40 
Chapter 5 - Osteoinductive Biomimetic Nanocomposites 
 150 
 
min at room temperature. After washing with PBS, a blocking solution, of 2% BSA, 
was applied overnight at 4oC. The samples were then washed with PBS and incubated 
with primary antibodies (CD44 (Millipore), CD90 (Millipore), CD146 (Millipore), 
CD19 (Millipore), CD14 (Millipore), OCN (Invitrogen), FABP-4 (R&D Systems) or 
aggrecan (R&D Systems)) overnight at 4oC. The next day, the cells were washed 
twice with PBS (5-10 min each) and twice with the blocking solution. The cells were 
subsequently incubated with the secondary antibodies conjugated with FITC 
(Millipore) or rhodamine (R&D Systems) in the dark for 90 min at room temperature. 
After washing 3±5 times (5±10 min each) with PBS, the cell nuclei were 
counterstained with DAPI for 30 min at room temperature. The samples were then 
washed twice with PBS and mounted on glass slides before imaging with the confocal 
laser scanning microscopy. 
Alizarin red S staining: this method is the same to that mentioned in section 3.2. 
Implant preparation for the in vivo study: Six types of implants were used in the 
animal study: PLLA/Col; PLLA/Col/HA; PLLA/Col+MSC; PLLA/Col/HA+MSC; 
Col membrane; and Col membrane/BMP-2. The PLLA/Col and the PLLA/Col/HA 
scaffolds were prepared as described above. The scaffolds were then cut into squares 
measuring 8 × 8 mm and gamma sterilized. For scaffolds seeded with MSCs, 100 PL 
of the passage 6 cells in the growth medium were placed on the scaffolds at a density 
of 104 cells per scaffold. After seeding, the scaffolds were incubated at 37°C in a 
humidified atmosphere of 5% CO2 for 30 min before implantation. The Col 
membrane is a commercialized product of type I Col (Koken, Japan, Cat.CLF-01). 
This membrane was also cut into 8 × 8 mm squares and was treated with UV for 30 
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min before use. Rh-BMP2 was purchased from Prospec, Israel (Cat. CYT-261), and 
used at a concentration of 150 Pg/Col membrane square. 
Subcutaneous implantation in nude mice: The animal study was approved by the 
Institutional Animal Care and Use Committee (IACUC) (Application 
#2010/SHS/589) and performed under the guidelines of The National Advisory 
Committee on Laboratory Animal Research (NACLAR) in SingHealth Experimental 
Medicine Centre, Singapore. Thirty adult BALB/c nude mice (6±8 weeks of age and 
weighing approximately 25 g each) were used. The mice were anesthetized by 
intraperitoneal administration of a mixture of ketamine (50 mg/kg body weight) and 
diazapam (5 mg/kg body weight). Toradol (ketorolac tromethamine) and Baytril 
(enrofloxacin) (0.5 mg/kg ) were also administered for the purposes of analgesic and 
antibiosis. Using sterile techniques, an incision was made on the skin layer of the 
medial thigh to open an area measuring 12 × 12 mm to place the implants. Each of the 
24 animals received bilateral implantations resulting in a total of 48 implants divided 
evenly into 4 groups: PLLA/Col and PLLA/Col+MSC; PLLA/Col/HA and 
PLLA/Col/HA+MSC; PLLA/Col and PLLA/Col/HA; and PLLA/Col+MSC and 
PLLA/Col/HA+MSC. Additionally, another six animals received the commercialized 
products and were divided evenly into two groups: Col membrane and Col 
membrane/BMP-2. Within 5 days after the operation, the mice were given Baytril (0.1  
mL in 100  mL of drinking water) and 0.5 mg/kg of Toradol via oral administration.  
After 12 weeks, the mice were sacrificed using carbon dioxide. The implants were 
collected together with the skin layer and were embedded in paraffin. Sections cut at a 
thickness of 5 Pm were deparaffinized and hydrated. The sections were then 
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processed using histological staining with haematoxylin and eosin (H&E), Masson's 
trichrome, and Von Kossa. 
Micro Computed Tomography: PCT was immediately performed following the 
surgery and on a weekly basis afterwards to observe any bone formation. Under 
anaesthesia, the animals were positioned on a secure object stage and scanned using 
3D PCT (In vivo micro-X-ray CT System R_mCT, Rigaku, Japan). This system was 
characterized by a high resolution (voxel size of 0.125 mm), quick operation 
(exposure time of 17 s), and a low effective dose (approximately 10 PSv/exposure). 
The X-ray source and sensor rotated 360° around the animals on the stage during 
exposure. The parameters employed for scanning were the X-ray voltage (90 kV), the 
X-ray current (88 µA), the focus object distance (237.5 mm), the focus detector 
distance (360.5 mm), and the isotropic voxel size (133 Pm). The i-Dixel-3DX 
software was used to process the images and to calculate the bone volume. 
Haematoxylin and eosin (H&E) staining: After the dehydration, the sections were 
stained with haematoxylin (Sigma-Aldrich) for 4 min at room temperature. This stain 
colors the nuclei of cells (and a few other objects, such as keratohyalin granules) blue. 
The sections were then clarified and applied with a bluing reagent (ammonia solution, 
Sigma-Aldrich) for 2 min at room temperature to change the reddish-purple 
haematoxylin to a blue or purple-blue colour. These samples were subsequently 
counterstained with eosin Y (Sigma-Aldrich) for 2 min at room temperature, which 
colors eosinophilic structures in various shades of red, pink and orange. 
0DVVRQ¶V WULFKURPH VWDLQLQJ: After the hydration, mercury pigment was removed 
from the sections by iodine and thiosulphate sequence. The cellular nuclei were then 
stained by the Celestin blue-haemalum method. The sections were next stained in acid 
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fuchsin solution (Sigma-Aldrich) for 5 min, treat with phosphomolybdic acid solution 
(Sigma-Aldrich) for 5 min and stained with methyl blue solution (Sigma-Aldrich) for 
2-5 min at room temperature. Finally, these samples were treated with 1% acetic acid 
for 2 min at room temperature. As a result, cellular nucleus was stained dark brown to 
black, cytoplasm was stained light red or pink, and Col fiber was stained blue. 
Von Kossa staining: After the hydration, the sections were placed in silver nitrate 
solution (Sigma-Aldrich) and exposed to strong light for 10±60 min at room 
temperature. The sections were next treated with sodium thiosulphate (Sigma-
Aldrich) for 5 min at room temperature. Finally, the samples were counterstained with 
toluidine blue O (Sigma-Aldrich) for 3 min at room temperature. As a result, 
mineralized bone and calcium deposits were stained black, whereas osteoid, 
supporting tissue and structures were stained blue. 
Statistical analysis: All experiments were performed at least in triplicate, and the 
results were expressed as mean ± standard deviation. Data were analysed by means of 
a one-factor ANOVA or multifactor ANOVA using STATGRAPHICS Centurion XV 
for different material groups. A p value below 0.05 was considered statistically 
significant. 
5.3 Results and discussion 
5.3.1 Material characterization 
Electrospinning was used to fabricate nanofibers with or without Col and fibers. 
Nano-HA on the surfaces of the fibers were created using mineralization in vitro 
(Figure 5.1). The mean fiber diameters of the PLLA (Figure 5.1A) and the 
PLLA+20% Col (Figure 5.1C) were 455 nm and 270 nm, respectively (Table 5.2). 
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The scaffolds were treated with Ca/P solutions to obtain a Ca/P ratio of 1.67, which is 
similar to that of HA. Small artificial minerals formed on the surfaces of the fibers 
(Figures 5.1B and D). Schematic structures of these scaffolds are illustrated in Figures 
5.%¶ anG'¶, respectively. It is conceivable that more minerals were deposited on the 
fibers when using Col because Col fibrils can nucleate nano-HA crystals on their 
surfaces, whereas PLLA has less capacity for the nucleation and the growth of these 
crystals. Nano-HA was uniformly distributed on the PLLA/Col nanofibers (Figure 
5.1D); however, only a few nano-HA minerals were observed on the PLLA 
nanofibers (Figure 5.1B), which was consistent with the mineral-quantification results 
(HA wt%) (Table 5.2). The surface mineralization not only significantly enhanced the 
hydrophilicity but also increased the surface area of the fibrous scaffolds.  
 
Figure 5.1 SEM micrographs of the non-mineralized and the mineralized scaffolds. (A) Nanofibrous PLLA; (B) 
mineralization of PLLA (PLLA/HA); (C) nanofibrous PLLA/Col (80:20); (D) mineralization of PLLA/Col 
(PLLA/Col/HA)DQGWKHLUVFKHPDWLFVWUXFWXUHV%¶'¶UHVSHFWLYHO\ 













PLLA 455±73  125.8±0.2 7.11±2.15 
PLLA/HA  10.8±4.4 111.0±8.5
Į 10.10±6.69 
PLLA/HA (3 cycles)  23.5±6.3 117.0±5.2 21.06±10.42 
PLLA/Col 270±71*  52.2±0.3 13.99±6.55 
PLLA/Col/HA  16.0±3.0 7.1±11.7
 Į¶ 22.59±21.28 
PLLA/Col/HA (3 cycles)  57.3±3.2 5.5±8.5 48.82±21.48 
Notes: * marks the statistically significant difference between the PLLA/Col and the PLLA groups; Į Į¶ refer to the 
statistically significant differences between the mineralized and non-mineralized groups, respectively. 
The possibility of fine-tuning the biomimetic scaffolds that contained nano-HA to 
enable controlled differentiation of MSCs in vitro and for ectopic bone formation in 
vivo was explored. We introduced only 10-16% nano-HA into the scaffolds (Table 
5.2), which was much lower than the nano-HA concentration in mature bone matrix 
and in previous work (approximately 60% for both cases) [340]. In that previous 
study, this greater amount of nano-HA significantly enhanced foetal osteoblastic cell 
adhesion within the first hour, compared with the adhesion on tissue-culture plate 
controls and pure fibrous scaffolds. However, the cell proliferation within the first 
week was inhibited on the mineralized scaffolds. A sudden immersion of the cells in a 
high Ca/P environment was speculated to hamper cellular activities. Therefore, a 
lower amount of nano-HA was chosen in the present study.  
5.3.2 Cell proliferation 
The proliferation of the MSCs on the various scaffolds is shown in Figure 5.2. For all 
scaffolds, there was a trend towards a continuous increase in the number of viable 
cells during 22 days of culture. The nanostructure scaffolds, with or without nano-
HA, were able to support osteoconductivity. However, the cell number on the 
PLLA/Col/HA scaffold was still lower than on the corresponding non-mineralized 
scaffold (p < 0.05). One possible reason for this observation was that the alkaline 
microenvironment created by the HA degradation products [336] was not ideally 
suited for cell proliferation, as it changes the pH of the culture medium. Also, when 
Chapter 5 - Osteoinductive Biomimetic Nanocomposites 
 156 
 
stem cells proliferate, their differentiation functions are reduced [147] (and vice 
versa). In other words, the lower proliferation of the MSCs on the mineralized 
scaffolds was probably caused by their preference towards the osteogenic 
differentiation pathway, even in the absence of osteogenic supplements. We observed 
that the number of viable (i.e. proliferating) cells on the Col-containing scaffolds at 
day 4 was significantly greater than the number of cells on the non-collagenous 
scaffolds. We also performed a cell-attachment study to assess the effects within 10 
min and 2 hr of seeding on the scaffolds and found that the presence of Col 
considerably increased initial cell attachment after 10 min (Appendix A - Figure A1). 
After 2 hr, almost 100% of the cells were attached to each of the scaffolds. The local 
microenvironment created by the initial cell attachment played an important role in 
the proliferation of MSCs, which probably helped the cells on the Col-containing 
scaffolds to grow faster than the cells on the non-collagenous scaffolds. 
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Figure 5.2 Changes in the number of viable cells during culture in growth medium versus Ost medium. 
Statistically significant differences are marked with an asterisk (*; p < 0.05). Each vertical error bar represents the 
standard deviation of three independent measurements. 
5.3.3 Alkaline phosphatase activity 
The effects of nanoscaffolds on osteogenic differentiation were evaluated by 
monitoring the activity of ALP ± a marker of early osteogenesis; the expression levels 
of OCN, OPN and the key osteogenic transcription factor Cbfa1, which are markers 
of early-stage and mid-stage osteogenesis; and the formation of a mineralized ECM 
containing HA (a marker of late-stage osteogenesis).  
The specific ALP activities are shown in Figure 5.3. Unsurprisingly, the specific ALP 
activities were greater in MSCs cultured in Ost medium than those in growth medium 
for all scaffolds, as the osteogenic supplements continually drove the MSCs towards 
an osteoblastic lineage. Most previous studies [341-344] used an Ost medium to 
directly drive osteogenic differentiation of cells cultured on scaffolds; thus, it was 
unclear whether the scaffold substrate could truly support osteogenic differentiation 
on its own. An understanding of this phenomenon would help to enhance bone 
formation without the use of osteogenic supplements. The MSCs on the 
PLLA/Col/HA scaffold had significantly lower specific ALP activities than the MSCs 
on the corresponding non-mineralized scaffold (p < 0.05). Ca/P coating of bioactive 
glass has previously been shown to reduce the ALP expression of adipose-tissue-
derived stem cells compared with uncoated glass [345]. As ALP hydrolyses organic 
phosphate into inorganic phosphate, which results in the precipitation of HA during 
the mineralization process, we hypothesized that the high inorganic phosphate 
environment in mineralized scaffolds could have down-regulated the expression of 
ALP or inhibited its activity. However, there was no significant difference in the ALP 
activities of the MSCs on the PLLA/HA versus the PLLA scaffolds. This result could 
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reflect the amount of HA on the PLLA/HA scaffolds being much lower than that on 
the PLLA/Col/HA scaffolds (Figure 5.1 and Table 5.2). When the HA concentration 
reached a certain level, it may have inhibited the ALP activity. 
 
Figure 5.3 ALP activity of the human MSCs cultured on different scaffolds in either growth medium or Ost 
medium at different time points (4, 7, 10, 16 and 22 days).  Statistically significant differences are marked with an 
asterisk (*; p < 0.05). Each vertical error bar represents the standard deviation of three independent measurements. 
5.3.4 Osteoblastic gene expression 
Real time RT-PCR was used to quantify the expression of the osteoblastic genes 
(Figure 5.4). Expression of OCN was significantly elevated on the PLLA/Col/HA 
scaffold (p < 0.05) compared with OCN expression by the MSCs on the 
corresponding non-mineralized scaffold in growth medium (Figure 5.4A). Similarly, 
the MSCs on that mineralized scaffold had a markedly higher OPN expression than 
the MSCs on the non-mineralized scaffold in the growth medium (p < 0.05) (Figure 
5.4B). In this medium, there was a continuous increase in OCN expression on the 
PLLA/Col/HA scaffold from day 10 to day 22. Conversely, the MSCs on this scaffold 
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reached a maximum OPN expression level on day 10, and the expression was 
considerably reduced thereafter. The cells on the PLLA/Col/HA scaffolds in the 
growth medium expressed significantly more OCN and OPN, not only compared to 
those cells on the PLLA/Col scaffolds in the same medium (p < 0.05) but also to those 
in the Ost medium (p < 0.05). The presence of nano-HA on the nanofibrous 
PLLA/Col scaffolds was more effective than supplementation with osteogenic solutes 
in the up-regulation of OCN and OPN. However, the expression of Cbfa1 
significantly decreased on the PLLA/Col/HA scaffold in both growth and osteogenic 
media compared with the non-mineralized scaffold (Figure 5.4C). In the Ost medium, 
the expression of Cbfa1 by the cells on all of the mineralized scaffolds was 
considerably lower than the expression on the non-mineralized scaffolds. The 
H[SUHVVLRQRIRWKHURVWHREODVWLFPDUNHUV%63:17$DQG7*)ȕ5DQGType I Col 
alpha 1 (COL1A1) is shown in Appendix A - Figures A3-A6. From these results, it is 
clear that nano-HA has a range of influences on the expression of osteoblastic genes. 
In general, the expression of OCN, OPN and WNT5A was increased on the 
mineralizeGVFDIIROGVEXWWKHOHYHOVRI&EID7*)ȕ5DQG&2/$ZHUHGHFUHDVHG
compared with the corresponding non-mineralized scaffolds. Until now, the 
mechanism by which biomimetic materials control the osteogenic differentiation of 
MSCs, as well as how stem cells respond to the topographical cues, has not been 
clear. The findings in this study regarding osteoblastic gene expression provide a 
basic differentiation profile of the MSCs on the nanocomposites. However, the exact 
mechanism of the effects of the biomimetic materials will have to be investigated 
further. 









Figure 5.4 Normalized gene expression of the human MSCs cultured on the mineralized and the non-mineralized 
scaffolds in either growth medium or Ost medium. Samples were taken on days 10, 16 and 22. (A) OCN, (B) OPN 
and (C) Cbfa1. Statistically significant differences are marked with an asterisk (*; p < 0.05). Each vertical error bar 
represents the standard deviation of three independent measurements.  
5.3.5 Matrix mineralization 
Cell morphology was studied using SEM. By day 10, significant amounts of bone 
mineral were formed by the cells that were cultured on the PLLA/Col/HA (Figure 
5.5A, B and D) even in the growth medium. Negligible bone-mineral aggregations 
were found on the PLLA/HA scaffold (Figure 5.5F) by day 10. Notably, on the 
PLLA/Col/HA scaffold, a vast aggregation of micrometre-scale bone minerals was 
deposited by most of the cells by day 16 (Appendix A - Figure A7). Figure 5.5C 
shows that in the area without cells, there was no nano-HA on the fibrous surface as 
observed on the PLLA/Col/HA scaffold before cell culture (Figure 5.1D). We 
considered that the nano-HA could have degraded and/or detached from the fibers, in 
addition to the degradation of the Col during cell culture. The fiber diameters of the 
PLLA/Col/HA scaffold in the culture after 10 and 16 days were 234±83 nm and 
263±64 nm, respectively, which is comparable to the original diameter of the 
PLLA/Col fibers (270±71nm). EDX detection with semi-quantification indicated that 
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the Ca/P ratio of bone mineral aggregation was 1.71±0.29 on day 10 (Figure 5.5E) 
and 1.60±0.26 on day 16 for the PLLA/Col/HA scaffold, which was comparable to 
that of native HA (1.67). 
 
Figure 5.5 The formation of bone minerals by the human MSCs cultured on mineralized scaffolds in growth 
medium at day 10. Bone minerals are marked with a red arrow. (A) Deposited bone minerals on the PLLA/Col/HA 
scaffold; (B) and (C) Enlarged views, showing the mineralized cells and the clean nanofibers, respectively; (D) 
Enlarged view of cells with an aggregation of minerals; (E) Energy-dispersive X-ray spectrum of the bone 
minerals on mineralized cells (as shown in panel B) with Ca/P=1.71±0.29 (n=15); and (F) Deposited bone 
minerals on the PLLA/HA scaffold.  
Quantitative assessments of calcium deposition by the cells (Figure 5.6A) were 
consistent with the results above. Significant amounts of calcium were deposited on 
the PLLA/Col/HA scaffold compared to the corresponding non-mineralized scaffold, 
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even in the growth medium. Also, in this medium the calcium produced by the MSCs 
on the PLLA/Col/HA scaffolds was significantly greater than the calcium produced 
by the MSCs on the PLLA/Col scaffolds in the Ost medium (p < 0.05). There was no 
significant difference in the calcium deposition of the MSCs on the PLLA/Col/HA 
scaffold in either media (p < 0.05). ARS staining also confirmed this phenomenon 
(Figure 5.6B). A possible explanation is that an adequate supply of HA was much 
more effective than the presence of osteogenic solutes in inducing the osteogenic 
differentiation of the MSCs. Stein and Lian [147] defined three principle periods of 
osteoblastic phenotype development ² proliferation, ECM development, and 
maturation and mineralization ² by the sequential and stringent expression of genes.  
Monolayers of bone-marrow cells and osteoblasts were cultured in Ost medium, and 
the cells reached confluence at approximately day 14; however, bone minerals were 
only observed after day 21.  




Figure 5.6 Calcium deposition on different scaffolds in growth medium or Ost medium when cultured with human 
MSCs. Samples were taken at days 10, 16 and 22. (A) Quantification of calcium deposition by a colorimetric 
assay, normalized relative to the HA from the scaffold itself. Statistically significant differences groups are marked 
with an asterisk (*; p < 0.05). Each vertical error bar represents the standard deviation of three independent 
measurements. (B) Alizarin-red-S staining for calcium salts produced by the human MSCs on the PLLA/Col/HA 
in growth (B1) and osteogenic (B2) media on day 16.  
In addition to soluble factors, the appropriate cell density, and spatial distributions, 
the presence of solid extracellular components of the culture also appeared to be 
critical for an efficient determination of the fate of MSCs [332]. Pittenger et al. [333] 
centrifuged 100,000 to 500,000 MSCs to form a pelleted micromass for chondrogenic 
differentiation culture, which typically required an extremely high cell density and 
close cellular contact. To eliminate cell±cell contact, a very low cell-seeding 
concentration (1×104 cells/scaffold, which corresponds to 0.56×104 per cm2) was used 
to maximize direct cell±biomaterial interactions. On day 10, although no significant 
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cell confluence was observed on the mineralized scaffolds, significant amounts of 
bone minerals were formed. Therefore, the mineralized scaffolds directly drove the 
MSCs towards osteoblastic differentiation. 
The in vitro study demonstrated that the PLLA/Col/HA scaffold directly drove the 
MSCs towards osteoblastic differentiation, without the need for osteogenic solutes. 
The biomimetic scaffolds of the PLLA/Col nanofibers, which were incorporated with 
approximately 16% nano-HA, were the best osteoinductive scaffolds considered in 
this study. This nanocomposite was also proven to drive the MSCs away from 
adipogenic or chondrogenic lineages in the medium without any induction agents 
(growth medium). The immunohistochemical staining showed that, in the growth 
medium, the MSCs cultured on PLLA/Col/HA could differentiate into the osteogenic 
lineage but not the adipogenic and chondrogenic lineages (Figure 5.7). In the 
differentiation medium with the corresponding inducing factors ± osteogenic, 
adipogenic or chondrogenic factors, the MSCs on this scaffold were able to 
differentiate into all three lineages. Therefore, we used this mineralized scaffold to 
assess the osteoinductivity of biomimetic nanocomposites in an animal model. 




Figure 5.7 The differentiation potential of MSCs on the PLLA/Col/HA scaffold in growth and differentiation 
media on day 21. Immunohistochemical stainings of osteocalcin (OCN, osteogenic differentiation marker), FABP-
4 (adipogenic differentiation marker) and aggrecan (chondrogenic differentiation marker) were performed. In 
growth medium, the cells could only direct the osteogenic differentiation. 
5.3.6 Animal study 
A subcutaneous implantation in a nude-mouse model was used to determine the 
osteoinduction effects on the PLLA/Col/HA scaffold. Typically, ectopic bone 
formation using the subcutaneous model has been performed using scaffold±stem cell 
constructs that were pre-differentiated in vitro [346], or the constructs were loaded 
with osteogenic solutes [305,347], as this model does not present an osteoinductive 
environment for implants. However, in this study, MSCs were seeded and allowed to 
attach for 30 min before implantation (PLLA/Col/HA+MSC), in order to provide 
substantial evidence for the osteoinductive properties of the nanocomposite. The cell-
free nanocomposites (PLLA/Col/HA) were implanted to evaluate the osteoinduction 
of the scaffolds in the absence of exogenous cells. Non-mineralized scaffolds 
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(PLLA/Col and PLLA/Col+MSC) were used as negative controls. Commercialized 
Col membranes were employed to assess the potential of Type I Col alone to induce 
osteogenesis. The Col membrane was also loaded with BMP-2 (a well-known 
osteogenic growth factor) for implantation as a positive control.  
Images were taken immediately after implantation and during the 12 weeks of 
implantation by PCT (Figure 5.8). No bone formation occurred on the PLLA/Col and 
the PLLA/Col+MSC scaffolds during this time, confirming the absence of osteogenic 
growth factors in the subcutaneous layer of the nude mouse. In contrast, formation of 
new bone was observed with the PLLA/Col/HA and the PLLA/Col/HA+MSC 
scaffolds. This result indicates that the formation of bone minerals on these scaffolds 
was caused by the presence of the biomimetic nanocomposite. The mineralized 
scaffold induced the osteogenesis of the implanted MSCs, as indicated by the 
significant bone formation on the PLLA/Col/HA+MSC scaffold. However, 
considerable bone formation also occurred on the mineralized scaffold without MSCs, 
suggesting that the PLLA/Col/HA nanocomposite might have the ability to recruit 
surrounding stem/progenitor cells and drive them towards mature osteoblasts. 
Conversely, during 12 weeks of implantation, no bone formation occurred on the 
membrane that contained Col alone. Therefore, type I Col was not an osteoinductive 
factor. By contrast, marked bone formation occurred on the Col membrane 
supplemented with BMP-2, which again confirms the osteoinductivity of BMP-2. 




Figure 5.8 PCT images of implantation sites (marked with red arrows) taken immediately after the surgery (week 
0) and at 1, 2, 4, 8 and 12 weeks after the surgery. Three were bone formations (white bands) on the 
PLLA/Col/HA, the PLLA/Col/HA+MSC and the Col membrane/BMP-2 implants, but none on the PLLA/Col, the 
PLLA/Col+MSC and the Col membrane implants.  
On the PCT images, a newly formed bone matrix was observed on the 
PLLA/Col/HA+MSC and the PLLA/Col/HA scaffolds after weeks 1 and 2, 
respectively. These time points were very early compared with those of other 
biomaterials that were studied for osteoinductivity in an ectopic bone formation 
model. Porous BCP ceramic only formed new bone on day 45 after implantation in 
the muscle of dogs [348]. Newly formed bone was also found after 56 days for ȕ-TCP 
implanted in dog dorsal muscles [349]. When the porous composite of uncalcined HA 
and poly-DL-lactide (PDLLA) was implanted into the extraosseous canine dorsal 
muscle, new-bone formation was detected only after 8 weeks [350]. Other 
Chapter 5 - Osteoinductive Biomimetic Nanocomposites 
 169 
 
osteoinductive scaffolds have also shown new-bone formation after 4 weeks [351]. 
However, some studies only evaluated the bone formation at a single point in time, 
thus making it difficult to conclude when the new bone matrix started to form 
[235,236].  
Our results suggest that the presence of MSCs accelerates the formation of bone 
minerals on the PLLA/Col/HA+MSC scaffold earlier than on the PLLA/Col/HA 
scaffold (1 week vs. 2 weeks). It seems plausible that the latter material could have 
taken an extra week to recruit enough stem/progenitor cells for the differentiation 
process. Similar to the PLLA/Col/HA scaffold, a new bone matrix also began to form 
on the Col membrane/BMP-2 after 2 weeks of implantation. In addition to secreting a 
bone matrix at a much earlier point in time, cells on the PLLA/Col/HA+MSC scaffold 
also produced significantly greater amounts of minerals during the 12 weeks of 
implantation, as shown by the measurement of bone volume (p < 0.05) (Figure 5.9). 
Therefore, enriching biomaterials with MSCs seems a good strategy for designing 
effective bone-graft substitutes. 
 
Figure 5.9 The volume of bone matrix produced by the PLLA/Col/HA, the PLLA/Col/HA+MSC and the Col 
membrane/BMP-2 implants after 12 weeks. Statistically significant differences between the groups are marked 
with an asterisk (*; p < 0.05). Each vertical error bar represents the standard deviation of three independent 
measurements. 
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After 12 weeks, the implants were extracted from the mice for histological staining 
analyses. All of the implants were found to be well integrated with the skin layer 
(Appendix A - Figure A10). Also, the scaffolds were well surrounded with host neo-
YDVFXODWXUH 7KH KLVWRORJLFDO VWDLQLQJ UHVXOWV +	( 0DVVRQ¶V WULFKURPH DQG 9RQ
Kossa) are shown in Figure 5.10 and Appendix A- Figure A11. These results were 
consistent with the PCT results. All of the implants revealed vasculatures that were 
permeated with red blood cells. No bone-matrix formation was observed on the non-
mineralized scaffolds or the Col membrane. New bone tissue was confirmed on the 
mineralized scaffolds by the formation of bone cavities. These bone cavities contained 
bone minerals and were surrounded with a Col matrix and bone-lining cells at their 
boundaries. However, the new bone tissue produced by the biomimetic 
nanocomposites was not as robust as the tissue produced by the Col membrane with 
BMP-2, which produced a significantly higher amount of bone minerals compared 
with the nanocomposite scaffolds (Figures 5.9 and 5.10). We found that the new bone 
formed by BMP-2 was much denser than the bone formed on the nanocomposite 
scaffolds. The Col membrane/BMP-2 also formed more Col, as indicated by 
0DVVRQ¶V WULFKURPH VWDLQLQJ 0RUHRYHU LQ WKH ERQH FDYLW\ FUHDWHG E\ WKH Col 
membrane/BMP-2, there was not only a mineralized matrix but also bone-marrow-
like tissue that created a trabecular bone-like structure and was not found with the 
nanocomposites.  




Figure 5.10 Histological-VWDLQLQJ LPDJHV +	(0DVVRQ¶V WULFKURPH DQG9RQ.RVVD RI WKH LPSODQWV H[WUDFWHG
after a 12-week study at both 10-fold and 40-fold magnifications. The locations of implants (IM) containing Col 
membranes are marked with arrows. However, because the PLLA is dissolved by xylene during the histological 
process, the PLLA-containing implants could not be observed in the images. They might have been positioned in 
the gap between skin layer and the new bone. Histological staining again confirmed bone formation on the 
PLLA/Col/HA, the PLLA/Col/HA+MSC and the Col membrane/BMP-2 implants and the absence of formation on 
the Col membrane. The implants with bone formation are well established with neo-vascularization, as shown by 
many red blood cells (RBC, stained strongly pink). These implants also induced the formation of bone cavities 
(BC) containing bone minerals (BM, stained black), Col matrix (COL, stained blue) and bone-lining cells (BLC, 
stained dark blue) on the surface of new-bone matrix. The Col membrane/BMP-2 indicates the presence of bone 
marrow-like tissue (BMT) inside the bone cavity.  
Taken together, the results of this study show that the biomimetic nanocomposite of 
PLLA/Col/HA is able to direct MSCs towards mature osteoblasts in vitro without the 
need for soluble osteogenic supplements and is able to form a new-bone matrix in a 
subcutaneous implantation model in vivo where no osteogenic growth factors were 
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provided. Bone formation was observed at very early time points: day 10 for in vitro 
culture with MSCs, week 1 for in vivo implantation with MSCs and week 2 for in vivo 
implantation without MSCs. Our biomimetic nanocomposite showed an extremely 
early bone induction in vitro and in vivo as well as a strong mineral deposition in 
vitro. However, it should be noted that the nanocomposite did not create a robust bone 
when compared with the Col membrane/BMP-2 that was subcutaneously implanted in 
the nude mice. These concerns are discussed in detail in the following paragraphs. 
5.3.7 The importance of nanotopography and HA as osteoinductive factors 
Until now, the underlying mechanism for bone induction has not been fully 
understood. Some previously proposed mechanisms could help to explain why the 
biomimetic nanocomposite in the present study was very effective at inducing 
osteogenic differentiation in vitro as well rapidly producing bone matrix in vivo 
[351,352].  
A source of Ca/P (or HA in the present case) is an important factor for the 
osteoinduction of biomaterials [351]. The local degradation of Ca/P sources causes 
the release of Ca2+, PO4
3- and HPO4
2- into the surrounding environment. This release 
may increase the local supersaturation of the biological fluid, which leads to the 
reprecipitation of carbonated apatite on the scaffolds. The carbonated apatite can 
incorporate Ca2+, PO4
3- and other ions (Mg2+, Na+, CO3
2-) as well as proteins and 
other osteogenic compounds [352]. In addition, the released ions may create an 
alkaline microenvironment and provide electrolytes that are necessary for the ECM 
mineralization by osteoblasts during bone formation. The surrounding cells can be 
recruited by this adjustable microenvironment and be allowed to acquire an 
osteoblastic phenotype and participate in the ossification process [336]. The 
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degradation (or dissolution) of Ca/P sources is phase dependent. Greater bone 
formation has been shown on BCP ceramics containing more soluble TCP, compared 
with HA ceramic, when both materials were implanted intramuscularly in goats [353]. 
Our SEM images (Figure 5.5C) indicated a significant degradation of the HA on the 
PLLA/Col/HA scaffold by day 10, and this degradaWLRQPLJKWFRQWULEXWHWRWKH+$¶V
impressive osteoinductivity. Whether the newly formed biological apatite layer is the 
trigger for the osteogenic differentiation of the MSCs or is simply a template for the 
osteogenic differentiation induced by different means remains unclear. However, we 
are able to confirm that the bone minerals detected on the cellular surfaces were the 
result of the osteogenic differentiation process rather than the reprecipitation process. 
The medium derived from MSCs cultured on HA substrates has been used to culture 
other MSCs [354]. This conditioned medium showed an excellent ability to up-
regulate ALP expression. The cells responded to HA and secreted potent inductive 
substances into the medium. In turn, these substances were able to induce the 
osteogenic differentiation of MSCs. This mentioned study demonstrates the direct 
impact of HA on osteoinduction. Moreover, HA may have an indirect effect: Ca/P 
sources, such as the HA or the newly formed biological apatite layer, can bind various 
proteins, including BMPs [355], in circulating body fluids in vivo [356]. The adsorbed 
BMPs or other relevant endogenous proteins would promote bone formation. 
Secondly, nanotopographies have been associated with osteogenic differentiation of 
stem cells in growth medium. On disordered nanopit substrates, bone-mineral nodules 
were identified on day 28 when the MSCs were cultured in growth medium, whereas 
there was no indication of osteogenic differentiation on the substrates with orderly 
defined patterns [121]. The enriched ions on the nanopits aggregated on some sites 
with narrow gaps. Thus, this nanotopography could have aided differentiation and 
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mineralization of the MSCs. In another study, osteogenic-specific matrix components 
were up-regulated on nanopillar surfaces (compared to micropillar surfaces) in the 
absence of inducing reagents [43]. The osteoinductive property of these disordered 
nanotopographies could be explained by their ability to induce changes in the 
adhesion formations and cell morphologies, thus affecting the cytoskeleton tension 
and the mechanotransductive pathways in a way that favours bone formation [121]. 
Therefore, the disordered nanotopography of the nanocomposites might contribute to 
their osteoinductivity. It has been hypothesized that mimicking the native bone ECM 
via mineralized nanofibers can cause the body to recognize the biomimetic materials 
DV µVHOI¶ DQG WKDW WKHVHPDWHULDOVPLPLF LQWHUFHOOXODU DQG LQWUDcellular responses to 
regenerate new corresponded tissues [46]. Furthermore, the large surface area of the 
nanometer-sized structure of the nanofibers and the nano-HA particles could provide 
more binding sites for cell-membrane receptors and promote the adsorption of serum 
proteins or growth factors from the circulating body fluid [47], which in turn may lead 
to osteogenesis. In our study, the rapid degradation of the nano-HA on the 
nanofibrous scaffolds when the substrates were cultured with the MSCs was evident. 
It is likely that the large surface area of the nanofibers promoted the attachment and 
deposition of autocrine cytokines, thereby enhancing the degradation of the scaffolds. 
Moreover, the nanofibrous scaffolds served as controlled-release systems in our 
design. Therefore, the nanofibers played an important role not only in the acceleration 
of HA degradation but also in controlling the release of Ca2+ and PO4
3-, which were 
speculated to induce bone formation. 
Thirdly, the surface roughness of the biomimetic nanocomposite might have a role in 
osteoinduction through an inflammatory response, although we did not find direct 
evidence of this in the present study. During the inflammation phase occurring post-
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implantation, inflammatory cytokines, which include prostaglandin E2 (PGE2), are 
produced by macrophages surrounding the implanted biomaterials, particularly on 
µPLFUR-URXJK¶ VXUIDFHV [357,358]. Macrophases have been found to produce greater 
amounts of PGE2 in response to micro-rough HA surfaces, compared with smooth 
HA surfaces [359]. In turn, PGE2 might cause chemotaxis of MSCs and stimulate 
their osteogenic differentiation.  
Finally, we included the presence of Col in the composite of PLLA/Col/HA as a 
factor to support the osteogenic differentiation. Although Type I Col did not 
demonstrate the ability to induce the osteogenesis by itself as shown by the absence of 
bone formation in the Col membrane group in our animal study (Figure 5.8), the 
osteogenesis that was initiated by other factors was further enhanced by the presence 
of Col. It has been suggested that the initial adhesion of MSCs to PLGA via type I Col 
promoted osteogenesis [360]. The fate of the MSCs on mineralized Col was more 
favourable (characterized by improved cell seeding and induced osteogenic 
differentiation) than those cells on ȕ-TCP alone [361]. The mineralized PLLA 
nanofibers without Col still supported slight bone-nodule formation in the present 
study. However, the PLLA/Col/HA scaffold showed the most promising result, that 
is, most bone minerals formed on it as compared with the rest of the scaffolds. 
Taken together, the synergistic effects of Ca/P, nanotopography, surface roughness 
and type I Col created a highly osteoinductive PLLA/Col/HA nanocomposite. Among 
these four factors, HA and nanotopographies are thought to be the factors that most 
directly affect osteoinduction. Although many previous studies have reported the 
concept of mineralising polymer scaffolds to mimic native ECM using various 
mineralization methods [362], no study has demonstrated an effective osteoinductivity 
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with clear in vitro and in vivo evidence that is as strong as the results observed using 
our biomimetic nanocomposite. Many of these previous studies only aimed to 
demonstrate the osteoconductivity of scaffolds by culturing stem cells in osteogenic 
media [235,363]. Nandakumar et al. [236] employed PEOT/PBT microfibers coated 
with calcium phosphate as a scaffold instead of using nanotopography as in our work. 
The cells on the scaffold±MSCs construct were able to form new bone after 6 weeks 
of subcutaneous implantation in nude mice. Some studies used mineralized polymeric 
nanofibers and attempted to mimic the chemical components of native mature bone 
with an HA ratio of approximately 60% [340,364]. However, our preliminary study 
(unpublished data) showed that the HA ratio significantly affected cellular 
behaviours, and that an extremely high HA ratio could considerably reduce the 
osteogenic differentiation ability of stem cells. The present study also showed a 
reduced cell number on mineralized scaffolds (Figure 5.2), which might have been 
caused by an alkaline environment created by the degradation products of HA. 
Therefore, a much greater concentration of HA could inhibit stem cell characteristics. 
Moreover, although PLLA/HA and PLLA/Col/HA are mineralized polymer scaffolds, 
only the PLLA/Col/HA scaffold achieved notable osteoinductivity. Almost no 
osteoinductivity was observed for the PLLA/HA scaffold, which has a lower HA 
ratio. As mentioned above, HA and nanotopography both play significant roles in the 
osteoinductivity of scaffolds. Therefore, designing a mineralized polymer scaffold 
with nanotopography and a suitable HA ratio is an important goal in the development 
of novel osteoinductive scaffolds.  
5.3.8 The efficacy of the biomimetic nanocomposite when compared to BMP-2 
There are some possible explanations for the observation that the biomimetic 
nanocomposite did not ultimately produce, as expected, a robust bone formation in the 
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animal study. The bone formation by osteoinductive biomaterials in ectopic models 
was usually observed in the pores and not on the periphery of the implant, which is 
often the case for the osteoinduction using BMPs [365,366]. It has been thought that 
µSURWHFWLYH DUHDV¶ VXFK DVSRUHV FRQFDYLWLHV FKDQQHOVRU VSDFHVEHWZHHQ LQGLYLGXDO
particles are beneficial for in vivo bone formation [351]. These formations may 
protect the ectopic bone formation from high body fluid refreshments or mechanical 
forces due to implant movement and may concentrate the osteogenic solutes 
generated by the differentiated cells or adsorbed from the body fluid. In our case, the 
scaffolds used were 2D meshes where the cells were differentiated on the surface of 
the scaffolds during the in vivo implantation. Therefore, although the bone formation 
was initiated early, it was not properly protected for long-term formation. Previous 
studies have also shown that ectopic bone formation by osteoinductive biomaterials is 
more successful in large-animal models compared with small-animal models, whereas 
BMPs easily induce bone formation in small animals [351]. Sintered BCP ceramics 
have been found to induce no bone formation until day 120 for implants in rats, 
rabbits and goats; in contrast, the bone formation was found as early as day 45 in dogs 
and pigs [367]. The immune response of animals also played an important role in the 
ectopic bone formation of osteoinductive biomaterials. For mice lacking mature B and 
T lymphocytes, the spread and the overall amount of ossification were shown to be 
less than in mice with mature lymphocytes [368]. It was suggested that the responses 
of macrophages stimulated local progenitor cells to differentiate into mature 
osteoblasts through the accumulation of osteogenic factors, including BMPs [368]. 
The animal used in the present study was the nude mouse model, which displays 
immunodeficiency owing to a greatly reduced number of T lymphocytes. Therefore, 
using nude mice might have reduced the efficiency the PLLA/Col/HA composite in 
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the in vivo study. There are differences in the mechanism of bone induction caused by 
osteoinductive biomaterials and BMPs. Biomaterials always form bone through 
intramembranous ossification, whereas BMPs mostly form bone through 
endochondral ossification [351]. Also, while ELRPDWHULDOVQHHGµSURWHFWLYHDUHDV¶ IRU
robust bone formation, BMPs regularly form bone at the periphery of their carrier and 
even in the soft tissue distant from the carrier surface [365,366]. BMPs also easily 
form bone in many different types of animal models, but osteoinductive materials are 
more successful in large animals. Any of these reasons may help to explain why our 
biomimetic nanocomposite induced the bone formation early but did not perform as 
well as BMP-2, during long-term subcutaneous implantation in nude mice. Designing 
a 3D PLLA/Col/HA scaffold with appropriate pores and implanting this scaffold in 
large animals could provide stronger evidence for the novel osteoinductivity of our 
scaffold. 
5.4 Conclusion 
This is the first time that the osteoinductivity property of the biomimetic 
nanocomposite in the absence of osteogenic supplements in vitro and subcutaneous 
bone formation in vivo KDVEHHQGHPRQVWUDWHG2XUVWXG\KLJKOLJKWVWKHµELRPLPHWLF¶
strategy for bone regeneration: nanotopographies and HA. For tissue-regeneration 
purposes, the biomimetic scaffold should ideally provide proper cues to guide new-
tissue formation. The uniform distribution of nano-HA on our nanofiber scaffolds 
could be used as building blocks for the hierarchical assembly of bone ECM in vivo.  
The PLLA/Col/HA nanocomposite enriched with MSCs is shown as a novel bone 
graft substitute which possesses all of the ideal properties ± osteoconduction, 
osteogenesis and osteoinduction. This material therefore has a great potential to 
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UHSODFH IRU µJROG VWDQGDUG¶ DXWRJUDIWV $FHOOXODU JUDIWV ± PLLA/Col/HA 
nanocomposites alone ± may also work very well for bone regeneration if the local 
bone marrow is available. 
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Chapter 6  
Three-Dimensional Nanofibrous Scaffolds 
6.1 Introduction 
Up to now, most studies on cellular characteristics, such as morphology, adhesion, 
migration, proliferation and differentiation, have been performed on 2D flat substrates 
because of the ease and convenience in handling, analyzing and observing under 
microscopes, as well as high cell viability obtained [153,154]. Those 2D flat 
substrates can be tissue culture flasks, petri dishes, micro-well plates or other 2D 
materials. 2D cell culture systems have notably provided basic knowledge of cellular 
biology.  
In the body, almost all tissue cells reside in a 3D environment where cell-cell 
interactions as well as the presentation of chemical, physical, mechanical and 
electrical stimuli cues in the surrounding fluid and ECM provide the guidance for 
cellular responses. Due to the lack of structural cues in 2D culture systems, cells have 
been forced to adapt to flat and rigid surfaces. This drawback can cause alterations in 
morphology, metabolism, gene expression patterns and cellular signaling which may 
reduce cellular functions [154-157]. As such, 2D substrates are significantly limited in 
reproducing the complex environments of the body.  
Although epithelial cells cultured on flat substrates can recapitulate multilayer sheets 
and exhibit differentiated 3D histoarchitecture, most cells require cues from truly 3D 
matrices to create 3D tissue models in vitro [369]. Hence, developing 3D scaffolds 
plays a key role in studying and regulating cellular characteristics. Advances in 
material chemistry and processing technologies have offered a wide range of 3D 
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scaffolds such as cell entrapping hydrogels, porous scaffolds and scaffolds based on 
computer-assistance [154]. The advantages of 3D scaffolds over 2D scaffolds in cell 
culture were shown in previous studies. Endothelial cells cultured on plastic or Col 
surfaces performed a flattened morphology with a hemispherical cell body, 
meanwhile the cells cultured inside 3D Col gels were characterized by a dendritic 
morphology with a round or spindle-shaped cell body [153]. 3D PEG-based hydrogels 
also assisted murine ESCs with the maintenance of their spherical cellular 
morphologies [168]. Stem cells cultured in 3D scaffolds such as fibrin and PEGylated 
fibrin gels [164], self-assembled PA nanofibrous matrix [162,163] and porous 
polyethylene terephthalate (PET) matrix [160,161], etc. had higher proliferation than 
those on tissue culture plates (TCPS). Xie et al. indicated that although MSCs on 2D 
surfaces (TCPS) had a higher initial rate, but they stopped their proliferation as the 
confluence reached (approximately on the 15th day) [161]. Meanwhile, the cells in the 
porous PET matrix grew at a stable and lower rate, but lasted for a longer time and 
achieved a higher final cell number. 
In addition to affecting cell morphology and proliferation, 3D scaffolds have shown to 
support stem cells to increase differentiation potentials than 2D scaffolds. Many 3D 
scaffolds enhanced the hepatocyte differentiation of stem cells (MSCs or ESCs) such 
as Col-coated-poly(lactic-co-glycolic acid) (PLGA) scaffolds over TCPS [169], 
nonwoven polyethylene terephthalate (PET) microfibers over TCPS [158], blended 
PLLA/PLGA sponges (with or without matrigel) over 2D fibronectin-coated dishes or 
matrigel alone [170] and Col sponges over Col-coated TCPS [171,172], etc. The 
chondrogenic differentiation of murine ESCs was also improved by 3D PEG-based 
hydrogels compared to gelatin-coated TCPS, in the presence of TGF-ȕ [168]. In 
addition, culturing stem cells in 3D scaffolds increased their osteogenic differentiation 
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ability [37,162,163,167]. MSCs in the self-assembled PA nanofibrous matrix had 
higher expressions of osteogenic markers (ALP and OCN) than those on TCPS 
[162,163]. This matrix also significantly promoted the differentiation of ESCs into 
osteoblast-like cells in comparison with TCPS as shown by higher levels of ALP, Col 
I marker, OPN and calcium phosphate deposits [167]. Also, ESCs expressed higher 
levels of ALP and OCN when cultured in 3D porous PLGA, than on gelatin-coated 
TCPS [37]. After 3 weeks of in vitro culture, the 3D constructs were implanted in the 
iliac crests of rabbits, and the new bone formation was detected as early as 4 weeks. 
Although the above studies have demonstrated the advantages of 3D scaffolds over 
2D scaffolds, it is still difficult to confirm whether those advantages are due to 
another dimension provided by the 3D structures because there have been too many 
differences in chemical natures, physical structures and initial cell seeding densities 
between the 2D and 3D structures. 
Recently, our group has developed an electrospinning technique for the fabrication of 
3D nanofibrous assemblies using a dynamic liquid support system [370,371]. In this 
study, we focused on the osteogenic differentiation ability which was induced by the 
presence of Ost medium. A comparative study was set up to indicate the role of 3D 
structures, with 2D nanofibrous meshes fabricated by the conventional 
electrospinning technique as controls. PLLA and Col were chosen as materials to 
fabricate the 2D and 3D scaffolds. PLLA has a high mechanical property, suitable for 
bone tissue regeneration. Meanwhile, Col is known to support the cell adhesion and 
proliferation [360,372]. The 3D PLLA/Col nanofibrous scaffolds were hypothesized 
to enhance the osteogenic differentiation of MSCs and support the cells to create a 
bone ECM-like structure.  
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6.2 Materials and methods 
Fabrication of electrospun nanofibers: PLLA (300,000 Da) and Type I Col with the 
ratio of 80/20 (w/w) were dissolved in HFP to obtain a final concentration of 3 wt%. 
Figures 1A and 1B describe the electrospinning techiques to fabricate 2D and 3D 
nanofibrous scaffolds, respectively. In both techniques, the polymer solution (3) was 
loaded into a syringe (2) connected with a BD 27G ½ needle (4). The feed rate was 
kept constantly at 1 mL/h by a KD Scientific syringe pump (1). Collectors were 
placed at a distance of 12 cm from the needle. A high voltage (12 kV) was applied 
between the needle and the collectors by a direct current high-voltage power supply 
(5). Electrospinning jets (6) were emitted from the needle and deposited on suitable 
collectors. For 2D scaffolds, the collector was a metal plate (7) covered by aluminum 
foil and placed over with 15-mm glass cover slips. After spinning, the scaffolds on the 
cover slips were vacuum dried overnight to remove any remaining solvent. The 
average mass of the 2D scaffold (Figure 6.2A) was 1 mg.  
 
Figure 6.1 The fabrication of 2D (A) and 3D (B) electrospun PLLA/Col nanofibrous scaffolds: (1) syringe pump, 
(2) syringe, (3) polymer solution, (4) needle, (5) high-voltage power supply, (6) electrospinning jet, (7) metal 
plate, (8) water votex, (9) receptacle, (10) dynamic pump, (11) nanofibrous bundles and (12) reservoir. 




Figure 6.2 The macroscopic images of 2D (A) and 3D (B); and the SEM images of 2D (C) and 3D (D) at 20000X 
magnification of electrospun PLLA/Col nanofibrous scaffolds. Smooth and uniform nanofibers were observed on 
both types of the scaffolds. The average diameters of nanofibers of the 2D and 3D scaffolds were 218.97 ± 66.14 
nm and 258.29 ± 70.10 nm, respectively. 
For 3D scaffolds, electrospinning jets were deposited on a receptacle (9) filled with 
DI water. When water was drained out from a hole at the bottom of the receptacle, a 
water vortex (8) was created. Nanofibrous bundles (11) were collected in a reservoir 
(12) below the receptacle. A dynamic pump (10) was used to circulate water between 
the receptacle and the reservoir. After spinning, the nanofibrous bundles were placed 
in a 50-mL centrifuge tube, frozen at 80oC for overnight and freeze-dried until they 
were totally dried. To be applied in cell culture, the 3D scaffold was cut into pieces 
with the mass of 10 mg (Figure 6.2B). 
Growth of human MSCs: this procedure is the same to that mentioned in section 3.2. 
Osteogenic differentiation of human MSCs: Before seeding with cells, 2D and 3D 
scaffolds were sterilized under UV light for 30 min and 60 min, respectively, and then 
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pre-wetted in 70% ethanol for 5 min. Subsequently, they were washed three times 
with PBS and once with the growth medium. The scaffolds were next incubated with 
the growth medium in the incubator for 2 hr to facilitate cell attachment.  
Human MSCs at passage 4 were suspended in the growth medium and seeded on 2D 
and 3D scaffolds with the density of 104 cells/mg scaffold. For the 2D scaffold, cell 
suspension was directly dropped on the scaffold. For the 3D scaffold, the scaffold was 
put in a 3 mL-syringe, and cell suspension was slowly passed through this syringe for 
10 times. The 2D/3D scaffolds and their cell suspension were then incubated together 
in 24-well plates. After 24 hr, all cell-scaffold constructs were changed with the Ost 
medium. The medium was then changed every three days. 
 SEM: After culturing for 3, 14 and 28 days, the cell-scaffold constructs were 
analyzed by SEM-EDX as mentioned in section 3.2. The samples were gold sputtered 
at 10 mA for 90 s (2D scaffolds) or 20 mA for 240 s (3D scaffolds). The average 
diameter of nanofibers was determined from the SEM micrographs using the image 
analysis software. 
Actin cytoskeleton staining: On day 14, the samples were collected and fixed in 4% 
formaldehyde for 1 hr. After washing with PBS, F-actin was stained with 
tetramethylrhodamine isothiocyanate (TRITC)-conjugated phalloidin (Invitrogen) for 
60 min at room temperature. Subsequently, the cell-scaffold constructs were 
incubated with DAPI for 30 min at room temperature, and then observed under Laser 
Scanning Confocal Microscope. 
Cell proliferation: in predetermined time intervals (14, 21 and 28 days), cell 
proliferation was measured by the Cell-7LWHU  $TXHRXV 2QH 6ROXWLRQ &HOO 
Proliferation Assay as mentioned in section 3.2. 
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Real time RT-PCR: At determined time points (days 14 and 21), gene expression of 
differentiated human MSCs was examined using the commercialized kits as 
mentioned in section 3.2. Designed primers of ALP, OPN, OCN, WNT5A and 
GAPDH are shown in Table 6.1. 
Table 6.1 Designed primers for real time ± PCR 
Gene FRUZDUGSULPHUV¶o ¶ 5HYHUVHSULPHUV¶o ¶ 
ALP CTGATGTGGAGTATGAGAGT AGTGGGAGTGCTTGTATC 
OPN GTGGGAAGGACAGTTATGA AATTCACGGCTGACTTTG 
OCN CAGCGAGGTAGTGAAGAG GATGTGGTCAGCCAACTC 
WNT5A GCCATGAAGAAGTCCATTG TAGCGACCACCAAGAATT 
GAPDH TGACAACAGCCTCAAGAT GTCCTTCCACGATACCAA 
Calcium content: After 21 and 28 days, the samples were washed thrice PBS and 
processed for calcium quantification using a colorimetric assay as mentioned in 
section 3.2.  
Alizarin red S staining: this method is the same to that mentioned in section 3.2. 
PCT: the original 3D scaffolds and the 3D cell-scaffold constructs after 14 and 28 
days in culture were scanned and reconstructed to create 3D images with the pixel 
size of 6.45 × 6.45 Pm2 using Phase Contrast Imaging and Tomography (PCIT) 
beamline at Singapore Synchrotron Light Source (SSLS). The energy range of white 
beam X-ray is about 4 ± 12 keV. 
Statistical analysis: The results given are representative of three independent 
experiments. Data were analyzed by means of one-factor ANOVA or multifactor 
ANOVA using STATGRAPHICS Centurion XV. 




6.3.1 Scaffold morphology 
The SEM morphologies of the 2D and 3D scaffolds are shown in Figures 6.2C-D 
(with 20000X magnification) and Appendix B - Figure B1 (with 2000X 
magnification). Smooth and uniform nanofibers were observed on both types of the 
scaffolds. Because of the difference in fabrication method, there was a difference in 
the morphologies of the 2D and 3D scaffolds. The 3D scaffold was formed by the 
bundles of curved and coiled nanofibers, while the nanofibers of the 2D scaffold were 
random and straight. However, there was no significant difference in the fibrous 
diameters of these scaffolds (p < 0.05). The average diameters of nanofibers of the 2D 
and 3D scaffolds were 219 ± 66 nm and 258 ± 70 nm, respectively.  
6.3.2 Cell morphology 
The morphology of human MSCs after 3 days cultured in the Ost medium on both 2D 
and 3D scaffolds were observed by SEM (Figure 6.3). The cells well attached and 
spread on both scaffolds. On the 2D scaffolds, all the cells were flattened on the 
surface (Figure 6.3A). Meanwhile, the cells on the 3D scaffolds curved round the 
scaffold geometry, and some of them started to form 3D shapes (Figure 6.3B). The F-
actin staining on day 14 also showed the formation of actin cytoskeleton in a 3D 
architecture for human MSCs cultured on 3D scaffolds (Figure 6.4). 




Figure 6.3 The morphology of human MSCs cultured on 2D (A) and 3D (B) electrospun PLLA/Col nanofibrous 
scaffolds on day 3. On the 2D scaffolds, the cells were flattened on the surface; meanwhile, the cells on the 3D 
scaffolds curved round the scaffold geometry, and some of them started to form 3D shapes. 
 
Figure 6.4 The actin cytoskeleton staining of human MSCs differentiated in the Ost medium on 2D (A) and 3D (B) 
electrospun PLLA/Col nanofibrous scaffolds on day 14. Dual labeling includes tetramethylrhodamine 
isothiocyanate (TRITC)-conjugated phalloidin (staining red F-actin) and DAPI (staining blue nuclei). The staining 
showed the formation of actin cytoskeleton in a 3D architecture for the cells cultured on the 3D scaffolds. 
6.3.3 Cell proliferation 
The changes in the proliferation of differentiated human MSCs on both scaffolds 
during 14, 21 and 28 days of culture are demonstrated in Figure 6.5. The cell 
proliferation rate was calculated as the percent change from the original to the 
collected time point. With the same initial cell seeding density of 104 cells/mg 
scaffold, the cells on the 2D and 3D scaffolds grew at different rates during the 
culture. The cells on 3D scaffolds had lower rate than those on 2D scaffolds. 
However, while the cells on the 3D scaffolds continued to grow during 28 days of 
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culture, the cells on the 2D scaffolds reached the confluence and stopped their 
proliferation after 21 days. 
 
Figure 6.5 Cell proliferation rate of human MSCs differentiated in the Ost medium on 2D and 3D electrospun 
PLLA/Col nanofibrous scaffolds on days 14, 21 and 28. Significant difference of investigated groups was denoted 
as * (p < 0.05). The cells on the 3D scaffolds had significant lower proliferation rate than those on the 2D 
scaffolds. 
6.3.4 Osteoblastic gene expression 
The expressions of osteoblastic genes including ALP, OPN, OCN and WNT5A of 
differentiated human MSCs on the 2D and 3D scaffolds after 14 and 21 days in 
culture are shown in Figure 6.6. On day 14, the cells differentiated on the 3D 
scaffolds had significantly higher expressions of all the osteoblastic genes. On day 21, 
the expression of ALP was still higher, but there was no considerable difference in the 
expressions of OPN, OCN and WNT5A of the cells on the 2D and 3D scaffolds. 




Figure 6.6 Normalized gene expression of human MSCs differentiated in the Ost medium on 2D and 3D 
electrospun PLLA/Col nanofibrous scaffolds on days 14 and 21: (A) ALP, (B) OPN, (C) OCN and (D) WNT5A. 
Significant difference of investigated groups was denoted as * (p < 0.05). The osteogenic markers were 
significantly higher in 3D up to 14 days and equated those of 2D beyond 14 days (except for ALP). 
6.3.5 Matrix mineralization 
The formation of bone minerals on the 2D and 3D scaffolds at predetermined time 
points (14 and 28 days) were observed and identified by SEM-EDX as shown in 
Figures 6.7-6.8 and Appendix B - Figures B2-B5. On day 14, there were only few 
minerals produced on the 2D surfaces (Figure 6.7A), but a lot of minerals were 
formed on the 3D scaffolds (Figure 6.7C and Appendix B - Figure B2). Moreover, the 
bone minerals on the 3D scaffolds were significantly different from those on the 2D 
scaffolds. Looking at the EDX spectra of the minerals, it could be seen that the Ca and 
P peaks on the 3D scaffolds (Figure 6.7D) were clearly shown at high levels; whereas, 
those on the 2D scaffolds (Figure 6.7B) were very low. Although there is no scale on 
Y axes of EDX spectra, the levels of Ca and P peaks can be compared to C and O 
Chapter 6 - 3D Nanofibrous Scaffolds 
 191 
 
peaks. The Ca and P peaks in Figure 6.7D were much higher than those peaks in 
Figure 6.7C in comparison with the respective C and O peaks. 
 
Figure 6.7 The SEM images at 5000X magnification of 2D (A) and 3D (C) electrospun PLLA/Col nanofibrous 
scaffolds cultured with human MSCs in the Ost medium on day 14, and their respective EDX spectra (B and D) of 
the indicated minerals. There were only few minerals produced on the 2D surfaces, but a lot of minerals were 
formed on the 3D scaffolds. 
The morphologies of bone minerals were also different between the 2D and 3D ones. 
The bone minerals looked like flakes on the 2D scaffolds, but bone nodules were 
produced on the 3D ones. As such, after 14 days in culture, human MSCs 
differentiated on the 3D scaffolds produced much more mature bone minerals than 
those on the 2D scaffolds. 
On day 28, many bone nodules were produced on the 2D scaffolds (Figures 6.8A-B). 
Meanwhile, an extremely high density of bone minerals was formed on the outer and 
the inner of the 3D scaffolds (Figures 6.8C-F and Appendix B - Figures B4-B5). 
Chapter 6 - 3D Nanofibrous Scaffolds 
 192 
 
Large bone aggregates were obviously shown with the size of up to 50 Pm on the 3D 
scaffolds (Figure 6.8E and Appendix - Figure B4.B), whereas it was only up to 10 Pm 
for the aggregates on the 2D scaffolds (Figure 6.8A). Especially, it was solely 
observed on the 3D scaffolds where bone nodules were deposited along the nanofibers 
to form a mineralized matrix mimicking the native bone ECM (Figures 6.8C&F and 
Appendix B - Figure B5.A). The calculation of Ca/P ratios as well as statistical 
analysis (p < 0.05) also indicated a higher bone quality on the 3D scaffolds, with the 
ratio = 1.763 ± 0.056 for the 3D ones, and 1.402 ± 0.024 for the 2D ones. In addition, 
there were some cells in a 3D shape on the 3D nanofibrous scaffolds (Figure 6.8D). 




Figure 6.8 The SEM images of 2D (A and B), the outer surface of 3D (C and D) and the center of 3D (E and F) 
electrospun PLLA/Col nanofibrous scaffolds cultured with human MSCs in the Ost medium on day 28. Figures C 
and F showed the deposition of bone minerals along the nanofibers at 5000X magnification. Figure E showed the 
formation of large bone aggregates at 5000X magnification. Figure D showed the presence of 3D-shaped cells at 
5000X magnification. 
The quantification of calcium deposition on both scaffolds after 21 and 28 days of 
culture with human MSCs is shown in Figure 6.9A. Although Ca2+ and H2PO4
- which 
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present in the D-MEM medium can precipitate on the scaffolds to form HA, our 
experiment showed that during 28 days of in vitro study, there was no calcium 
deposition on both 2D and 3D scaffolds incubated with the Ost medium (D-MEM 
medium VXSSOHPHQWHGZLWKȕ-GP, AsP and 100nM Dex) in the absence of the cells. 
As such, the calcium contents found in this study were purely derived from the 
differentiated cells. The calcium amounts deposited per cell on the 3D scaffolds were 
significantly higher than those on the 2D scaffolds (p < 0.05), approximately 5 times. 
The 3D scaffolds also demonstrated a large amount of total calcium deposition as 
shown by a dense orange-red mass in ARS staining (Figure 6.9C) in comparison with 
lighter orange-red spots on the 2D scaffolds (Figure 6.9B). The formation and 
distribution of bone minerals within the 3D scaffolds are shown by PCT images 
(Figure 6.10). The bone minerals were distributed throughout the scaffolds quite 
evenly, with considerably higher density on day 28 (Figure 6.10C) compared to those 
on day 14 (Figure 6.10B).  




Figure 6.9 Calcium deposition (A) on 2D and 3D electrospun PLLA/Col nanofibrous scaffolds on days 21 and 28 
of culture with human MSCs in the Ost medium; and ARS staining of the 2D (B) and 3D (C) scaffolds on day 28. 
Significant difference of investigated groups was denoted as * (p < 0.05). The calcium amounts deposited per cell 
on the 3D scaffolds were significantly higher than those on the 2D scaffolds. 
 
Figure 6.10 PCT images of the original 3D electrospun PLLA/Col nanofibrous scaffold (A) and the scaffold 
cultured with human MSCs in the Ost medium after 14 (B) and 28 (C) days. The bone minerals were distributed 
throughout the scaffolds quite evenly, with considerably higher density on day 28. 
6.4 Discussion 
To guide cell behaviour, it is important to design 3D scaffolds mimicking the 
structure of native ECM. Electrospun nanofibers have been employed for a long time 
to mimic the nanostructure of Col nanofibrils of the ECM. However, most of 
electrospun nanofibrous structures used in previous studies have been 2D membranes 
with limited pore sizes, around 1 ± 2 Pm [332,373,374]. With these sizes, although 2D 
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scaffolds have many layers of nanofibers deposited, the seeded cells cannot migrate 
deeply into the scaffolds to create a 3D structure of multi-layered cells. Recently, we 
have developed an electrospinning technique which is able to fabricate 3D 
nanofibrous assemblies with the pore size of approximately 50 Pm, enough for 
supporting cell ingrowth and migration to create a 3D cell ± matrix structure 
[370,371]. As such, the difference in pore size makes a truly difference in the 
dimensionality of cell ± matrix structures (2D vs. 3D). In this study, we demonstrated 
the advantages of this 3D scaffold over the conventional 2D electrospun nanofibrous 
scaffold in the osteogenic differentiation of human MSCs. In addition, the novelty of 
our 3D scaffold in comparison with other available 3D systems in enhancing the 
osteogenesis was emphasized. 
6.4.1 The advantages of 3D scaffolds over 2D scaffolds 
Although many studies have shown the advantages of 3D scaffolds over 2D scaffolds, 
it has been really difficult to conclude whether another dimension provided by 3D 
structures would help to increase cellular responses or not. Most of the studies have 
used TCPS as a 2D surface to compare with 3D scaffolds [37,138,158,160-164,167-
170]. It is obvious to see that there are two fundamental differences between TCPS 
and 3D scaffolds: chemical natures and physical structures. Thus, it is not reliable to 
draw a conclusion about the role of 3D structures by this way. Some studies designed 
better systems where Col sponges [171,172] and Col gels [153] compared to Col-
coated TCPS in the protrusion and migration of endothelial cell, and the 
differentiation of ESCs into hepatocytes, respectively. However, the initial cell 
seeding density, which is important to the assessment of cell proliferation and 
differentiation during cell culture, in these studies was randomly chosen with no 
criteria given for the 2D and 3D structures.  
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In our study, both 2D and 3D scaffolds were nanofibers made from PLLA/Col and 
fabricated by electrospinning, with no statistical significant difference in fiber 
diameters between these scaffolds. They also possessed similar specific surface areas 
(data not shown). In addition, the cells were seeded on the 2D and 3D scaffolds at the 
same density of 104 cells/mg scaffold. As such, the 2D and 3D scaffolds employed in 
this study appeared to be the same in chemical nature (PLLA/Col), size (nanofibers 
with similar diameters) and initial cell seeding density. The role of dimensionality 
(2D vs. 3D) in the osteogenic differentiation of human MSCs, therefore, would be 
demonstrated in a more conclusive way. However, due to the difference in fabrication 
method, there were some differences in morphology and mechanical property of these 
scaffolds. The nanofibers of the 2D scaffold, which was deposited on a flat and solid 
surface, were stiffer and appeared random and straight. Meanwhile, deposited on a 
liquid surface, the nanofibers of the 3D scaffold were softer and formed curved and 
coiled bundles. Matrix stiffness has been shown as one of key factors that influence 
on stem cell behaviours [294,295]. So, the difference in matrix stiffness of the 2D and 
3D scaffolds might play a part in their various responses on the osteogenic 
differentiation of human MSCs. 
While human MSCs on the 2D scaffolds were flattened on the surface (Figures 6.3A, 
6.7A and 6.8A), there was an appearance of some 3D-shaped cells on the 3D 
scaffolds (Figures 6.3B and 6.8D). Although the proliferation rate of human MSCs on 
the 3D scaffolds were significantly lower than on the 2D scaffolds during 28 days of 
culture, the cells on the 3D ones kept a continuous growth in the whole study (Figure 
6.5). Meanwhile, the cells on the 2D ones seemed to reach the confluence and stop 
their proliferation from the 21st day onwards. Some previous studies showed a higher 
cell number on 3D scaffolds than 2D scaffolds at all times [162-164]. However, the 
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initial cell seeding densities of these studies were not comparable, and TCPS ± a total 
different object ± was used as a 2D control. In other studies, it was indicated that 
while MSCs on 2D surfaces had a higher initial rate, but they stopped their growth as 
the confluence reached; the cells in 3D scaffolds grew at a stable and lower rate, but 
lasted for a longer time and achieved a higher final cell number [160,161].  As such, 
these studies supported our observation. It could be said that if our in vitro study was 
performed for a longer time, the cells in the 3D scaffolds could reach a higher 
proliferation rate.  
Despite the lower proliferation rate, the osteogenic functions of human MSCs on the 
3D scaffolds were remarkably higher than on the 2D scaffolds as shown by the 
expression of osteoblastic genes (Figure 6.6) and the matrix mineralization (Figures 
6.7-6.9).  One possible reason for the lower proliferation rate of MSCs on the 3D 
scaffolds was that in the Ost medium, the MSCs were induced to differentiate into 
osteoblastic cells. In response to the medium, the 3D scaffolds accelerated 
signals/interactions/reactions towards the osteogenic differentiation pathway in 
comparison with the 2D scaffolds. It was well-accepted that when stem cells were 
busy with differentiation, their proliferation could be reduced [147], and vice versa. 
So, the proliferation rate of human MSCs on the 3D scaffolds was lower than the 2D 
ones during the course of study. 
We tested the gene expression of various markers during the osteogenic 
differentiation including ALP (an early marker, necessary for mineralization process 
by hydrolyzing organic phosphate to inorganic phosphate which results in the 
precipitation of HA), OPN and OCN (middle and late markers, binding to HA and 
modulating the crystal growth) and WNT5A (a growth factor, strongly stimulating the 
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osteogenesis) [289,375]. The osteogenic markers were higher in 3D up to 14 days and 
equated those of 2D beyond 14 days (except for ALP). We chose days 14 and 21 to 
investigate the gene expression since in the osteogenic condition, the expression of 
osteoblastic genes of human MSCs usually peak within this period. Looking at the 
expression of ALP (Figure 6.6A), it can be seen that there was a tendency towards a 
decreased expression of ALP from day 14 to day 21 on the 3D scaffolds, but it did not 
significantly change on the 2D scaffolds. Normally, ALP increases in the early stage 
and then decreases when the culture becomes well-mineralized [289]. Thus, it can be 
said that the ECM of human MSCs differentiated on the 3D scaffolds became well-
mineralized earlier than those on the 2D surfaces. As such, the expression of the 
osteoblastic genes could help to explain the early formation and the impressive 
amount of bone nodules produced on the 3D scaffolds in comparison with the 2D 
ones. Large bone aggregates, highly mineralized nanofibers and significantly 
increased calcium deposition were found on the 3D nanofibrous scaffolds.  
From the all above results, it can be concluded that the 3D PLLA/Col nanofibrous 
scaffolds increased and accelerated the osteogenic differentiation of human MSCs 
compared to the 2D ones. There are some possible reasons to explain the role of 3D 
systems. In addition to closely mimicking tissue architecture in vivo, 3D environments 
provide another dimension for cell adhesion and external mechanical inputs. The 
enhancement in cell adhesion remarkably affects cell contraction, integrin ligation and 
related intracellular signals [174,175]. Also, another dimension provided by 3D 
structures aided to enhance cell-matrix interactions and cell-cell communications [37]. 
These are important to regulating many cell signaling pathways to efficiently promote 
tissue development [176]. They may also lead to correct ECM organization and the 
increase of differentiation abilities [177,178]. 
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6.4.2 The novelty of the 3D electrospun nanofibrous scaffolds 
In addition to claiming the advantages of 3D scaffolds over 2D scaffolds, our aim in 
this work was to indicate the novelty of the 3D electrospun PLLA/Col nanofibrous 
scaffolds in the osteogenic differentiation of human MSCs. Most of 3D biomaterials 
used for bone regeneration till now are macro- or micro-sized structures which can be 
fabricated by various methods such as thermally induced phase separation (TIPS), 
solvent casting, gas forming and rapid prototyping (includes stereolithography, laser 
sintering, 3D printing and fused deposition modeling), etc [323,376-378]. However, 
mimicking the nanoscale structure of the native ECM is important to stimulating the 
healing and the regeneration of tissues and organs. In addition, with large surface-
area-to-volume ratio, nanofibers provide more binding sites to cell membrane 
receptors and promote the adsorption of serum proteins [47,48] which may create a 
better niche to enhance cellular functions. Currently, modified TIPS and self-
assembly are two common techniques to fabricate 3D nanofibrous scaffolds for bone 
regeneration. Nevertheless, these techniques are not able to make long, continuous 
and uniform nanofibers as well as limited in material selection. These problems can 
be overcome by the electrospinning technique. This technique can fabricate a wide 
range of materials including synthetic, natural and blended polymers such as 
poly(lactic acid) (PLA), PCL, poly(ethylene/vinyl acetate) (PEVA), polyurethane 
(PU), poly(vinyl alcohol) (PVA), PLGA, PEUU, Col, gelatin, fibrinogen, chitosan, 
silk, gelatin/PCL, Col/PEUU, etc [379]. Although electrospinning technique has been 
fairly well explored for the fabrication of nanofibrous scaffolds in bone tissue 
engineering, these scaffolds have been only based on 2D meshes/membranes with 
limited pore sizes [235,237]. However, to efficiently treat large bone defects, it is 
necessary to develop truly 3D nanofibrous matrices. To our best knowledge, this is 
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the first study where the 3D electrospun nanofibrous scaffolds have been employed 
for the osteogenic differentiation of human MSCs. 
PLLA and Col with the ratio of 80/20 (w/w) were chosen to fabricate the nanofibrous 
materials in our study. Col has a rapid degradation rate and weak mechanical property 
[323], but it is important to initial cell adhesion and proliferation. The degradation of 
Col can be found after 1 week of culture. Meanwhile, with high mechanical property 
and a low degradation rate of up to 24 months [323], PLLA is very stable during the 
in vitro study. So, the structures of the PLLA/Col scaffolds were well-maintained in 
the whole study. 
Our study showed impressive results of the osteogenesis in vitro using the 3D 
electrospun PLLA/Col nanofibrous scaffolds. As early as day 14, a lot of bone 
minerals were deposited on nanofibers and many bone aggregates were produced on 
the 3D scaffolds (Figure 6.7C and Appendix B - Figure B2). On day 28, bone nodules 
with a remarkably high density were formed on both the inner and the outer of the 
scaffolds (Figures 6.8C-F and Appendix B - Figures B4-B5). Very large bone 
aggregates were found (Figure 6.8E and Appendix B - Figure B4.B). Especially, a 
vast number of the minerals were deposited on nanofibers which create an ECM 
matrix mimicking the bone native ECM (Figures 6.8C&F and Appendix B - Figure 
B5.A). In addition, the Ca/P ratio of these minerals was 1.763 ± 0.056, similar to that 
ratio of HA of the native bone. In the native bone, Col fibrils had a diameter range in 
nanometer scale, 50 to 200nm, and orderly deposited by nano-HA mineral crystals. 
As such, differentiating human MSCs on the 3D electrospun nanofibrous scaffolds 
helped to create the ECM mimicking the nanostructure of the native bone and the 
bone mineral component. The nearly even distribution of the bone minerals within the 
Chapter 6 - 3D Nanofibrous Scaffolds 
 202 
 
3D structure was also clearly indicated by PCT images on days 14 and 28 (Figure 
6.10). Although some other 3D nanofibrous scaffolds have been employed for the 
osteogenic differentiation of stem cells, there has been no study providing such 
obvious evidences of the bone-like ECM in vitro. They only presented the advantages 
of the scaffolds based on high expressions of osteoblastic genes and strong 
histological stainings (von Kossa and ARS) [162,163,380-382].  
All of our results demonstrated a promising potential of using the 3D nanofibrous 
scaffolds to facilitate bone regeneration. These scaffolds can be utilized to implant 
directly to bone defects, or culture with human MSCs in the Ost medium for 14 ± 28 
days to create a bone ECM matrix before implantation. Using the bone-mimicking 
matrix produced on the 3D nanofibrous scaffolds could be a novel approach to induce 
an accelerated bone healing.  
6.5 Conclusions 
The 3D PLLA/Col nanofibrous scaffolds fabricated by the electrospinning technique 
supported by a dynamic liquid system showed their significant advantages over the 
conventional 2D electrospun PLLA/Col nanofibrous scaffolds in the osteogenic 
differentiation of human MSCs. The cells cultured on the 3D scaffolds had 
significantly higher expressions of osteoblastic genes (ALP, OPN, OCN and 
WNT5A) as well as greater amounts and better quality of bone minerals. Some cells 
in 3D shapes were found on the 3D scaffolds. As such, the 3D physical structure 
played an important role in facilitating the osteogenic differentiation of human MSCs. 
In addition, with the dense deposition of bone minerals aligned along nanofibers, the 
formation of large bone aggregates and the even distribution of the minerals within 
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the 3D structures, the 3D electrospun PLLA/Col nanofibrous scaffold would deserve 
to be a promising scaffold for bone regeneration. 
(Note: Most of the text and results in this chapter have been published and reprinted 
from Nanomedicine 7(10). Luong TH Nguyen, Susan Liao, Casey K Chan and 
Seeram Ramakrishna. Enhanced Osteogenic Differentiation with 3D Electrospun 
Nanofibrous Scaffolds, 1561-1575, Copyright 2012, with permission from Future 
Medicine) 
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Chapter 7  
 Conclusions and Recommendations 
7.1 Conclusions 
Biodegradable PLLA electrospun nanofibrous scaffold was shown as an 
osteoconductive material which supported the proliferation of human MSCs and their 
differentiated cells during 28 days of culture. Nanofibrous topography of this scaffold 
also significantly increased the osteogenic differentiation of human MSCs as proven 
by greater levels of ALP activity, mineral deposition and BSP expression than those 
of the control (TCPS plate). Especially, the expression level of BSP ± a nucleator of 
HA crystals - of the cells on PLLA was 10 ± 12 times higher than on TCPS in both 
investigated time points (days 14 and 21). Moreover, the PLLA nanofibrous scaffolds 
showed a significant support in recovering the osteogenic abilities of human MSCs 
which had been severely affected by prolonged culture (from passage 2 to passage 8). 
As such, the biodegradable PLLA nanofibrous scaffold with biomimetic property and 
large surface-area-to-volume ratio were an osteoconductive bone graft material 
capable of promoting the osteogenic differentiation of human MSCs. 
Our first approach to developing an osteoinductive scaffold was incorporation of Dex 
± an osteoinductive drug ± into PLLA nanofibers by electrospinning. Dex was loaded 
into PLLA nanofibers with the concentration of 0.333 wt %. Interactions between Dex 
and PLLA nanofibers ± such as intermolecular hydrogen bonding, Van der Waals 
force, and hydrophobic interactions ± increased the tensile strength of this scaffold 
compared to that of pure PLLA scaffold. In addition, these interactions helped to 
retard the initial quick release of Dex as well as maintain the drug in the nanofibers 
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for a long period of time ± over two months. This release provided a sustained 
osteoinductive environment surrounding human MSCs to differentiate the cells into 
mature osteoblasts as evident by osteoblastic morphology and high levels of ALP 
activity, BSP expression and mineral deposition. Moreover, the Dex-loaded PLLA 
nanofibers significantly supported the osteoconductivity as shown by continuous 
growth of human MSCs and their differentiated cells during 28 days of in vitro 
culture.  
Although the Dex-loaded PLLA nanofibrous scaffold was demonstrated as an 
effective osteoconductive and osteoinductive bone graft material, using soluble 
osteogenic factors ± such as Dex, BMP and FGF ± encounters some problems of 
storage, cost and side-effects. Therefore, we then aimed to develop osteoinductive 
biomimetic nanocomposites without the use of those soluble factors. PLLA/Col 
nanofibers were fabricated by electrospinning and then mineralized with nano-HA at 
room temperature using an alternate Ca/P solution dipping method. The resultant 
PLLA/Col/HA scaffold had a HA concentration of approximately 16%. This 
nanocomposite mimics the structure of mineralized Col nanofibrils in native bone 
ECM. The osteoconductive and osteoinductive properties of the PLLA/Col/HA 
nanocomposite were assessed by in vitro culture with human MSCs in growth 
medium, and subcutaneous implantation in nude mice. Our results showed that the 
biomimetic nanocomposite significantly supported cell proliferation in vitro and bone 
growth in vivo. In addition, the nanocomposite directed human MSCs towards mature 
osteoblasts with significant amounts of deposited minerals in vitro and obvious bone 
formation in vivo, without need for the osteogenic solutes. Moreover, bone formation 
by the nanocomposite was observed at very early time points: day 10 for in vitro 
culture with human MSCs, and week 2 for in vivo implantation. The synergistic 
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effects of nanotopography and Ca/P in HA were hypothesized to create the highly 
osteoinductive nanocomposite. Especially, when the nanocomposite was enriched 
with human MSCs, the development of the bone matrix was accelerated to within one 
week. As such, the PLLA/Col/HA nanocomposite enriched with MSCs can be 
considered as a novel bone graft substitute possessing osteoconductive, osteogenic 
and osteoinductive properties, and as a replacement for autograft. Our approach could 
potentially facilitate the translation of de novo bone-formation technologies to the 
clinic. 
In the body, almost all tissue cells reside in a 3D environment, thus, instead of using 
2D nanofibrous meshes as above, we further developed 3D nanofibrous scaffolds. 3D 
PLLA/Col nanofibrous scaffolds were fabricated by a modified electrospinning 
technique using a dynamic liquid support system. MSCs on the 3D scaffolds kept a 
continuous growth during 28 days of culture. Compared to 2D PLLA/Col nanofibers, 
the 3D scaffolds significantly increased the osteogenic differentiation of human MSCs 
as shown by greater levels of ALP, OPN, OCN and WNT5A expression, and mineral 
deposition. When cultured with human MSCs in the Ost medium, a lot of bone 
minerals were deposited on nanofibers and many bone aggregates were produced on 
the 3D scaffolds as early as day 14. On day 28, dense bone nodules and large bone 
aggregates were formed throughout the 3D scaffolds creating a bone ECM-like 
structure, as shown by SEM-EDX and PCT results. As such, 3D environments 
provided another dimension for cell adhesion and external mechanical inputs, and 
aided to enhance cell-matrix interactions and cell-cell communications, which helped 
to enhance the osteogenic differentiation of human MSCs. 




In this project, the 3D PLLA/Col nanofibrous scaffold was shown to be effective in 
increasing the osteogenic differentiation of human MSCs. Further studies should be 
done to develop 3D PLLA/Col/HA nanocomposites. After electrospun by the 
modified electrospinning method, PLLA/Col nanofibers are mineralized with the 
alternate Ca/P solution dipping method. The 3D composites should be designed to 
have interconnected pores with the average pore size of 100 - 200Pm [15,383]. This is 
important for 3D scaffolds to achieve a complete cell migration, infiltration and 
vascularization. Large animals (e.g, dogs and pigs) should be employed to evaluate 
the osteoconductivity and osteoinductivity of the 3D nanocomposites. In addition, 
bone marrow aspirated from the own animals and concentrated by centrifugation can 
be applied with the 3D scaffolds to test the osteogenicity. Animal studies should be 
done in two models: intramuscular implantation and critical-sized bone defects. 
Intramuscular implantation is necessary to examine the efficacy of the 3D scaffolds in 
ectopic bone formation. Meanwhile, in critical-sized bone defects, the 
osteoinductivity can be confirmed if the bone fragments are formed spontaneously 
and uniformly throughout the defects, not only from the both ends. 
From a clinical perspective, to minimize drawbacks of surgical procedures such as 
SDWLHQW¶VGLVFRPIRUWVFDU formation, risk of infection and cost of the operation, using 
injectable scaffolds is more attractive than implantable scaffolds [384-387]. Many of 
available bone graft materials are injectable scaffolds in the forms of gel, putty, paste 
such as AlloFuseTM, InterGro®, Optefil®, Acell Connexus®, OrthoBlast II, Ostefil® 
DBM, Norian® SRS® and Healos® Fx [19]. Therefore, an injectable PLLA/Col/HA 
nanocomposite should be considered. The nanofibers produced by the modified 
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electrospinning technique are deposited with nano-HA crystals using the alternate 
Ca/P solution dipping method. These 3D mineralized scaffolds are then broken into 
short mineralized nanofibers with the length of several micrometers. The short 
mineralized nanofibers are then mixed with concentrated bone marrow aspirate and 
Col hydrogel to produce an injectable system uniformly before injecting into the 
defect site. Due to tiny pieces of nanofibers, the composite can be injected easily 
using 16 gauge needles (inner diameter: 1.194mm). By adjusting the pH of the Col 
solution to 7.0 ± 7.2 before injection, the injectable scaffold can be set to cure at body 
temperature within  1 hr. Schematic of the injectable system is illustrated in Figure 
7.1. This injectable system may be useful in osteoporotic compression fractures.  
 
Figure 7.1 Schematic illustration of injectable system 
Until now, the mechanism by which biomimetic materials control the osteogenic 
differentiation of MSCs, as well as how stem cells respond to the topographical cues, 
has not been clear. It has been said that MSCs treated with Dex perform wide-ranging 
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and unspecific actions including a large number of canonical and functional pathways 
stimulated, whereas the nanotopography is more selective in the canonical pathways 
affected [120]. There are differences in the mechanism of bone induction caused by 
osteoinductive biomaterials and BMPs. Biomaterials always form bone through 
intramembranous ossification, whereas BMPs mostly form bone through 
endochondral ossification [351]. However, the exact molecular mechanism of the 
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Supplementary Information for Chapter 5 
A1. Early cell attachment 
The early attachment of MSCs to all of the scaffolds was studied at 10 min and 2 hr 
after seeding (Figure A1). The result showed that the presence of Col, as well as HA, 
considerably increased the initial cell attachment (10 min). However, after 2 hr, 
almost 100% of the cells were attached to all of the scaffolds. 
 
Figure A1. The percentage of cell attachment within 10 min and 2 hr after cell seeding. Statistically significant 
differences between groups are marked with an asterisk (*; p < 0.05). Each vertical error bar represents the 
standard deviation of three independent measurements. 
A2. Gene expression of ALP 
The gene expression levels of ALP showed consistent results (Figure A2) with the 
ALP activities (Figure 5.3). Lower ALP expression levels were observed in the 
mineralized scaffolds compared with the non-mineralized scaffolds and for the cells 





Figure A2. Normalized ALP expression of the MSCs cultured on mineralized and non-mineralized scaffolds in 
both media types on day 10, 16 and 22. Statistically significant differences between the groups are marked with an 
asterisk (*; p < 0.05). Each vertical error bar represents the standard deviation of three independent measurements. 
A3. *HQHH[SUHVVLRQVRI%63:17$7*)ȕ5DQG&2/$ 
The expression of BSP, WNT5A, 7*)ȕ5DQG&2/$ DV VKRZQ LQFigures A3-
A6, provided more information on the gene expression profile of the MCSs grown on 
the nanocomposites. The expression of BSP was extremely low in the growth medium 
compared to Ost medium for all of the scaffolds, and it was difficult to conclude the 
effects of local Ca/P supply on the BSP expression (Figure A3). In the growth 
medium, the expression of WNT5A was increased for cells on the PLLA/Col/HA 
scaffold when compared with those on the corresponding non-mineralized scaffold 
(Figure A4). The cells on the PLLA/Col VFDIIROGVH[SUHVVHGKLJKHUOHYHOVRI7*)ȕ5
compared with the cells on the PLLA/Col/HA scaffolds in both media (Figure A5). In 
general, COL1A1 expression on mineralized scaffolds was lower when compared 
with the non-mineralized scaffolds (Figure A6), which might be related to lower 





Figure A3. Normalized BSP expression of the MSCs cultured on mineralized and non-mineralized scaffolds in 
both media types on days 10, 16 and 22. Statistically significant differences between the groups are marked with 
an asterisk (p < 0.05). Each vertical error bar represents the standard deviation of three independent measurements. 
 
Figure A4. Normalized WNT5A expression of the MSCs cultured on mineralized and non-mineralized scaffolds in 
both media types on days 10, 16 and 22. Statistically significant differences between the groups are marked with 






Figure A5. NormalizeG7*)ȕ5H[SUHVVLRQRIWKH06&VFXOWXUHGRQPLQHUDOized and non-mineralized scaffolds in 
both media types on days 10, 16 and 22. Statistically significant differences between the groups are marked with 
an asterisk (*, p < 0.05). Each vertical error bar represents the standard deviation of three independent 
measurements. 
 
Figure A6. Normalized COL1A1 expression of MSCs cultured on mineralized and non-mineralized scaffolds in 
both media types on day 10, 16 and 22. Statistically significant differences between the groups are marked with an 
asterisk (*; p < 0.05). Each vertical error bar represents the standard deviation of three independent measurements. 





Additional SEM micrographs of the MSCs on different scaffolds in the growth 
medium are shown. On day 16, the bone formation of cells on the PLLA/Col/HA 
scaffold followed the trend observed on day 10 (Figure A7). More minerals were 
found on the PLLA/HA scaffold on day 16 compared with day 10 (Figure A8). There 
was no mineral formation on the PLLA/Col scaffold on either day 10 or day 16 
(Figure A9).  
 
Figure A7. SEM micrographs of the MSCs on the PLLA/Col/HA scaffolds in growth medium on day 16: (A) 
Overall mineralization with cells, (B) Single cell with minerals, and (C) Enlarged minerals. 
 





Figure A9. SEM micrographs of the MSCs on the PLLA/Col scaffolds in growth medium on (A) day 10 and (B) 
day 16. 
A5. In vivo study: subcutaneous implantation in nude mice 
 
Figure A10. Photos of the PLLA/Col, the PLLA/Col/HA and the Col membrane before implantation and when 





Figure A11+LVWRORJLFDO VWDLQLQJ LPDJHV +	(0DVVRQ¶V WULFKURPHDQG9RQ.RVVDRI WKHPLLA/Col and the 
PLLA/Col+MSCs implants as well as the blank control extracted after a 12-week study under both 10-fold and 40-






Gene )RUZDUGSULPHUV¶o ¶ 5HYHUVHSULPHUV¶o ¶ 
ALP TATGAGAGTGACGAGAAAGC GTGCGGTTCCAGATGAAG 
BSP CGAGCCTATGAAGATGAG GTGGTGGTAGTAATTCTGA 
WNT5A ATATTAAGCCCAGGAGTTG TAGCGACCACCAAGAATT 
TGFER1 GTTTCTGCCACCTCTGTA ACATACAAACGGCCTATCT 






Supplementary Information for Chapter 6 
 
Figure B1. The SEM images at 2000X magnification of 2D (A) and 3D (B) electrospun PLLA/Col nanofibrous 
scaffolds. 
 
Figure B2. The SEM images of 3D electrospun PLLA/Col nanofibrous scaffolds cultured with human MSCs in the 
Ost medium on day 14. Figures A showed the formation of large bone aggregates at 20000X magnification. 






Figure B3. The EDX spectrum of the minerals formed on 2D electrospun PLLA/Col nanofibrous scaffolds on day 
28. 
 
Figure B4. The SEM images (A and B) and EDX spectrum (C) of the minerals formed at the outer surface of 3D 
electrospun PLLA/Col nanofibrous scaffolds on day 28. Figures A-B showed the formation of large bone 





Figure B5. The SEM images (A and B) and EDX spectrum (C) of the minerals formed at the center of 3D 
electrospun PLLA/Col nanofibrous scaffolds on day 28. Figure A showed the deposition of minerals along 
nanofibers at 5000X magnification. Figure B showed the formation of large bone aggregates at 20000X 
magnification. 
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Appendix C 
Standard Curves 
 
 
 
